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Abstract 
Background  
Myocardial perfusion imaging with cardiovascular magnetic resonance (CMR) is 
bound by spatio-temporal constraints. Standard perfusion CMR techniques permit 
the acquisition of 3-4 myocardial slices with a spatial resolution of 2-3mm. However, 
acceleration techniques can be applied to achieve higher spatial resolution (<2mm) 
or 3-dimensional (3D) acquisitions with increased spatial coverage (12-16 slices). 
Acceleration can also be used to simultaneously acquire perfusion data at different 
time-points in the cardiac cycle. Accordingly, this thesis includes studies that modify 
the standard approach to perfusion CMR in order to investigate the impact of spatial 
resolution, spatial coverage and cardiac phase of acquisition.  
Methods and Results  
Study 1 and 2 compared high-resolution and standard-resolution perfusion CMR in 
patients with suspected coronary artery disease (CAD). Study 1 found high-
resolution acquisition had greater diagnostic accuracy compared to standard-
resolution for detecting CAD (area under curve [AUC]: 0.93 vs. 0.83; p<0.001); and 
study 2 found it also had greater diagnostic accuracy for specifically identifying 3-
vessel CAD (AUC: 0.90 vs. 0.69; p<0.0001). Study 3 compared high-resolution and 3D 
perfusion CMR in patients with CAD and found limited agreement between 
myocardial ischaemic burden estimates (95% limits of agreement: -8.68%, 9.82%). 
Study 4 and 5 compared systolic and diastolic acquisitions using standard perfusion 
CMR (limited to 1 slice) and 3D perfusion CMR respectively. Both studies found 
14 
 
higher estimates of myocardial blood flow (MBF) in diastole compared to systole at 
stress (p<0.05). Study 6 utilised accelerated perfusion CMR to compare MBF 
estimates at 5 different time-points in the cardiac cycle in healthy volunteers. 
Estimates of stress MBF peaked at end-diastole and fell steadily to end-systole 
(p<0.0001). 
Conclusion  
By altering the spatial resolution, spatial coverage and cardiac phase of acquisition 
of perfusion CMR, we have gained valuable insights into the relative impact of these 
parameters on both qualitative and quantitative assessment of ischaemia. 
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QCA = quantitative coronary angiography 
RCA = right coronary artery  
ROC = receiver operating characteristic 
ROI = region of interest 
SENSE = sensitivity encoding 
SPECT = single photon emission computed tomography 
SNR = signal to noise ratio 
SSFP = steady state free precession  
T = Tesla 
TE = Echo Time 
TR = Repetition Time 
2D = 2-dimensional 
3D = 3-dimensional 
1VD = 1-vessel coronary artery disease 
2VD = 2-vessel coronary artery disease 
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1 Introduction 
1.1 Background 
Coronary artery disease (CAD) is a leading cause of death and disability worldwide. 
In the United Kingdom (UK) alone there are an estimated 2 million people with 
angina costing the UK economy £9.0 billion/year (British Heart Foundation, 2010). 
National and international guidelines recommend a variety of investigative 
strategies in those presenting with chest pain to inform diagnosis, risk stratify and 
determine the need for revascularisation (Fihn et al., 2012; Montalescot et al., 2013). 
These may involve anatomical imaging of the coronary arterial tree with computed 
tomography (CT) or invasive X-ray coronary angiography; or assessment for 
functionally significant coronary artery stenosis with single photon emission 
computed tomography (SPECT), positron emission tomography (PET), stress 
echocardiography or cardiovascular magnetic resonance (CMR).  
CMR produces high resolution images which can be acquired in any plane and allows 
assessment of global and regional cardiac function, myocardial perfusion, 
myocardial viability, tissue characterisation and proximal coronary anatomy - all 
within a single study and without the use of ionising radiation. This unique multi-
parametric approach leads to a high diagnostic accuracy for the detection of CAD 
and the assessment of myocardial ischaemia to guide appropriate therapy (Figure 
1.1). 
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Panels A and B are cine images (short-axis and 4-chamber views respectively) which give 
anatomical and functional information. Panel C is a stress perfusion image showing an 
inferior perfusion defect (white arrow) in the mid-ventricular slice. Panel D is late gadolinium 
enhancement (LGE) imaging showing inferior wall transmural myocardial infarction (white 
arrow). Panel E shows coronary magnetic resonance angiography (MRA) demonstrating a 
mid right coronary artery stenosis. Panel F is an example of three-dimensional volume 
rendered contrast enhanced MRA showing the right coronary artery. 
 
1.2 Perfusion CMR 
 Myocardial Ischaemia 
The detection of reversible myocardial ischaemia is a cornerstone in the 
investigation and treatment of patients with stable CAD. Large scale studies have 
shown that in the absence of inducible ischaemia, patients with CAD have an 
excellent prognosis with an adverse event rate of less than 1% per annum 
(Hachamovitch et al., 2003b; Klocke et al., 2003). Large perfusion defects and defects 
Figure 1.1 CMR Techniques 
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in multiple coronary territories, however, suggest a poor prognosis (Iskandrian et al., 
1993; Klocke et al., 2003; Hachamovitch et al., 1998). In addition, those with a low 
burden of ischaemia have been found to gain little benefit from coronary 
revascularisation compared to optimal medical therapy (Shaw et al., 2008).  
 Perfusion CMR Technique 
The feasibility of myocardial perfusion imaging with CMR was first reported in 1990 
and since then the technique has undergone continuous technical development, 
experimental validation, and clinical evaluation (Atkinson et al., 1990).  In contrast 
to nuclear imaging techniques, perfusion CMR is a dynamic contrast technique, 
which monitors the first-pass of a T1-shortening contrast agent bolus through the 
myocardium during a hyperaemic state. In territories supplied by significantly 
stenosed coronary arteries, the dynamic wash-in of contrast media (CM) and thus 
signal enhancement is diminished. Several different magnetic resonance imaging 
(MRI) pulse sequences have been used for perfusion CMR, such as spoiled gradient 
echo, balanced steady state free precession (SSFP) and segmented echo planar 
imaging (EPI) (Kellman & Arai, 2007; Gebker et al., 2007a). All of these pulse 
sequences are T1-sensitive and are thus suitable to track the T1-shortening effect of 
the CM. Importantly, in the multi-centre, multi-vendor MR-IMPACT study, several 
different pulse sequences were used with similar performance (Schwitter et al., 
2008). 
The T1-shortening CM agents currently used for perfusion CMR are gadolinium-
based and diffuse partly into the extracellular space unlike the potassium analogues 
used in SPECT imaging that are taken up by perfused myocardium. Hyperaemia is 
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typically induced with an adenosine infusion via a brachial vein (140mcg/kg/min) 
over 3 min. During the first-pass, the patient is instructed to hold their breath to 
eliminate respiratory motion artefacts. Stress induced images can be compared to 
an acquisition at rest after 10-15 min, when most of the CM has washed out of the 
myocardium. Although absolute quantification of regional myocardial blood flow is 
possible, analysis of perfusion images in clinical practice is most commonly 
qualitative (visual). 
Most perfusion CMR studies also include late gadolinium enhancement (LGE) 
imaging, acquired 10-15 min after the completion of perfusion CMR to detect areas 
of infarction and provide a morphological assessment of viability. Unlike nuclear 
techniques, the assessment of scar in CMR is thus not based on a matched stress-
rest perfusion defect, but on direct morphological assessment. Provided the 
transmural extent of infarction on LGE imaging is <50% there remains a good 
likelihood of contractile recovery after revascularisation with either percutaneous 
coronary intervention or coronary artery bypass grafting (Gerber, 2008; Kim et al., 
2000).  
As well as the lack of exposure to ionising radiation, the major advantage of CMR 
versus SPECT perfusion imaging is considered to be its higher spatial resolution 
(typically 2-3mm versus 5-10mm), which allows the detection of smaller perfusion 
defects and the recognition of subendocardial ischaemia (Panting et al., 2002).  
 Clinical Validation of Perfusion CMR 
The use of  perfusion  CMR  as a first line diagnostic tool in patients with suspected 
CAD has been the subject of several recent clinical studies and meta-analyses 
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(Greenwood et al., 2012; Schwitter et al., 2013; Jaarsma et al., 2012; Hamon et al., 
2010). The most recent meta-analysis of 37 studies demonstrated a pooled 
sensitivity of 89% (95%CI: 88%-91%) and pooled specificity of 76% (95%CI: 73%-78%) 
of CMR for the detection of angiographically-defined IHD (Jaarsma et al., 2012). In 
the large single centre CE-MARC study (n=752), CMR had higher sensitivity (87% vs. 
67%, p<0.0001), similar specificity (83% vs. 83% p=0.916) and greater overall 
diagnostic accuracy (area under curve [AUC]:0.89 vs. 0.74, p<0.0001) compared with 
SPECT (Greenwood et al., 2012). The subsequent multi-centre, multi-vendor MR-
IMPACT II trial also confirmed a greater overall diagnostic accuracy  for CMR 
compared to SPECT (AUC: 0.75 vs. 0.6, p=0.018)  with a higher sensitivity, but lower 
specificity (Table 1.1) (Schwitter et al., 2013, 2012). Health economic analyses have 
demonstrated that diagnostic pathways integrating stress perfusion CMR can be 
more cost effective than other strategies including the most common practice of 
exercise treadmill testing (ETT) (Walker et al., 2013). In addition, the prognostic value 
of a negative stress CMR (perfusion or dobutamine) has been further confirmed with 
corresponding annualised event rates for myocardial infarction (MI) and death of 
≤1%/year over a 2 year follow-up period (Table 1.1)(Lipinski et al., 2013; Gargiulo et 
al., 2013; Bingham & Hachamovitch, 2011). 
The 2013 European Society of Cardiology (ESC) guidelines on the management of 
stable CAD recommend non-invasive stress imaging as the first-line strategy for 
investigating suspected angina in patients with a pre-test probability of 15-85% 
(Class I recommendation) with stress perfusion CMR as one of the suggested options 
(Table 1.2) (Montalescot et al., 2013). The 2012 ACCF/AHA chest pain guidelines 
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reserve Class I recommendations for exercise ECG, nuclear perfusion imaging and 
stress echocardiography based on their more extensive historical data and the 
option for non-pharmacological stress, but do allocate a Class IIa recommendation 
to stress perfusion CMR for several scenarios, reflecting its growing evidence-base 
(Table 1.2)(Fihn et al., 2012). 
Table 1-1 Large Scale Clinical Validation of Perfusion CMR 
 
 
 
* including 4 studies using dobutamine stress for inducible wall-motion abnormality 
Ϯ including 6 studies using dobutamine stress for inducible wall-motion abnormality 
AER = combined annualised event rate (cardiac death or myocardial infarction) 
Authors Year Study design n Results 
Diagnostic accuracy    
Hamon et al 2010 Meta-analysis 
 35 studies 
2154 Sensitivity = 89% 
Specificity = 80% 
Greenwood et al 2011 Prospective 
 Single-centre 
752 Sensitivity = 87% 
Specificity = 83% 
Schwitter et al 2012 Retrospective 
 Multi-centre 
515 Sensitivity = 67% 
Specificity = 61% 
Jaarsma et al 2012 Meta-analysis  
37 studies 
2841 Sensitivity = 89% 
          Specificity =76% 
Prognostic data     
Bingham et al 2011 Retrospective 
 Single-centre 
908 AER for negative stress 
CMR <1%/year 
Lipinski et al 2013 Meta-analysis 
 19 studies* 
11636 AER for negative stress 
CMR <1%/year 
Gargiulo et al 2013 Meta-analysis 
14 studiesϮ 
12178 AER for negative stress 
CMR = 1%/year 
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Table 1-2 ESC and AHA Recommendations for Perfusion CMR in Stable CAD 
 
 
 
 
ESC = European Society of Cardiology; ACCF = American College of Cardiology Foundation; AHA = 
American Heart Association; CMR = cardiovascular magnetic resonance; CAD = coronary artery 
disease. PTP = Pre-test probability.  Note that CMR in this table refers specifically to stress perfusion 
CMR. 
  
Recommendation  Class 
ESC Guidelines (2013)  
CMR is a recommended initial test to diagnose CAD in patients with 
intermediate PTP (15-85%) 
I 
CMR used for diagnosis of CAD may be combined with clinical assessment for 
event risk-stratification  
I 
CMR is a recommended test for patients with known CAD for new or recurrent 
symptoms (once instability excluded) 
I 
CMR is a recommended test after MI (before or after discharge) to detect  
ischaemia from bystander lesions if further revascularisation is 
considered[w5] 
I 
ACCF/AHA Guidelines (2012)  
CMR is reasonable as the initial test to diagnose CAD in patients with 
intermediate (10-90%) or high (>90%) PTP and unable to exercise 
IIa 
CMR can be useful as the initial test to diagnose CAD in patients with 
intermediate (10-90%) or high (>90%) PTP, able to exercise but with an 
uninterpretable resting ECG. 
IIa 
It is reasonable to use CMR in patients with known CAD, requiring prognostic 
risk assessment and who are unable to exercise 
IIa 
CMR is reasonable to assess patients with known CAD who have new or 
worsening symptoms (but not unstable) and who are unable to exercise 
IIa 
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 Challenges of Perfusion CMR 
Combined with the assessment of ventricular function by cine imaging, and viability 
by LGE imaging, perfusion CMR allows for the comprehensive assessment of CAD 
(Plein et al., 2004; Bodi et al., 2005). However, standard perfusion CMR (despite 
having higher spatial resolution than SPECT and PET) still yields a lower spatial 
resolution than cine or LGE imaging CMR techniques (Greenwood et al., 2012; 
Schwitter et al., 2008; Wolff et al., 2004; Keijer et al., 2000a, 2000b; Sakuma et al., 
2005; Gerber, 2008; Kim et al., 2000; Jahnke et al., 2007; Panting et al., 2002; 
Atkinson et al., 1990). The main reason for this limitation is that perfusion CMR is 
bound by spatio-temporal constraints as data acquisition is limited to short windows 
in each cardiac cycle in order to limit the effects of cardiac motion and track the rapid 
myocardial passage of contrast. Standard perfusion CMR techniques therefore 
permit the acquisition of 3-4 myocardial slices with a spatial resolution of only 2-
3mm. Acquisition of cine and LGE CMR data on the other hand is typically segmented 
and acquired over several heartbeats to boost spatial resolution (typically 1.5-1.8 
mm) and/or signal-to-noise ratio (SNR).  
For this reason, there has been a high demand for development of perfusion CMR 
methods that can boost spatial resolution to match that of other CMR methods. 
Several such techniques are now available which ‘accelerate’ the data acquisition to 
improve spatial resolution <2mm (high-resolution perfusion CMR) without sacrificing 
temporal resolution or spatial coverage. Alternatively, the speed-up afforded by 
acceleration techniques can be used to achieve 3-dimensional (3D) acquisitions with 
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increased spatial coverage (12-16 slices) - in order to overcome the assumptions of 
the standard 3-4 slice approach.  
1.3 Basic Principles of MRI 
Prior to discussing acceleration techniques applicable to CMR, it is necessary to 
review our understanding of how MRI signals are generated and of the spatial 
encoding scheme used - which is inherently responsible for the relatively low imaging 
speed of MRI. When a subject is placed in the magnetic field, it causes millions of 
protons or ‘spins’ in the body to either align themselves with the magnetic field (low-
energy spins) or against it (high-energy spins). The small difference in energy 
between the two spin populations constitutes the magnetisation used for imaging 
and is proportional to the field strength of the scanner. Short excitation pulses of 
radio-frequency (RF) energy (preparation pulse) are applied to disrupt the 
magnetisation equilibrium – ‘magnetisation preparation’. This causes some spins to 
move to a higher energy state (align against the field) and some to move to a lower 
energy state (align with the field). After the excitation preparation pulse, 
magnetisation returns to its equilibrium and a small RF signal is emitted which is then 
detected by sensitive receiver coils and used to form an image after amplification 
and processing.  
A slice selection gradient (Gs) or magnetic field is applied at the same time as the 
preparation pulse to direct the excitation effect to the image slice of interest. 
Additionally, once the slice selection process has created resonance within the 
selected slice, two further gradients are applied at right angles to each other within 
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the imaging plane. Firstly, the phase encoding gradient (Gp) is applied for a specified 
time such that when it is switched off, the protons will have changed their relative 
phase by a prescribed amount depending on their position along the gradient - which 
therefore leaves the signal ‘phase-encoded’.  Secondly, the frequency encoding 
gradient (Gf) is applied to encode the frequency of the signal and the signal is 
simultaneously sampled.  This sequence of slice selection, phase encoding, 
frequency encoding and signal sampling is repeated many times with a repetition 
interval known as the ‘repetition time’ (TR). 
The final signals are therefore quite complex and contain frequency-encoded and 
phase-encoded data which is then stored in a virtual grid or matrix known as k-space. 
A single data point in k-space contributes to the whole image and conversely a single 
pixel in the image may have contributions from all of the MRI signals collected. The 
data in the centre of k-space holds most of the signal content and therefore provides 
the image contrast.  If only the centre of k-space is obtained, the image formed is 
high in signal but of low resolution. The data at the edges of k-space hold fine detail 
of the image and therefore define its spatial resolution. A sophisticated 
mathematical process (Fourier transformation) is required to extract the individual 
components from each dimension of k-space and reconstruct the image. However 
powerful, data acquisition in k-space is very time consuming as conventionally only 
one data point can be sampled at a time and consequently MRI is not a real-time 
technique. For example, acquisition of a typical image of 128 x 128 pixels would take 
400 ms, thus allowing acquisition of only 2 slices per heart-beat. Doubling the 
resolution to 256 x 256 pixels would at least double the acquisition time and allow 
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imaging of only one slice. Therefore, imaging speed-up techniques are required if a 
sufficient number of slices are to be imaged with an increased spatial resolution. 
1.4 Acceleration Techniques 
There are essentially two ways to accelerate data acquisition with MRI: either k-
space is sampled faster, or fewer points in k-space and/or time are sampled (spatio-
temporal undersampling). Previously, advances in accelerated imaging have come 
from  developments in gradient hardware and gradient encoding such as EPI and 
spiral imaging that allow faster sampling of k-space (Mansfield, 1984; Meyer et al., 
1992). However, it seems unlikely that there will be further advances in speed from 
these areas, since physiological limits for peripheral nerve stimulation and 
radiofrequency deposition have been reached (Schaefer, 1998). Any further 
reduction in scan time or data acquisition is therefore only possible by reducing the 
amount of acquired k-space data by a given factor (acceleration factor). This is not a 
simple strategy however, as undersampling of k-space causes signal aliasing in the 
reconstructed image if the Nyquist sampling limits are exceeded. Imaging speed-up 
techniques are able to avoid or resolve this aliasing without significantly 
compromising image quality because image series often exhibit a high degree of 
spatio-temporal correlations and image redundancy.  
Although several methods of accelerated imaging have now been described and this 
continues to be an area of active research, we will only discuss the most notable 
examples and those relevant to perfusion CMR here (Kozerke & Plein, 2008). We will 
also pay preferential attention to advanced acceleration techniques where speed-up 
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can be invested into spatial resolution or spatial coverage to facilitate high-
resolution and 3D perfusion CMR respectively.  
 Basic Acceleration Methods 
The basic methods of acceleration below are commonly used to reduce the 
acquisition time per slice per cardiac cycle in perfusion CMR. Whilst this is helpful in 
reducing breath-hold durations and motion artefact during stress imaging with high 
heart rates, coverage is still limited to 3-4 slices with a relatively standard in-plane 
spatial resolution of 2-3 mm.  More advanced acceleration is required to afford 
sufficient investment of speed-up in spatial-resolution or coverage without 
compromising SNR. 
1.4.1.1  Echo Planar Imaging 
Although a number of pulse sequences are used for perfusion imaging, one of the 
most common is EPI and this is because it is one of the fastest techniques available. 
Conventional imaging sequences acquire only one line of k-space per heart beat and 
are therefore slow to acquire a full dataset. In EPI pulse sequences, several lines of 
k-space lines are acquired together following one single RF excitation. This pulse 
design has been validated in larger trials with good results and therefore is 
frequently used in perfusion CMR (Wolff et al., 2004; Schwitter et al., 2001, 2008).  
The initial part is very similar to a standard sequence but the frequency encoding 
gradient is successively re-applied with alternating direction which generates 
multiple gradient echoes (signals) all from a single RF excitation. In order to rapidly 
sample the multiple echoes before they decay, a wide receiver bandwidth is used. 
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To ensure that each echo fills a different line of k-space, a small phase encoding 
gradient is applied prior to each sampling.  
The benefits of the fast imaging time are not without cost. EPI is relatively demanding 
on the scanner hardware, in particular on gradient strengths, gradient switching 
times, and receiver bandwidth. In addition, the decay of multiple echoes and the 
high receiver bandwidth result in a low SNR and therefore EPI can be vulnerable to 
image artefacts and distortions.  
1.4.1.2 Interleaved Notched Saturation 
In all pulse sequences, the magnetisation recovery time (TI) plays a major role in 
determining contrast, SNR and the maximum number of sections that can be 
acquired. A preparation pulse with a long TI provides higher SNR and better contrast, 
but the consequent delay inserted between preparation and acquisition reduces 
spatial coverage. 
The ‘interleaved notched saturation’ technique has two major differences from 
conventional pulse sequences used in multi-section perfusion CMR (Slavin et al., 
2001). Firstly, there is no insertion of physical dead time into the sequence to allow 
relaxation between preparation and acquisition of each section. Secondly, the 
consecutive preparation and acquisition pulses do not affect the same section – 
instead any given section is prepared before acquisition of the preceding section. 
This is achieved by an alternative method of magnetization preparation using a 
preparation pulse with a notched profile. Saturation bands are created on both sides 
of the ‘notch’, which is centred such that spins in the subsequently imaged section 
are unaffected by the preparation pulse. The presence of the notch essentially 
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decouples the preparation-acquisition combination and enables the most time 
efficient implementation of long TI recovery without sacrificing section coverage.  
1.4.1.3 Parallel Imaging  
Among all the different parallel imaging techniques presented to date, sensitivity 
encoding  (SENSE) and generalized autocalibrating partial parallel acquisition 
(GRAPPA) have been the most successful and are now widely available on 
commercial MRI systems (Pruessmann et al., 2001; Griswold et al., 2002). Central to 
parallel imaging is the availability of dedicated receiver coils. The speed-up is 
achieved by undersampling k-space (skipping phase encoding steps) during the 
acquisition. For example, in two-fold undersampling, only every other line of k-space 
is filled which would ordinarily lead to significant image aliasing. However, the 
missing information is re-populated, based on differences in perception of the signal 
by multiple receiver coils positioned around the object. This reconstruction process 
therefore requires knowledge of the coil sensitivity map - a 3D plot of how the signal 
varies with distance from each receiver coil. Coil sensitivity maps are formed from 
the central lines of k-space and can either be acquired as a separate low-resolution 
reference scan (SENSE); or as part of the acquisition with a few profiles of fully 
encoded data for coil calibration (GRAPPA). By comparing the signal from each 
receiver coil and with reference to the coil sensitivity map, there is sufficient data to 
reconstruct the image without aliasing.  
In dynamic imaging applications such as perfusion CMR, the undersampling pattern 
can be shifted as a function of time, such that coil sensitivity maps can be estimated 
from a time-average image. This therefore removes the need for separate calibration 
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data. The use of interleaved sampling for calibration purposes in combination with 
SENSE reconstruction is known as temporal sensitivity encoding (TSENSE) (Kellman 
et al., 2001). 
Theoretically, in parallel imaging the unaliasing is possible as long as the acceleration 
factor (undersampling factor) does not exceed the number of receive coils. In 
practice however it is difficult to achieve acceleration greater than 2-3-fold without 
SNR penalties and unresolved aliasing. Nonetheless, the significant reduction in 
acquisition time that can be achieved means that parallel imaging techniques are a 
well-established method of accelerating perfusion CMR and almost any MRI 
application (Kozerke & Plein, 2008). 
 Advanced Acceleration Methods 
Accelerating data acquisition with parallel imaging or EPI methods has been standard 
practice in perfusion CMR for over a decade, but trade-offs in SNR and artefacts limit 
the achievable acceleration to 2-3 fold. In a typical stress perfusion study, these 
methods still only permit the acquisition of 3-4 myocardial slices with an in-plane 
spatial resolution of 2-3mm. More recently proposed ‘prior-knowledge’ based 
techniques allow much higher acceleration factors for data acquisition (Kozerke & 
Plein, 2008; Tsao & Kozerke, 2012). The ‘prior-knowledge’ principle is not limited to 
CMR or even MRI per se and has also been applied to CT and PET (Chen et al., 2008; 
Christian et al., 2010). Prior-knowledge methods are based on the observation that 
image data sets exhibit considerable correlation in space and time. Perfusion CMR 
datasets in particular contain a high degree of temporal redundancy, because data 
are acquired at a single time point in the cardiac cycle using ECG-gating and during 
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breath-holding, so that most of the image is static and the predominant change 
between neighbouring time frames is related to the relatively slow contrast passage. 
This image redundancy can be exploited by undersampling data in the time (t) 
domain in addition to the more conventional undersampling in the spatial (k-space) 
domain (Kozerke & Plein, 2008; Motwani et al., 2011; Tsao & Kozerke, 2012). 
Examples of these spatiotemporal (or k-t) undersampling techniques are k-t broad 
linear acquisition speed up technique (k-t BLAST), k-t sensitivity encoding (k-t SENSE) 
and k-t principal component analysis (k-t PCA). In k-t BLAST, k-t SENSE and k-t PCA 
perfusion CMR sequences, under-sampling is applied along k-space and time whilst 
a low spatial resolution image (‘training data’) is obtained in an interleaved fashion 
during the acquisition (Plein et al., 2007).  A non-aliased, full image series is then 
reconstructed using prior knowledge derived from the training data (Figure 1.2). In 
k-t SENSE and k-t PCA receiver coil sensitivity information is additionally employed 
to facilitate image reconstruction. Further technical details beyond the scope of this 
introduction can be found in recent technical reviews (Tsao & Kozerke, 2012; 
Kozerke & Plein, 2008). 
Other related methods have also been proposed such as the highly constrained back-
projection reconstruction (HYPR) method, in which spatial and temporal redundancy 
are exploited serially (Kozerke & Plein, 2008; Tsao et al., 2003; Ge et al., 2009). In 
HYPR and its variants k-space data is acquired with undersampled radial projections 
and overall rotation of the undersampling pattern at different time points (Ge et al., 
2009; Mistretta et al., 2006; Ma et al., 2012). In image reconstruction, a fully sampled 
composite image is formed by populating missing data from neighbouring time 
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frames. This very low temporal resolution composite is then used to constrain back-
projection of the undersampled data acquired for each individual time frame (Ge et 
al., 2009; Ma et al., 2012). Other promising acceleration techniques such as spiral 
imaging are in early development but their clinical utility has yet to be assessed 
(Salerno et al., 2011; Shin et al., 2013; Chen et al., 2012).  
With the techniques listed above, it is possible to accelerate image acquisition up to 
a factor of 10 times or more. This speed-up has been utilised to improve spatial 
resolution (high-resolution perfusion CMR) or to acquire 3D myocardial perfusion 
data within a single acquisition shot facilitating greater spatial coverage (Maredia et 
al., 2010; Shin et al., 2008; Plein et al., 2008a; Manka et al., 2010, 2012; Jogiya et al., 
2012). 
 
Figure 1.2 k-t acceleration techniques 
 (a) In k-t BLAST and k-t SENSE, data acquisition is accelerated by under-sampling along the 
spatial encoding (k) and time (t) axes which leads to an aliased image. (b) Low resolution 
‘training data’ is also obtained to determine data correlations i.e. ‘prior-knowledge’. (c) 
Finally, a non-aliased full image series is reconstructed using a statistical model derived from 
the training data. BLAST= broad linear speed-up technique; SENSE=sensitivity encoding. 
46 
 
1.5 High-resolution Perfusion CMR 
Although no accepted definition exists, perfusion CMR is considered as “high spatial 
resolution” when the in-plane resolution is better than 2mm, making the resolution 
comparable to that of other common CMR methods. The first feasibility study of 
high-resolution perfusion CMR used  5-fold k-t SENSE  to achieve an in-plane spatial 
resolution of 1.5mm in a group of 10 volunteers (Plein et al., 2007).  Image quality 
was similar to that from a standard-resolution sequence (in-plane spatial resolution 
of 2.6mm) but there was a significant reduction in the extent of dark rim artefact 
(mean thickness: 1.7 vs. 2.4mm; p<0.01) (Figure 1.3).  
 
 
 
 
 
   
Figure 1.3 Dark Rim Artefact: Standard-resolution vs. High-resolution 
 A 60-year-old man with suspected angina underwent stress perfusion CMR at 1.5T with 
both standard-resolution (2.5mm in-plane) and high-resolution (1.5mm in-plane) 
acquisition. High-resolution acquisition was facilitated by 8-fold k-t BLAST acceleration). 
There were no significant stress-induced perfusion defects seen with either acquisition 
(mid-ventricular slices shown) but there was significant dark-rim artefact on the standard-
resolution images (arrows).  Subsequent X-ray angiography confirmed normal coronary 
arteries 
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Images acquired at high-resolution also displayed an increased SNR compared to 
standard-resolution when corrected for pixel size – facilitated by constraining the 
reconstruction with the low resolution, high SNR training data. In 3 of the volunteers, 
higher k-t SENSE acceleration factors of 8 and 10 were successfully used, without 
compromise in image quality or temporal signal intensity profiles.  
The reduction of dark rim artefact with high-resolution acquisition was confirmed in 
another volunteer study (n=10) (Maredia et al., 2010). In this study, mean artefact 
thickness was 3.4 mm with standard-resolution, compared to only 1.1mm with a k-t 
SENSE high-resolution acquisition (p<0.001). Dark rim artefacts  are a common 
finding in conventional perfusion CMR and are thought to be caused by magnetic 
susceptibility effects, Gibbs ringing and cardiac motion during acquisition (Di Bella et 
al., 2005). As these artefacts are directly proportional to voxel size, the use of high-
resolution perfusion CMR offers a significant advantage (Figures 1.3 and 1.4).  
Following the feasibility studies in volunteers, high-resolution perfusion CMR has 
been validated in several patient studies (Table 1.3)(Maredia et al., 2010; Plein et al., 
2008a, 2008b; Manka et al., 2010). In the first of these, Plein et al used an identical 
sequence to their previous volunteer study (1.5T, 5-fold k-t SENSE, in-plane 
resolution 1.4mm) in 51 patients with known or suspected CAD (Plein et al., 2008a).  
High-resolution acquisition was found to have a high image quality and high 
diagnostic accuracy (area under the curve [AUC] = 0.85) against quantitative 
coronary angiography (QCA). Notably, the diagnostic accuracy in single-vessel 
disease and multi-vessel disease was similar (AUC: 0.87 vs. 0.82 respectively) 
suggesting that sufficient spatial resolution to resolve a transmural ischaemic 
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gradient can overcome one of the major limitations of perfusion imaging in multi-
vessel disease i.e. its dependence on a reference area of normal perfusion (Figures 
1.5 and 1.6). Other benefits of high-resolution acquisition noted in the study were 
better integration with cine and LGE data and minimal dark rim artefact. A 
subsequent study demonstrated the clinical feasibility of high-resolution perfusion 
CMR at 3.0T and confirmed the expected improvement in image quality and SNR 
compared to 1.5T (Table 1.3)(Plein et al., 2008b).  
 
Figure 1.4 Dark Rim Artefact  
This example shows a midventricular slice during standard-resolution perfusion-CMR. Dark 
rim artefact (arrows) is a frequent finding and relates to several factors including cardiac 
motion, Gibb’s ringing, susceptibility, and partial volume cancellation between the 
myocardium and blood pool. Although dark rim artefacts may mimic perfusion defects, they 
can be distinguished by characteristic features: they occur at the arrival of contrast in the 
left ventricular cavity and before its arrival in the myocardium (Frame 1); they tend to 
disappear within 8 to 10 frames (Frame 7); their location is usually typical for a particular 
pulse sequence; and their width roughly equates to the in-plane spatial resolution, which 
was 2.5 mm in this example (Frame 3). DRA = dark rim artefact 
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Manka et al followed with an extension of the k-t SENSE technique at 3.0T to achieve 
8-fold acceleration and an in-plane spatial resolution of 1.1 mm which was then 
evaluated in 20 patients with suspected CAD. The combined benefits of higher field 
strength and  greater acceleration led to an incremental improvement in spatial 
resolution and an even greater AUC of 0.94 (95% CI: 0.74-0.99)(Manka et al., 2010).  
Most recently, in the only study to offer a direct comparison (and which forms part 
of the current thesis), high-resolution perfusion CMR (8-fold k-t BLAST, in-plane 
spatial resolution 1.6mm) was found to have a significantly greater overall diagnostic 
accuracy compared to standard-resolution in 100 patients with suspected CAD (AUC 
0.93 vs. 0.83; p <0.001). The improved diagnostic performance was attributed to 
Figure 1.5 Standard-resolution vs. high-resolution stress perfusion CMR  
A 53 yr old man had proximal LAD 80% stenosis on x-ray angiography. Standard-resolution 
acquisition at 1.5T shows a subtle anterior wall perfusion defect (white arrows) at the 
basal (A), mid-ventricular (B) and apical (C) level. With high-resolution acquisition (using 8-
fold k-t BLAST) the anterior defect is much better defined (D-F) and the presence of a 
transmural ischaemic gradient is seen (E). 
50 
 
better detection of subendocardial ischaemia (Figures 1.5 and 1.6)(Motwani et al., 
2012a) As the endocardial layer is the most vulnerable to ischaemia, the ability to 
confidently detect subendocardial perfusion deficits can be expected to improve the 
detection of CAD in a perfusion study (Bache & Schwartz, 1982).  Furthermore, a 
recent study by Hautvast et al showed that high-resolution perfusion CMR data can 
be used to accurately quantify transmural perfusion gradients and these new 
measurements may serve as diagnostic markers for the detection and 
characterisation of epicardial coronary disease as well as microvascular disease 
(Hautvast et al., 2011). 
The HYPR method was used in one recent single-centre study, in a variant known as 
sliding-window conjugate-gradient HYPR (6 contiguous slices, 1.6mm in plane spatial 
resolution). The study demonstrated clinical feasibility and a high diagnostic 
accuracy in 50 patients with suspected CAD (Ma et al., 2012). Whereas the previous 
studies have all used QCA as their reference standard, Lockie et al validated high-
resolution perfusion CMR against invasive pressure-wire derived fractional flow 
reserve (FFR)(2011). In the 42 patients studied,  high-resolution perfusion CMR (5-
fold k-t BLAST, in-plane resolution 1.2mm) had a high diagnostic accuracy (AUC=0.92) 
for the detection of hemodynamically significant lesions (FFR<0.75)(Lockie et al., 
2011). To have a non-invasive method that so closely correlates with FFR is highly 
attractive and more widespread use could have a significant impact on clinical 
pathways - especially in patients with anatomically complex and multi-vessel disease 
(Tonino et al., 2010). However, whether high-resolution perfusion CMR conveys a 
diagnostic increment against FFR is not certain and notably in a previous study using 
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FFR<0.75 as the reference standard, Watkins et al found a high level of diagnostic 
performance  with a standard-resolution acquisition (sensitivity 91%, specificity 
94%), comparable to the high-resolution method used by Lockie at al (Watkins et al., 
2009). 
  
Figure 1.6 High-resolution Perfusion CMR in Multi-vessel CAD 
A 48yr old lady with suspected angina underwent stress perfusion CMR at 1.5-T 
using a high-resolution (1.4mm in-plane) technique facilitated by 5-fold k-t-BLAST. 
Stress-induced perfusion defects were seen in all three territories (arrows, A, B) and 
are clearly demarcated as subendocardial. Subsequent X-ray angiography revealed 
significant three-vessel disease (arrows, C, D). This case highlights the ability of 
high-resolution acquisition to overcome the potential effects of balanced ischaemia 
in multi-vessel disease by detecting transmural perfusion gradients and 
subendocardial ischaemia.  
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Table 1-3 Diagnostic Performance of Advanced Perfusion CMR 
 
 
†In these studies, temporal resolution was 2 R-R intervals whereas in all others it was 1 R-R interval. 
‡In these studies, diagnostic accuracy was calculated by receiver-operating characteristic analysis 
and expressed as area under the curve. §In these studies, diagnostic accuracy was expressed as the 
proportion of correctly classified subjects (true positives + true negatives) among all subjects. FFR = 
fractional flow reserve; HYPR = highly constrained back-projection reconstruction; SENSE = 
sensitivity encoding; BLAST = broad linear speed-up technique; PCA = principal component analysis; 
SW-CG-HYPR= sliding-window conjugate-gradient HYPR; NC = non-contiguous; WH= whole-heart; 
QCA = quantitative coronary angiography.  
 n Field Strength &  
Acceleration 
Spatial Resolution & 
Spatial Coverage 
Reference standard & 
Diagnostic Accuracy 
High-Field Strength       
Cheng 2007 61 3.0T - 2.6mm 4 slices (NC) QCA>50% 0.87 
Ebersberger 
2013 
116 3.0T - 3.0mm 3 slices (NC) QCA> 75%  or 
FFR≤0.8* 
0.93 
High-Resolution       
Plein 2008 51 1.5-T 5 x k-t-SENSE 1.4mm 4 slices (NC)† QCA>50% 0.85‡ 
Plein 2008 33 1.5-T 5 x k-t SENSE 1.5mm 4 slices (NC)† QCA>50% 0.80‡ 
Plein 2008 33 3.0-T 5 x k-t SENSE 1.3mm 4 slices (NC)† QCA>50% 0.89‡ 
Manka 2010 20 3.0-T 8 x k-t SENSE 1.1mm 3 slices (NC) QCA>50% 0.94‡ 
Motwani 2012 100 1.5-T 8 x k-t BLAST 1.6mm 3 slices (NC) QCA ≥50% 0.93‡ 
Lockie 2011 42 3.0-T 5 x k-t BLAST 1.2mm 3 slices (NC) FFR<0.75 0.92‡ 
3-D        
Manka 2011 146 3.0-T 6 x k-t SENSE 2.3mm 16 slices (WH) QCA ≥50% 0.83§ 
Manka 2012 120 1.5-T 10 x k-t PCA 2.0mm 16 slices (WH) FFR<0.75 0.87§ 
Jogiya 2012 53 3.0-T 10 x k-t PCA 2.3mm 12 slices (WH) FFR<0.75 0.91§ 
HYPR        
Ma 2012 50 3.0-T SW-CG-HYPR 1.6mm 6 slices (WH) QCA ≥50% 0.90§ 
53 
 
1.6 Three-Dimensional Perfusion CMR  
Conventionally, cardiac coverage with perfusion CMR is limited to 3-4 non-
contiguous slices through the left ventricle (LV). However, nuclear perfusion studies 
have demonstrated that the extent of hypoperfusion and overall myocardial 
ischaemic burden (MIB) is a strong marker of clinical outcome (Brown et al., 1983; 
Hachamovitch et al., 1998). It is unknown how accurately MIB can be measured from 
non-contiguous image sections. Therefore, despite the demonstrated high 
diagnostic accuracy of conventional 2-dimenional (2D) perfusion CMR, the lack of 
complete myocardial coverage remains a potential limitation of the method.  
 
 
Figure 1.7 Example of 3D Perfusion CMR 
12 short-axis slices are covered rather than the conventional 3 slices seen in standard 
imaging. Perfusion defects (arrows)  are seen in the inferior segments from base to apex (A-
L), mid anterolateral segments (E-H), and lateral segments from mid-ventricle to apex (A-H) 
– consistent with the severe RCA and 1st -diagonal disease seen at coronary angiography 
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The same speed-up methods that permit high-resolution myocardial perfusion CMR 
can also be used to acquire a single 3D stack covering all or a large proportion of the 
heart whilst preserving adequate temporal and spatial resolution (Figures 1.2 and 
1.8)(Schwitter et al., 2008). Advanced acceleration methods allow the acquisition of  
3D data  covering the whole heart in up to 16 contiguous slices within an acquisition 
duration of less than 200ms (Manka et al., 2011). The most significant advantage of 
3D acquisition is that contiguous spatial coverage allows the true extent of perfusion 
defects to be visualised (Shin et al., 2008). Additionally, although data in the 
literature regarding the incidence of pure apical ischaemia is lacking and it is 
presumed to be rare, the inability of 2D perfusion CMR to image the apical cap is 
sometimes stated as a limitation – and this is  overcome by 3D acquisition (Elkington 
et al., 2004; Schwitter et al., 2008). Another limitation of conventional 2D perfusion 
CMR is that each slice is acquired in a different phase of the cardiac cycle (Figure 
1.8). In practice this means that the acquisition cannot be optimised for all slices and 
may coincide with rapid cardiac motion in some slices, leading to motion artefacts in 
the images. In 3D acquisition all data are acquired in the same cardiac phase and the 
time-point for acquisition in the cardiac cycle can be optimised to minimise artefact. 
Furthermore, the cardiac phase can be matched with other acquired data such as 
LGE imaging for improved co-registration. As a related benefit, 3D acquisition also 
permits the optimal choice of the saturation recovery time and the ability to scan at 
high heart rates because only one preparation pulse and one readout per heart beat 
is applied (Shin et al., 2008, 2010). The optimal phase within the cardiac cycle for 3D 
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acquisition is the subject of ongoing research, with end-systole and mid-diastole the 
favoured options (Shin et al., 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Pulse Sequence Diagrams for 2D and 3D Perfusion CMR 
 In 2D perfusion CMR (A), 3-4 non-contiguous slices are acquired in different phases of the 
cardiac cycle in order to maximise spatial coverage. Each slice is acquired after a saturation 
pre-pulse (black bar). A shared pre-pulse can be used to save time but results in different 
contrast characteristics for each slice. In 3D-perfusion CMR (B), a single saturation pre-pulse 
is followed by a saturation recovery time (TSR) and undersampled 3D perfusion data readout. 
The use of advanced spatiotemporal undersampling allows sufficient data acquisition to 
reconstruct 12-16 contiguous slices i.e. whole-heart coverage. The ‘training data’ is acquired 
with the undersampled data in an interleaved fashion. As all perfusion data in the 3D 
technique are acquired at the same point in the cardiac cycle, the reconstructed slices all 
appear in the same cardiac phase.  
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In mid-diastole, the heart is usually at its most stationary, but the relatively thin 
myocardium can compound the effect of dark-rim artefact and limit the assessment 
of the transmurality perfusion defects.  End-systole, on the other hand, has a shorter 
quiescent period but the thicker myocardium reduces the effect of dark rim artefact 
and facilitates the grading of defect transmurality. Systolic acquisition is also less 
sensitive to R-R variability and arrhythmia, which is relevant to the increasing burden 
of patients with atrial fibrillation(Shin et al., 2010). Notably, recent studies have 
found significant differences between systolic and diastolic myocardial blood flow 
estimates with perfusion CMR (Motwani et al., 2012b; Radjenovic et al., 2010) and 
the choice of either cardiac phase for 3D myocardial perfusion may therefore be of 
physiological interest or relevant to certain disease processes such as hypertrophic 
cardiomyopathy (Rakowski & Carasso, 2007; Shin et al., 2010). 
3D myocardial perfusion CMR is therefore a highly promising development and 
recent studies have shown it to be clinically feasible, highly accurate and to have a 
potential role in the assessment and follow-up of MIB (Manka et al., 2011; Shin et 
al., 2008; Manka et al., 2012; Jogiya et al., 2012). In the first clinical study of 3D 
perfusion CMR, Manka et al evaluated 146 patients with suspected CAD using k-t 
acceleration to achieve 16-slice coverage and an in-plane spatial resolution of 2.3mm 
(Manka et al., 2011).  Image quality was consistently high and the overall sensitivity, 
specificity, and diagnostic accuracy to detect significant CAD (QCA ≥ 50%) were 92%, 
74% and 83% respectively, comparable to conventional 2D perfusion CMR (Manka 
et al., 2011; Greenwood et al., 2012).  Furthermore, MIB (expressed as a percentage 
of LV myocardial hypo-enhancement to total LV myocardium) was calculated from 
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3D perfusion CMR data (Figure 1.9). In 48 patients that had a repeat scan after PCI, 
there was a relative reduction in MIB of 79 ± 25%, highlighting the potential role of 
3D perfusion CMR to serially monitor the response to anti-ischaemic therapies 
(Manka et al., 2011). In addition, the quantification of ischaemic burden using 
myocardial hypo-enhancement volumetry (with an arbitrary signal intensity 
threshold of 2 standard deviations below remote myocardium) was found to be 
highly reproducible on intra-reader and inter-reader assessment.   
While the previous study used QCA ≥ 50% as the reference standard for CAD, two 
recent studies (one at 1.5T and one at 3.0T) have validated 3D perfusion CMR against 
FFR and shown high diagnostic accuracy of the method (Manka et al., 2012; Jogiya 
et al., 2012).  In a study by Manka et al, 3D perfusion CMR at 1.5T was found to have 
a sensitivity, specificity and diagnostic accuracy of 90%, 82% and 87% respectively 
(2012).  At 3.0T, a study by Jogiya et al found similar figures of 91%, 90% and 91% 
respectively (Jogiya et al., 2012). Both of these studies further verified the feasibility 
and reproducibility of ischaemic burden quantification using volumetry of 
myocardial hypo-enhancement. Additionally, Manka et al also found that the 
quantified MIB had a high diagnostic accuracy (AUC=0.90) for identifying FFR-defined 
CAD - with an optimal cut-off value of >4.4% (2012). 
Although FFR is widely considered the invasive reference standard for determining 
the hemodynamic significance of a coronary stenosis, it does not provide any 
information about the magnitude of consequent ischaemia. This deficiency 
highlights a potential role for 3D perfusion CMR -  and in both of the validation 
studies against FFR, it demonstrated a higher ischaemic burden with proximal lesions 
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compared to distal lesions (Manka et al., 2012; Jogiya et al., 2012). Furthermore, 
Jogiya et al, found a strong correlation (r = 0.82; 95% CI: 0.70 to 0.89; p<0.0001) 
between the MIB on 3D perfusion CMR and the Duke Jeopardy score - which is a 
validated invasive assessment of ischaemic burden based on lesion severity and 
location (2012).  
 
 
Figure 1.9 MIB Quantification with 3D Perfusion CMR 
Panel (A) shows consecutive slices of a 3D perfusion CMR scan during adenosine stress in a 
patient with significant stenoses in the proximal right coronary artery and distal left anterior 
descending coronary artery. Panel (B) shows identical images illustrating volumetry of 
myocardial hypo-enhancement using a signal intensity threshold of 2 standard deviations 
below remote myocardium (red areas). The volume of myocardial hypo-enhancement was 
30.4% of total myocardium. 3D = 3-dimensional; CMR = cardiovascular magnetic resonance 
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1.7 Limitations of Highly Accelerated Perfusion CMR 
k-t techniques add complexity to the acquisition of perfusion CMR and they are 
sensitive to respiratory motion and cardiac arrhythmias.  In order to reduce 
respiration-related artefacts when using these techniques, fewer dynamic images 
tend to be acquired compared with conventional methods and more emphasis is 
placed on respiratory coaching  (Plein et al., 2008a). The acquisition of fewer dynamic 
images does however confer a risk of inadequate temporal sampling of myocardial 
contrast passage, particularly if there is significant arrhythmia - and therefore 
patients with arrhythmia may not be ideal for these techniques. In practice, the 
breath-hold capacity of patients can be maximised by clear breathing instructions, 
trial runs and acquisition in inspiration. Alternative strategies are shallow respiration 
throughout the acquisition or a more focused breath-hold during myocardial 
contrast passage (Manka et al., 2010). Previous studies have shown that in compliant 
patients, respiratory artefacts are rare and tend to occur at the end of a breath-hold; 
if the timing of the acquisition is correctly synchronised to the breath-hold 
command, such artefacts rarely interfere with image interpretation (Motwani et al., 
2012a).  Furthermore, recent improvements such as k-t PCA are less sensitive to 
respiratory motion and improve temporal fidelity (compared to k-t  SENSE and k-t 
BLAST reconstructions which can suffer from temporal blurring) because image 
reconstruction is constrained using temporal basis functions derived from the low-
resolution training data acquired in every heartbeat (Pedersen et al., 2009). 
Advanced motion correction techniques that allow free-breathing throughout 
acquisition are also in development (Pedersen & Kelle, 2008). 
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A further limitation is that the described reconstruction techniques all assume the 
heart remains entirely static but there are of course small movements throughout 
the cardiac cycle which can cause motion-related artefacts including DRA. 3D 
acquisition is more vulnerable to motion-related artefact than 2D acquisition, as well 
as respiratory artefact, because of its larger temporal footprint (length of acquisition 
is approximately 200ms for 3D vs. <100ms for most 2D acquisitions). 
Finally, and this applies to all undersampling methods, reducing the number of 
sampled data points leads to an SNR reduction that is proportional to 1/ √R  where 
R is the acceleration factor (Kozerke & Plein, 2008). In k-t methods, the actual SNR 
reduction may, however, be much less if the dynamics of the object are highly 
correlated in successive time-frames (Gebker et al., 2007b). 
1.8 High Spatial Resolution or Full Cardiac Coverage?  
Whether the benefits of high spatial resolution such as detection of subendocardial 
ischaemia and reduction of dark rim artefact outweigh the potential benefits of 
whole-heart coverage including more reliable ischaemia quantification is a complex 
and as yet unanswered question. Initial studies albeit in selected and small patient 
populations, suggest that the diagnostic accuracy of the two approaches is similar - 
but there has not yet been a direct head-to-head comparison and further large-scale 
studies are required (Motwani et al., 2012a; Manka et al., 2010, 2012; Jogiya et al., 
2012). In clinical practice, the two different approaches may have specific benefits 
for individual patients. In a patient with a de-novo suspicion of CAD, the available 
limited data on diagnostic accuracy suggest that either technique – or indeed 
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conventional 2D perfusion CMR would be appropriate choices. However, in a patient 
who has already undergone angiography and is found to have diffuse multi-vessel 
disease with possible PCI targets, high-resolution acquisition might be favourable on 
account of its ability to detect subendocardial ischaemia in the presence of balanced 
ischaemia (Figure 1.6).  In patients with a history of myocardial infarction and 
suspected peri-infarct ischaemia, a 3D perfusion scan may better allow matching of 
LGE and perfusion images over the entire heart with more reliable quantification of 
peri-infarct ischaemia - rather than an assumption based on three sparse slices. 
Figures 1.10 - 1.13, show examples of patients undergoing both acquisitions and the 
relative merits (Table 1.4) of both techniques are discussed in each case.  
An alternative strategy to either high-resolution or whole-heart coverage would be 
to divide the speed-up afforded by acceleration techniques between spatial 
resolution and cardiac coverage.  However, at present there is insufficient data to 
adequately define the optimal compromise between these parameters. The 
subendocardial layer is the most vulnerable to ischaemia and therefore sufficient 
spatial resolution to resolve a transmural perfusion gradient is preferable -  and this 
remains a significant advantage of CMR over SPECT (Greenwood et al., 2012). 
However, it is unclear how far this notion needs to be taken or whether the spatial 
resolution used in recent large-scale studies is sufficient - particularly given the high 
levels of diagnostic performance. Only a large-scale clinical study comparing 
acquisitions of varying spatial resolution and differing degrees of cardiac coverage 
can answer this question. Furthermore, whether an optimal compromise is best 
acquired throughout the cardiac cycle with a multi-slice 2D approach, en-bloc with a 
62 
 
3D approach or with newer techniques such as HYPR would also have to be 
determined. Finally, beyond studies of diagnostic accuracy we also need to evaluate 
whether the various approaches differ in their quantification of ischaemic burden, 
particularly given the increasing use of CMR for this purpose in clinical studies and 
for accurate prognostic information (Bingham & Hachamovitch, 2011).  
 
Table 1-4  Relative Merits of High-Resolution and 3D Perfusion CMR 
 
3D = 3-dimensional; CMR =cardiovascular magnetic resonance; SNR= signal-to-noise ratio; 
LGE= late-gadolinium enhancement; TPG= transmural perfusion gradient; MIB= myocardial 
ischaemic burden. 
  
High-Resolution Perfusion CMR 3D-Whole Heart Perfusion CMR 
Greater detection of subendocardial ischaemia Assesses true extent of perfusion defects 
Less dark rim artefact High SNR 
Similar spatial resolution to LGE imaging Single selected phase for all slices 
Quantitative analysis of TPG Quantitative assessment of MIB  
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Figure 1.10 3D versus High-resolution Perfusion CMR - Case 1 
A 62-year-old man with a history of previous bypass surgery 10 years ago, re-presented with 
increasing angina. The top panel dimensional shows 3D perfusion CMR at stress (2.5mm in-
plane resolution, 12 slices); the middle panel shows LGE imaging (1.5mm in-plane resolution) 
and the bottom panel shows high-resolution stress perfusion CMR (1.1mm in-plane 
resolution, 3 slices) -  all performed on the same patient at 3.0-T. Both 3D perfusion and high-
resolution techniques show inferior perfusion defects from base to apex. The benefit of 
whole-heart coverage with the 3D technique is demonstrated in this case, as hypoperfusion 
is seen to extend beyond the scar into the apical cap (top panel, arrows) which is not covered 
by the three-slice high-resolution technique. On the other hand, the perfusion defects and 
their transmural extent are better delineated with the high-resolution technique particularly 
at the mid-ventricular level. By virtue of their similar in-plane spatial resolution, it is easier to 
correlate LGE images with high-resolution perfusion CMR on a per slice basis, compared to 
the 3D technique.  
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Figure 1.11  3D versus High-resolution Perfusion CMR - Case 2 
A 45-year-old man with previous PCI to the LAD re-presented with significant angina. The top 
panel dimensional shows 3D perfusion CMR (12 slices) at stress; the middle panel shows LGE 
imaging and the bottom panel shows high-resolution (1.1mm in-plane) stress perfusion CMR 
- all performed at 3.0-T. 3D perfusion CMR shows stress-induced hypo-perfusion throughout 
the anterior wall from base to apex – i.e. well beyond the area of scar seen in the mid-anterior 
wall on LGE imaging.   This example shows the benefit of whole-heart coverage with the 3D 
acquisition, as the 3-slice high-resolution techniques did not demonstrate any significant 
ischaemia beyond the established scar in the mid-ventricle. X-ray angiography confirmed a 
sub-total occlusion of a large diagonal branch, accounting for the anterior ischaemia (black 
arrow). VLA=vertical long axis. 
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Figure 1.12 3D versus High-resolution Perfusion CMR - Case 3 
 A 57-year-old man presented with worsening angina after a myocardial infarction 6 months 
ago.  The top panel dimensional shows stress 3D perfusion CMR (12 slices); the middle panel 
shows LGE imaging; and the bottom panel shows high-resolution (1.1mm in-plane) stress 
perfusion CMR  - all performed at 3.0-T. Both 3D perfusion and high-resolution perfusion 
techniques show an inferior perfusion defect from base to apex consistent with the infarction 
seen on LGE imaging. However, the perfusion defects are better delineated at high-resolution 
and a small amount of peri-infarct ischaemia can be seen in each of the 3 slices (arrows) 
beyond the established scar on corresponding LGE images.  With 3D acquisition, the lower 
spatial resolution (2.5mm in-plane) means that the borders of the perfusion defect within 
each slice are less distinct and are more difficult to distinguish from dark-rim artefact in the 
mid to apical anteroseptal regions (endocardial border opposite  dashed lines).  
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Figure 1.13 3D versus High-resolution Perfusion CMR - Case 4 
The top panel dimensional shows stress 3D perfusion CMR; the middle panel shows LGE 
imaging; and the bottom panel shows high-resolution (1.1mm in-plane) stress perfusion CMR 
- all performed at 3.0T.  The 3D technique demonstrated significant stress-induced 
hypoperfusion in the inferior wall from base to apex and extending into the basal 
inferolateral segments; but there was also significant dark-rim artefact in the septum 
(endocardial border opposite dashed lines). X-ray angiography confirmed total occlusion of 
the mid left circumflex artery (arrow). Due to the sparsity of coverage, the 3-slice high-
resolution technique only detected a significant perfusion defect at the mid-ventricular level 
and therefore significantly underestimated the ischaemic burden in this case, compared to 
the 3D technique.  Additionally, interpretation of the apical high-resolution slice is difficult as 
it is significantly more diastolic than the other slices, which is a disadvantage of all 2-
dimensional acquisitions which employ a single-shot technique. By comparison, with 3D 
perfusion CMR all slices are acquired at the same point in the cardiac cycle which makes it 
easier to determine the extent of perfusion defects across different myocardial sections.  
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1.9 Other Advances in Perfusion CMR 
 Perfusion CMR at 3-Tesla 
CMR imaging at 3T offers an increased SNR and increased contrast enhancement 
(Araoz et al., 2005; Gutberlet et al., 2006). Several studies have demonstrated the 
clinical feasibility of myocardial perfusion CMR at 3T and one direct comparison to 
1.5T by Cheng et al (n=61) found that 3T perfusion imaging provided a superior 
diagnostic accuracy in single-vessel (AUC: 0.89 vs. 0.70; p< 0.05) and in multi-vessel 
disease (AUC: 0.95 vs. 0.82; p < 0.05) (2007)(Table 1.3).  
More recently, a study by Ebersberger et al (n=116), compared perfusion CMR at 3T 
to a clinical routine algorithm in which coronary stenoses exceeding 75% on coronary 
angiography were deemed pathological and FFR measurements were performed in 
intermediate lesions (50-75%) (2013). In this study, 3T perfusion CMR provided a 
consistently high image quality and an excellent diagnostic performance for 
detecting significant CAD (AUC = 0.93). 
In clinical practice, CMR at 3T has in the past been hampered by artefacts related to 
magnetic field inhomogeneities and dielectric shading as well as restrictions related 
to local energy deposition (Bernstein et al., 2006). These challenges are largely 
overcome today, for example with the introduction of multi-transmit radiofrequency 
magnetic resonance imaging (MRI) techniques which reduce dielectric shading and 
improve homogeneity of the MRI signal (Willinek et al., 2010). 
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 Quantitative Perfusion CMR 
One of the limitations of myocardial perfusion imaging and standard visual 
interpretation is the dependence on a reference area of normal perfusion. This can 
be a particular impediment in diffuse or balanced multi-vessel disease, although the 
high resolution of CMR usually allows the detection of endo-epicardial perfusion 
gradients as a marker of widespread ischaemia in such instances. The limitations of 
visual analysis can also be avoided by using absolute quantification of myocardial 
blood flow (MBF)(Patel et al., 2010). The current clinical reference standard to 
quantify MBF noninvasively is PET (Knuuti et al., 2009; Uren et al., 1994). 
Quantitative analysis of myocardial perfusion CMR follows similar principles as 
quantitative PET, but without exposure to ionizing radiation and with higher in-plane 
spatial resolution. Following earlier validation in animal models and volunteers, 
recent clinical studies have demonstrated high diagnostic accuracy of CMR derived 
estimates of absolute MBF and myocardial perfusion reserve (MPR) against both 
QCA and FFR (Costa et al., 2007; Lockie et al., 2011; Motwani et al., 2012b; Patel et 
al., 2010; Futamatsu et al., 2007).  A direct comparison of quantitative CMR and PET 
demonstrated good agreement between the two methods for the measurement of 
MPR but agreement for absolute MBF values at rest and stress was weaker (Morton 
et al., 2012). 
The scope for quantitative perfusion CMR in clinical practice and cardiovascular 
research is immense but there remain a number of limitations that currently 
constrain this advance.  The most important of these is a lack of standardisation in 
image acquisition, contrast dosing protocols, post-processing and mathematical 
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modelling - but efforts to standardise these are under way. There is also no widely 
available, validated software for quantitative analysis and therefore research groups 
generally use different in-house solutions. Recently, several studies have used a 
dual-bolus method of contrast administration to improve accuracy of the analysis, 
and there have also been improvements in post-processing using non-rigid 
registration techniques that allow pixel-by-pixel quantification (Utz et al., 2008; Hsu 
et al., 2012; Salerno & Kramer, 2013) 
1.10  Implications of Cardiac Phase on Perfusion CMR  
MBF follows a phasic pattern due to the interaction between myocardium and 
coronary vessels. As early as 1695, Scaramucci was the first to speculate that cardiac 
contraction cases a phasic impediment to MBF -  and since then micro-angiography 
techniques have directly observed the compression of intramyocardial vessels 
confirming this hypothesis (Yada et al., 1993; Hiramatsu et al., 1998; Kassab et al., 
1993).  In contrast to other organs, coronary arterial inflow is predominantly diastolic 
when myocardial tension is low, and venous outflow is systolic when myocardial 
tension is high (Sabsiton Jr & Gregg, 1957).  It has been shown that even in distal 
extramural coronary arteries, virtually no forward flow occurs during systole under 
physiological conditions (Chilian & Marcus, 1982, 1985; Carew & Covell, 1976; 
Eckstein et al., 1963; Kajiya et al., 1985).  This phasic nature of MBF raises a number 
of important considerations for perfusion CMR. 
Firstly, in perfusion CMR, data acquisition is limited to short windows in the cardiac 
cycle (typically ~100ms) in order to limit the effects of cardiac motion. As a result, 
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each of the 3-4 slices obtained with standard 2D perfusion CMR are acquired at 
different time-points in the cardiac cycle in order to preserve spatial coverage.  
However, given that MBF is not uniform throughout the cardiac cycle, the impact of 
a variable phase of acquisition is speculated to affect quantitative estimates of MBF 
using CMR. This is particularly important given the desire to develop and better 
standardise quantitative perfusion CMR analysis as discussed above. Notably, a 
previous volunteer study demonstrated significantly greater stress MBF estimates in 
diastole than systole (Radjenovic et al., 2010). However, whether these findings exist 
in disease and whether they have potential diagnostic consequences has not been 
studied before.  
Secondly, the development of 3D perfusion CMR, facilitated by advanced 
acceleration, now allows for contiguous whole-heart coverage - all in a single cardiac 
phase which can be freely chosen. However, the optimal cardiac phase for 
acquisition has yet to be determined or standardised (Shin et al., 2008). Most 
previous 3D perfusion CMR studies have acquired data in systole but to date it is 
unknown whether systolic or diastolic acquisition leads to better image quality or 
diagnostic yield. Mid-diastole is an attractive window for data acquisition as the 
heart is at its most stationary, but has the disadvantage of being more prone to dark-
rim artefact due to partial volume effects (Plein et al., 2007, 2008b) (Kellman & Arai, 
2007). End-systole has a shorter quiescent period but on the other hand is less 
sensitive to R-R variability and arrhythmia (Gharib et al., 2007). Finally, as with 2D 
perfusion CMR it is unknown whether quantitative estimates of MBF from 3D data 
demonstrate significant phasic differences and whether these are clinically relevant.  
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As part of this thesis, we investigate the impact from variable phase of acquisition 
by utilising novel 2D and 3D pulse sequences to directly compare simultaneous 
acquisitions of systolic and diastolic perfusion data. 
1.11  Aims of Thesis 
Perfusion CMR is a highly accurate method for detecting CAD, but is hindered by 
spatial-temporal constraints. Advanced acceleration techniques have been used to 
improve spatial resolution, or alternatively achieve 3D whole-heart coverage – but it 
is not clear which of these alternative strategies offers greater benefit. Acceleration 
can also be used to simultaneously acquire perfusion data at different time-points in 
the cardiac cycle.  The latter is particularly important as the impact of a variable 
cardiac phase of acquisition on quantitative estimates of MBF is poorly understood. 
Accordingly, this thesis includes studies that modify the standard approach to 
perfusion CMR in order to investigate the relative impact of spatial resolution, spatial 
coverage and cardiac phase of acquisition on both qualitative and quantitative 
assessment of ischaemia. We have specifically focused on the following aims and 
each is dealt with in the subsequent chapters with an appropriate introduction, 
methods, results and discussion section: 
1. To compare the diagnostic accuracy of 2D high-resolution and standard-
resolution perfusion CMR in patients with suspected CAD – [Chapter 2]. 
2. To compare estimates of MIB in patients with angiographic three-vessel CAD 
using 2D high-resolution and standard-resolution perfusion CMR – [Chapter 3] 
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3. To compare image quality, diagnostic confidence and estimates of MIB  by 2D 
high-resolution and 3D perfusion CMR – [Chapter 4] 
4. To compare estimates of MBF from quantitative 2D perfusion CMR acquired in 
systole and diastole;  and determine the diagnostic accuracy of both cardiac 
phases in patients with suspected CAD – [Chapter 5] 
5. To establish the feasibility of quantitative 3D perfusion CMR for the detection 
of CAD and to compare systolic and diastolic estimates of MBF – [Chapter 6] 
6. To determine if quantitative perfusion CMR can accurately track physiological 
variations in MBF throughout the cardiac cycle – [Chapter 7] 
 
  
73 
 
2 Study 1 - High-resolution Versus Standard-resolution 
Perfusion CMR for the Detection of Coronary Artery Disease  
 
2.1 Abstract 
Background: Although accelerated high-spatial-resolution perfusion CMR has been 
shown to be clinically feasible, there has not yet been a direct comparison with 
standard-resolution methods. We hypothesised that higher spatial resolution 
detects more subendocardial ischaemia and leads to greater diagnostic accuracy for 
the detection of CAD. This study compared the diagnostic accuracy of high-resolution 
and standard-resolution perfusion CMR in patients with suspected CAD. 
Methods and Results: One-hundred and eleven patients were recruited to undergo 
two separate perfusion CMR studies at 1.5T, one with standard-resolution (2.5 x 
2.5mm in-plane) and one with high-resolution (1.6 x 1.6 mm in-plane) acquisition. 
High-resolution acquisition was facilitated by eight-fold k-t BLAST acceleration. Two 
observers visually graded perfusion in each myocardial segment on a 4-point scale. 
Segmental scores were summed to produce a perfusion score for each patient.  All 
patients underwent invasive coronary angiography and CAD was defined as stenosis 
≥ 50% luminal diameter (quantitative coronary angiography). CMR data were 
successfully obtained in 100 patients. In patients with CAD (n=70), more segments 
were determined to have subendocardial ischaemia with high-resolution than with 
standard-resolution acquisition (279 vs.108; p<0.001). High-resolution acquisition 
had a greater diagnostic accuracy than standard-resolution for identifying single-
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vessel disease (area under the curve [AUC]: 0.88 vs. 0.73; p<0.001) or multi-vessel 
disease (AUC: 0.98 vs. 0.91; p=0.002) and overall (AUC: 0.93 vs. 0.83; p<0.001). 
Conclusions: High-resolution perfusion CMR has greater overall diagnostic accuracy 
than standard-resolution acquisition for the detection of CAD in both single and 
multi-vessel disease and detects more subendocardial ischaemia. 
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2.2 Introduction 
Myocardial perfusion imaging with CMR is a highly accurate method of detecting 
significant CAD in single and multi-vessel disease (Schwitter et al., 2008; Sakuma et 
al., 2005; Greenwood et al., 2012). Recent comparative studies have suggested a 
higher diagnostic accuracy of CMR compared with SPECT (Greenwood et al., 2012). 
This increase in accuracy is thought to relate in part to the higher spatial resolution 
of CMR (typically 2-3 mm versus 5-10 mm). 
With recently developed spatio-temporal undersampling methods such as k-t BLAST 
and k-t SENSE, the in-plane spatial resolution of perfusion CMR can be improved 
further, from 2-3 mm to 1-2 mm (Tsao et al., 2003). The feasibility and clinical 
applicability of high-resolution perfusion CMR has been demonstrated in a number 
of studies (Gebker et al., 2007b; Plein et al., 2008a, 2008b; Maredia et al., 2010); but 
to date only one small-scale study in volunteers has directly compared high-
resolution and standard-resolution acquisition. In their study, Maredia et al 
demonstrated a reduction in endocardial dark rim artefact and improved image 
quality of high-resolution perfusion images (Maredia et al., 2010). 
We hypothesised that in patients with CAD, high-spatial-resolution perfusion CMR 
would improve detection of subendocardial ischaemia and thus the overall 
diagnostic accuracy compared with standard-resolution perfusion CMR. 
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2.3 Methods 
 Population 
A total of 111 patients with suspected CAD were recruited. Each patient’s pre-test 
probability of CAD was calculated based on their age, sex and symptoms (Diamond 
& Forrester, 1979).  All had undergone or were scheduled to undergo diagnostic 
coronary angiography within the previous/next 30 days as part of routine clinical 
care. No coronary intervention or clinical events occurred between angiography and 
recruitment. Exclusion criteria were contra-indications to CMR, adenosine or 
gadolinium contrast agents; a history of recent (within 6 months) myocardial 
infarction or unstable angina; or poorly controlled arrhythmias. Patients were 
instructed to refrain from caffeine for 24hrs prior to their CMR study but continue 
cardiac medications as normal. All patients gave written consent to participate and 
the study was approved by the regional ethics committee. 
 CMR protocol 
Studies were carried out on a 1.5T CMR system (Philips Healthcare, Best, The 
Netherlands) using a five-element cardiac phased array receiver coil for signal 
reception. All patients underwent two CMR studies on separate days within 4 weeks. 
For each patient, both scans were performed before or after coronary angiography. 
On one occasion, a ‘standard’ perfusion pulse sequence was used, and on the other 
a high-resolution method accelerated with k-t BLAST was employed. The order of 
methods was randomly chosen.  
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For both techniques, perfusion data was acquired in 3 short-axis slices (basal, mid 
and apical) in each R-R interval. The standard pulse sequence was a saturation 
recovery gradient echo method accelerated with SENSE (acceleration factor 2, half 
Fourier sampling, partial echo, repetition time (TR) 2.7 ms, echo time (TE) 1.0 ms, flip 
angle 15o, image acquisition time per slice 136 ms, single saturation pre-pulse per R-
R interval shared over three slices, matrix 144 x 144, median field of view (FOV) 360 
mm, 2.5 x 2.5 mm in-plane spatial resolution). The high-resolution pulse sequence 
used a similar saturation recovery gradient echo method, but was accelerated with 
k-t BLAST (acceleration factor 8 with 11 training profiles, no partial Fourier or partial 
echo acquisition, TR 3.4 ms, TE 1.7ms, flip angle 15o, one saturation pre-pulse per 
slice, image acquisition time per slice 103 ms, matrix 192 x 192, median FOV 310 
mm, and 1.6 x 1.6 mm in-plane spatial resolution). 
For both studies, stress perfusion commenced after 4 minutes of an intravenous 
adenosine infusion (140 mcg/kg/min), during an intravenous bolus injection of 
dimeglumine gadopentetate (Magnevist, Schering AG, West Sussex, UK) and a 
15ml saline flush delivered at 5ml/s while the patient held their breath in end-
expiration. For the standard-resolution method, a contrast agent dose of 
0.05mmol/kg bodyweight was used during perfusion data acquisition as in previous 
studies with this pulse sequence (Greenwood et al., 2012). In order to compensate 
for the lower signal-to-noise ratio associated with the smaller voxel size, a contrast 
agent dose of 0.1mmol/kg bodyweight was used for the high-resolution method, 
consistent with previous reports (Plein et al., 2008b, 2007; Manka et al., 2010). Rest 
perfusion imaging was performed 15mins later using identical imaging parameters. 
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Late gadolinium enhanced imaging (LGE) was performed in all patients on their first 
visit using conventional methods (1.6 x 1.6 mm in-plane spatial resolution) with a 
cumulative contrast agent dose of 0.2mmol/kg bodyweight (the same for both 
protocols) (Kramer et al., 2008).  During standard-resolution perfusion CMR scans, 
this cumulative dose was achieved by administration of an additional bolus of 
0.1mmol/kg bodyweight of contrast agent immediately following rest perfusion. 
 CMR analysis 
CMR images were interpreted in random order by 2 observers (S.P., M.M; 10 years 
and 1 year experience in CMR) acting in consensus and blinded to all clinical 
information (QMASS 6.1.6 , Medis, Leiden, The Netherlands). Visual analysis used a 
16-segment American Heart Association (AHA) model (Cerqueira et al., 2002). 
Perfusion in a segment was considered abnormal if signal intensity was reduced 
compared with remote myocardial segments or an endocardial to epicardial 
perfusion gradient within a segment was present (Plein et al., 2008a). Additionally, 
any perfusion defect was required to persist longer than the contrast media first-
pass to distinguish it from artefact. Corresponding LGE images were reviewed side-
by-side with the perfusion data. Perfusion defects present at stress but not rest and 
occurring outside any hyperenhanced myocardial tissue on LGE images were 
considered as inducible defects according to the Duke algorithm (Klem et al., 2006). 
Perfusion in each myocardial segment was graded on a 4-point scale (transmural 
ischaemia index) from 0-3 (0 = normal, 1 = inconclusive, 2 = subendocardial defect, 
3 = transmural defect). All segmental scores were summed to produce a perfusion 
score (0-48) for each patient.  In addition, perfusion scores were calculated for the 
79 
 
left anterior descending (LAD), left circumflex (LCX) and right coronary artery (RCA) 
territories according to the 16-segment AHA model adjusted for arterial dominance 
(Cerqueira et al., 2002; Marie et al., 1993).  Image quality was graded 1-4 (1 = 
unusable, 2 = poor, 3 = adequate, 4 = excellent) by consensus of the two observers. 
Occurrence of artefacts related to k-t reconstruction, respiratory motion, 
electrocardiographic gating, and endocardial dark rim artefact was scored between 
0 and 3 (0 = none, 1 = minor, 2 = moderate, 3 = severe). Dark rim artefacts were 
recorded if an endocardial dark rim appeared at the arrival of contrast in the left 
ventricular (LV) cavity and prior to contrast arrival in the myocardium (Figure 1.4). 
Where present, the maximum width of dark rim artefact was measured with 
electronic callipers at standardized window settings.  
 Quantitative coronary angiography 
Quantitative coronary angiography (QCA) was performed (QCAPlus, Sanders Data 
Systems, Palo Alto, California, USA) on all X-ray angiography images by an 
experienced observer blinded to clinical and CMR data (M.M.; 6 years of experience 
in coronary angiography). Each myocardial segment was ascribed a coronary artery 
territory according to the standard AHA 16-segment model adjusted for arterial 
dominance (Cerqueira et al., 2002; Marie et al., 1993). Significant CAD was defined 
angiographically as stenosis ≥ 50% diameter in any of the main epicardial coronary 
arteries or their branches with a diameter of ≥2mm.  
 Statistical analysis  
Analysis was performed using SPSS 17.0 (SPSS, Chicago, IL, USA). Data are presented 
as mean ± SD. Group means were compared using the paired Student t test.  Ordinal 
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data were compared using Chi-square or Wilcoxon signed-rank tests as appropriate.  
All statistical tests were two-tailed and a p value <0.05 was considered significant. 
Receiver operating characteristic (ROC) analysis was performed on a per patient 
basis using summed perfusion scores to determine the diagnostic accuracies of 
standard and high-resolution acquisition to detect coronary stenosis of ≥50% on 
QCA.  A secondary analysis, using a stenosis severity of ≥70% was also performed. 
Optimal perfusion score cut-off values were determined as the values that 
maximized the sum of sensitivity and specificity. Diagnostic accuracies are presented 
as areas under the curve (AUCs) and compared using the methods described by 
Delong and Delong (DeLong et al., 1988).  The study was designed to have a statistical 
power of 80% to detect a 10% difference in AUC with an alpha level of 0.05. 
Sensitivity, specificity and positive/negative predictor values were also calculated for 
each technique but these values were not directly compared as the study was not 
statistically powered for such analyses (Eng, 2003). 
2.4 Results 
 Study population 
A total of 111 patients were enrolled in the study. In 5 patients, both standard and 
high-resolution CMR scans could not be completed (3 patients were claustrophobic 
and 2 patients declined to return for a second visit). Three patients successfully 
completed both scans but X-ray angiography was cancelled for clinical reasons 
unrelated to the CMR findings. Three patients had to be excluded due to technical 
problems on either one of their visits. Therefore, 100 patients (90% of the cohort) 
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were included in the final analysis and all images were of analysable quality. Clinical 
details of the 100 study patients (74% men, mean age 61 ± 7 yrs) are summarised in 
Table 2.1. 
Table 2-1 Patient Characteristics  
 
 *Pre-test likelihood of CAD is expressed as median % (interquartile range); 
**Significant CAD defined as coronary stenosis ≥50% on QCA. 
CAD = coronary artery disease; IQR = interquartile range; MI = myocardial infarction; PCI = 
percutaneous coronary intervention 
Parameter Data (n=100) 
Age (yrs ± SD) 61 ± 7 
Male, n (%) 74 (74) 
Medical history, n (%)  
    Hypertension 67 (67) 
    Hypercholesterolemia 65 (65) 
    Diabetes Mellitus 18 (18) 
    Smoking 42 (42) 
    Family history of CAD 37 (37) 
    Previous MI 12 (12) 
    Previous PCI 8 (8) 
    Atrial Fibrillation 2 (2) 
LV Ejection Fraction , % 58 ± 9 
Pre-test likelihood of CAD,% (IQR)* 51 (31-65) 
Presenting cardiac symptoms, n (%)  
    Non-anginal chest pain  22 (22) 
    Atypical angina 37 (37) 
    Typical angina 32 (32) 
    Dyspnoea 9 (9) 
Angiography findings, n (%) **  
    No significant disease 30 (30) 
    One-vessel disease 32 (32) 
    Two-vessel disease 14 (14) 
    Three -vessel disease 24 (24) 
    LAD disease 46 (46) 
    LCX disease 42 (42) 
    RCA disease 43 (43) 
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QCA confirmed significant CAD in 70 patients (70%). Thirty-two patients (32%) had 
single-vessel disease and 38 patients (38%) had multi-vessel disease (two or three 
vessel disease) (Table 2.1). In terms of anatomic location of coronary artery stenoses, 
46 patients (46%) had significant LAD stenoses, 42 patients (42%) had significant LCX 
stenoses and 43 patients (43%) had significant RCA stenoses. Typical examples of 
patients with ischaemia are shown in Figures 1.5 and 2.1. The hemodynamic stress 
response achieved with adenosine during standard and high-resolution imaging was 
similar (rate-pressure product, mmHg x beats/min: 10262 ± 2491 vs. 10247 ± 2279; 
p=0.90). All patients were in sinus rhythm and heart rate allowed acquisition at each 
R-R interval in all. All 12 patients with a clinical history of MI but no additional 
patients had evidence of hyperenhancement on LGE imaging. 
 Detection of CAD 
The diagnostic accuracy (AUC) of standard-resolution perfusion CMR for the 
detection of CAD ≥ 50% was 0.83 (Table 2.2, Figure 2.2). The optimal perfusion score 
cut-off value was determined as ≥4, which resulted in a sensitivity and specificity of 
84% and 73% respectively (Table 2.3). 
The diagnostic accuracy of high-resolution perfusion CMR to detect CAD ≥ 50% was 
significantly higher with an AUC of 0.93 (p<0.001) (Table 2.2, Figure 2.2). The optimal 
perfusion score cut-off value was also ≥4 with this technique, which resulted in a 
sensitivity and specificity of 91% and 80% respectively (Table 2.3). Similar diagnostic 
performance was seen using a CAD threshold ≥ 70%  and the diagnostic accuracy of 
high-resolution perfusion CMR remained significantly higher than standard-
resolution acquisition (AUC:0.92, 95% CI 0.87-0.97 vs 0.83, 95% CI 0.75-91; p<0.001). 
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The statistical power for the comparison of AUCs was 0.93 (alpha 0.05, beta 0.07) 
(Hanley & McNeil, 1983). 
The diagnostic performance of high-resolution acquisition to detect CAD ≥ 50% was 
significantly greater than standard-resolution for both single-vessel disease (AUC: 
0.88 vs. 0.73; p< 0.001) and multi-vessel disease (AUC: 0.98 vs. 0.91; p=0.002) (Table 
2.2). 
  
Figure 2.1 Case Example: Standard vs. High-Resolution Perfusion CMR  
An inferior scar with thinning of the myocardium is seen in all images (open arrows, A-I). 
Dark-rim artifact seen on the basal slice (dashed arrows, A) at standard-resolution (2.5mm 
in-plane spatial resolution) is not present at high-resolution (G). By virtue of their identical 
spatial-resolution, LGE imaging and high-resolution perfusion-CMR allow for a better 
correlation between scar and perfusion than LGE imaging and standard resolution perfusion-
CMR. An area of peri-infarct ischemia (small arrows, H) is therefore more clearly identified 
at high-resolution. In this patient, coronary angiography showed a chronic total occlusion of 
the right coronary artery and the patient’s symptoms were relieved by subsequent PCI. 
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Table 2-2 Diagnostic Accuracy of Standard-resolution and High-resolution 
perfusion CMR for the Detection of CAD 
Values expressed as mean (95% confidence interval). CAD defined as stenosis ≥50%.  
  
Area Under Receiver-Operator Characteristic Curve  
 Standard-resolution High-resolution p value 
Overall 0.83 (0.75-0.91) 0.93 (0.88-0.98) <0.001 
Single-vessel disease 0.73 (0.60-0.86) 0.88 (0.79-0.97) <0.001 
Multi-vessel disease 0.91 (0.83-0.99) 0.98 (0.95-1.00) 0.002 
LAD disease 0.81  (0.71-0.90) 0.92 (0.86-0.97) <0.001 
LCX disease 0.73  (0.64-0.83) 0.87 (0.79-0.94) <0.001 
RCA disease 0.81  (0.72-0.90) 0.88 (0.81-0.95) 0.08 
Figure 2.2 ROC Curves: Standard-resolution vs High-resolution Perfusion CMR 
Standard and high-resolution perfusion CMR both had a high diagnostic accuracy for the detection 
of CAD (≥50% stenosis) but the high-resolution technique was superior. The areas under the curve 
were 0.83 for standard-resolution and 0.93 for high-resolution (p<0.001). 
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Table 2-3 Sensitivity, Specificity and Predictive values for Standard-resolution and 
High-resolution perfusion CMR for the detection of CAD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are expressed as percentage (95% confidence interval) and are quoted at optimal 
perfusion score cut-off thresholds (determined by receiver-operator curve analysis). 
Coronary artery disease defined as ≥50% stenosis. PPV = positive predictive value; NPV = 
negative predictive value.  
 
 Detection of anatomic location of CAD 
High-resolution acquisition had a significantly higher diagnostic accuracy than 
standard-resolution in the LAD and LCX territories for the detection of CAD ≥ 50% 
(AUC: LAD 0.92 vs. 0.81, LCX 0.87 vs. 0.73; both p values <0.001). Differences for the 
 Standard-resolution High-resolution 
Overall   
Sensitivity, % 84 (74-91) 91 (82-96) 
Specificity, % 73 (55-86) 80 (62-91) 
PPV, % 88 (77-94) 91 (82-96) 
NPV, % 67 (48-82) 80 (61-92) 
Single-vessel disease   
Sensitivity, % 78 (61-89) 88 (71-96) 
Specificity, % 73 (55-86) 80 (62-91) 
PPV, % 76 (57-88) 82 (65-93) 
NPV, % 76 (56-89) 86 (67-95) 
Multi-vessel disease   
Sensitivity, % 84 (69-93) 95 (82-99) 
Specificity, % 93  (73-97) 97 (82-100) 
PPV, % 91 (76-98) 97 (85-99) 
NPV, % 82 (64-93) 94 (78-99) 
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RCA territory did not reach statistical significance (AUC: 0.88 vs. 0.80; p =0.08) (Table 
2.2). 
In single-vessel disease (n=32), both standard and high-resolution imaging identified 
perfusion defects in only one territory in a similar number of patients (25 [78%] vs. 
27 [84%]; p=0.75). However, in multi-vessel disease, high-resolution imaging 
identified perfusion defects in more than one territory in significantly more patients 
than standard resolution (32 [84%] vs. 23 [61%]; p = 0.04). 
 Subendocardial ischaemia  
Using the 16-segment model, 1120 myocardial segments were available from the 70 
patients with CAD for further analysis.  With high-resolution acquisition, significantly 
more segments were determined as having subendocardial ischaemia (transmural 
index score of 2) than with standard-resolution (279 vs. 108; p<0.001); and there was 
a significant reduction in the number of segments determined as being normal (692 
vs. 831; p<0.001) or inconclusive (47 vs. 70; p= 0.04) (Figure 2.3). By contrast, the 
number of segments assessed as having transmural ischaemia was similar with both 
techniques (102 vs. 111; p =0.56). 
 Image quality  
Overall image quality (median score = 3 for both; p =0.58) and artefact score (median 
score = 0 for both; p = 0.10) were similar for both standard and high-resolution 
techniques. However, dark rim artefact was significantly less frequent with high-
resolution (8% vs. 30 %; p<0.001) and when it did occur it was less marked than with 
standard-resolution (1.7 ± 0.3 vs. 3.3 ± 0.8 mm; p<0.001). Fifteen high-resolution 
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data sets (15%) were affected by k-t reconstruction artefacts at stress and/or rest 
due to respiratory motion – but this did not affect myocardial contrast passage and 
generally occurred at the end of a breath-hold. 
 
2.5 Discussion 
This study has demonstrated a high diagnostic accuracy for both standard and high-
resolution perfusion CMR. However, the high-resolution technique outperformed 
the standard-resolution technique with greater diagnostic accuracy in single-vessel 
Figure 2.3 Distribution of Transmural Ischaemia Index  
In patients with coronary artery disease (≥50% stenosis), high-resolution perfusion CMR 
determined significantly more segments as having subendocardial ischaemia than the 
standard resolution technique; and fewer as normal or inconclusive. 
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disease, multi-vessel disease and overall. In particular, high-resolution acquisition 
was better at distinguishing a multi-vessel pattern of disease. These benefits are 
likely to be derived from better detection of subendocardial ischaemia at greater 
spatial resolution.  Our findings may therefore have important implications for the 
non-invasive assessment of myocardial ischaemia and for defining the role of high-
resolution perfusion CMR in current clinical practice. 
CMR perfusion imaging requires rapid data acquisition, which necessitates a trade-
off between spatial resolution, temporal resolution, SNR and spatial coverage. k-t 
BLAST exploits correlations in time and space to accelerate data acquisition and the 
speed-up afforded can be used to improve spatial resolution with relatively 
preserved SNR (Motwani et al., 2011; Kozerke & Plein, 2008; Plein et al., 2008a). 
Although the clinical feasibility of k-t BLAST and similar acceleration techniques such 
as  k-t SENSE have been demonstrated, their advantages over commonly used 
standard-resolution methods has not been defined in a clinical setting (Gebker et al., 
2007b; Plein et al., 2008a, 2008b; Maredia et al., 2010). In particular there has been 
no previous direct comparison between standard and high-resolution techniques in 
a patient population.  
In this study, the overall diagnostic accuracy of standard-resolution perfusion CMR 
for detecting angiographically defined CAD was within the range of previous studies 
with an AUC of 0.83 compared to 0.86 by Schwitter et al, 0.78  by Cheng et al  and 
0.89 in the perfusion analysis of  the CE-MARC study (2008; 2007; Greenwood et al., 
2012). Similarly, the overall diagnostic accuracy of high-resolution perfusion CMR 
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was within the range of previous studies using k-t SENSE or k-t BLAST  with an AUC 
of 0.93 compared to 0.94 by Manka et al and 0.85 by Plein et al (2010; 2008a). 
We speculate that the demonstrated superiority of high-resolution acquisition 
relates to a better specificity due to reduction in subendocardial dark rim artefacts 
and a greater sensitivity due to better detection of subendocardial ischaemia (Table 
2.3). Previous work investigating dark rim image artefacts has shown the prominent 
role of spatial resolution on the occurrence and extent of this artefact (Plein et al., 
2007; Di Bella et al., 2005).The significant reduction in both frequency and severity 
of dark rim artefact with high-resolution acquisition seen in this study confirms 
similar findings in a previous volunteer study (Maredia et al., 2010).  
In this study, high-resolution perfusion CMR detected more segments with 
subendocardial ischaemia than the standard-resolution method. The two possible 
explanations for this observation are that standard-resolution acquisition failed to 
detect subendocardial ischaemia in some patients or that high-resolution acquisition 
over-estimated ischaemia in normal segments. Without an available reference 
standard for determining subendocardial ischaemia this question cannot be 
conclusively resolved. However, given that the overall diagnostic accuracy for 
detection of CAD was significantly better with high-resolution than standard-
resolution, the more plausible explanation is that high-resolution acquisition leads 
to better detection of subendocardial ischaemia.  As well as the benefits this 
provides in typical CAD detection, high-resolution perfusion CMR could potentially 
provide an improved tool for the evaluation of conditions where there are 
microvascular perfusion abnormalities at the subendocardial level, such as 
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syndrome X, hypertensive heart disease or hypertrophic cardiomyopathy (Stanton & 
Marwick, 2010). 
In this study, contrast agent dose was optimised for visual analysis. However, 
quantitative methods for the estimation of myocardial blood flow (MBF) based on 
myocardial perfusion CMR data have been validated in animal models and applied 
to clinical studies (Christian et al., 2004; Costa et al., 2007; Patel et al., 2010). High-
resolution perfusion CMR offers further intriguing opportunities for quantitative 
analysis such sharper delineation of transmural perfusion gradients (Hautvast et al., 
2011). However, the algorithms applied for the reconstruction of high-resolution 
perfusion CMR data acquired with spatio-temporal undersampling methods give rise 
to a degree of low-pass temporal filtering, posing additional challenges to 
quantitative assessment. Recent developments such as k-t Principal Component 
Analysis are likely to overcome some of these challenges and will require evaluation 
in future studies (Pedersen et al., 2009).  
One of the limitations of myocardial perfusion imaging and visual analysis is the 
dependence on a reference area of normal perfusion. This is a particular impediment 
in diffuse or multi-vessel disease –the group of patients who are at greatest risk and 
would benefit most from accurate diagnosis and correct risk-stratification (Emond et 
al., 1994). The ability of high-resolution perfusion CMR to adequately resolve 
subendocardial ischaemia and transmural perfusion gradients should therefore be a 
major advantage as it reduces the need for an intra-patient comparison. Our study 
demonstrated this advantage as 84% of patients with multi-vessel disease were 
correctly identified as having perfusion defects in more than one territory compared 
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to only 61% with standard-resolution. This finding is of considerable significance as 
the assessment of multi-vessel disease has long been recognised as a weakness of 
myocardial perfusion imaging.  With SPECT, as few as 29% of patients with known 
angiographic three-vessel disease (3VD) are recognised as having inducible perfusion 
abnormalities in all three coronary artery territories (Christian et al., 1992). Similarly, 
in the only study that has evaluated standard-resolution perfusion CMR specifically 
in the setting of angiographic 3VD, the detection of a 3VD pattern was only 57% 
(Chung et al., 2010). Therefore, the demonstrated ability of high-resolution 
acquisition to more accurately identify the extent of ischaemia in multi-vessel 
disease may represent a significant step-forward in non-invasive imaging with 
potential implications for correctly stratifying and managing this high-risk group. 
2.6 Study limitations 
k-t BLAST adds complexity to the acquisition of perfusion data. In particular, the 
method is sensitive to respiratory motion and cardiac arrhythmia. In our study, 
respiratory artefacts affected 15% of high-resolution studies which is similar to 
previous studies (Plein et al., 2008b, 2008a). For this reason image quality and 
artefact scores for both techniques were similar, despite the significant reduction of 
dark rim artefact seen at high-resolution. Newer spatio-temporal undersampling 
methods for high-resolution acquisition are less susceptible to respiratory motion 
but were not available at the time of this study (Pedersen et al., 2009). Potentially 
these techniques could offer the demonstrated benefits of high-resolution 
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acquisition without the respiratory artefact trade-off - but this is yet to be 
investigated.  
This study was powered to detect a difference in overall diagnostic performance as 
defined by the AUC of ROC analysis, but not to compare individual sensitivity or 
specificity values in a dichotomous model as this would have required a very large 
sample size (Eng, 2003).  Such large comparative studies pose considerable logistic 
challenges and are unlikely to be conducted for incremental optimisations of an 
established imaging test such as perfusion CMR. The presented diagnostic accuracies 
must also be interpreted within the context of referral bias as all patients had been 
clinically preselected for coronary angiography. We also acknowledge that because 
transmural ischaemic index can only be assessed at a segmental level, data clustering 
may affect the analysis of its distribution - but as each patient contributed the same 
number of segments, the presented estimates remain valid.  
Finally, similar to the majority of previous perfusion CMR studies, another limitation 
was the use of X-ray coronary angiography to determine the presence of significant 
CAD as this only provides an anatomical rather than functional assessment of a 
coronary artery stenosis. However, X-ray coronary angiography remains the most 
widespread investigation in clinical-decision making and thus relates this study to 
real-world practice. 
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2.7 Conclusions 
This study showed that accelerated, high-resolution perfusion CMR imaging has 
higher diagnostic accuracy that standard-resolution acquisition for the detection of 
CAD in both single and multi-vessel disease. Dark rim artefact is reduced and the 
extent of multi-vessel disease is better identified at high-resolution. High-spatial-
resolution perfusion CMR may also provide an improved tool for identifying 
subendocardial ischaemia. 
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3 Study 2 - Assessment of Myocardial Ischaemic Burden 
in Angiographic Three-Vessel Coronary Artery Disease Using 
High-Resolution Perfusion CMR 
3.1 Abstract 
Aims: This study compared the myocardial ischaemic burden (MIB) in patients with 
angiographic three-vessel CAD (3VD) using high-resolution and standard-resolution 
perfusion CMR imaging. 
Methods: 105 patients undergoing coronary angiography had two separate 
stress/rest perfusion CMR studies, one with standard-resolution (2.5 mm in-plane) 
and one with high-resolution (1.6 mm in-plane). Quantitative coronary angiography 
(QCA) was used to define patients with angiographic 3VD. Perfusion CMR images 
were anonymised, randomly ordered and visually reported by 2 observers acting in 
consensus and blinded to all clinical and angiographic data. Perfusion was graded in 
each segment on a 4-point scale and summed to produce a perfusion score and 
estimate of MIB for each patient. 
Results: In patients with angiographic 3VD (n=35), high-resolution acquisition 
identified more abnormal segments (7.2 ± 3.8 vs. 5.3 ± 4.0; p=0.004) and territories 
(2.4 ± 0.9 vs. 1.6 ± 1.1; p=0.002) and a higher overall perfusion score (20.1 ± 7.7 vs. 
11.9±9.4; p<0.0001) per patient compared to standard-resolution. The number of 
segments with subendocardial ischaemia was greater with high-resolution 
acquisition (195 vs. 101; p<0.0001). Hypoperfusion in all three territories was 
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identified in 57% of 3VD patients by high-resolution compared to only 29% by 
standard-resolution (p=0.04). The area-under-curve (AUC) for detecting 
angiographic 3VD using the estimated MIB was significantly greater with high-
resolution than standard-resolution acquisition (AUC=0.90 vs. 0.69; p<0.0001).  
Conclusion: In patients with angiographic 3VD, the ischaemic burden detected by 
perfusion CMR was greater with high-resolution acquisition due to better detection 
of subendocardial ischaemia. High-resolution perfusion CMR may therefore be 
preferred for risk stratification and management of this high-risk patient group.  
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3.2 Introduction 
Three-vessel CAD (3VD) is found in approximately 9% of patients undergoing elective 
coronary angiography and these patients have a considerably poorer prognosis than 
those with less extensive disease (Emond et al., 1994). Detection of 3VD with non-
invasive imaging can be challenging due to the effects of balanced ischaemia leading 
to false-negative results in up to 20% of cases (Christian et al., 1992; Martin et al., 
1992). This limitation has been well-documented with SPECT, and although its 
overall sensitivity for detecting CAD in multi-vessel disease is 80-95%, it often only 
detects perfusion defects in one territory (Christian et al., 1992; Mahmarian et al., 
1990; DePasquale et al., 1988). In one SPECT study, inducible perfusion 
abnormalities in all three territories were identified in only 12% of patients with 
known angiographic 3VD (Chung et al., 2010).  
Myocardial perfusion imaging with CMR is a highly accurate method for the 
detection of significant CAD (Schwitter et al., 2008; Sakuma et al., 2005; Greenwood 
et al., 2012). One of the major advantages of perfusion CMR compared to SPECT is 
its higher spatial resolution (typically 2-3mm versus 8-10mm). Balanced ischaemia 
can lead to diffuse subendocardial hypoperfusion and although there are few 
comparisons between perfusion CMR and SPECT in 3VD, it is expected that the 
higher resolution of CMR can better resolve the transmural perfusion gradient in 
balanced ischaemia and thereby potentially improve the detection of 3VD (Bache & 
Schwartz, 1982). With recently developed spatio-temporal undersampling methods 
such as k-t BLAST, the spatial resolution of perfusion CMR can be improved further 
to under 2 mm (Tsao et al., 2003).  
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Several studies have demonstrated the feasibility and accuracy of high-resolution 
perfusion CMR (Plein et al., 2008a, 2008b; Manka et al., 2010; Lockie et al., 2011; 
Motwani et al., 2012a).  In a direct comparison, we have previously shown that high-
resolution perfusion CMR has a higher overall diagnostic accuracy compared to 
standard-resolution imaging in patients with suspected CAD. This previous study 
included a small subset of patients with multi-vessel disease (Motwani et al., 2012a). 
The present study aims to compare the distribution of and extent of ischaemia in 
patients with 3VD detected by both techniques and tests the hypothesis that 
improved performance of high resolution CMR is due to better detection of 
subendocardial ischaemia in 3VD.  
3.3 Methods 
 Study population 
One-hundred-and-five patients were included in this analysis. All had undergone 
coronary angiography for suspected angina within the last 30 days. Seventy patients 
were prospectively recruited; 35 had 3VD on quantitative coronary angiography and 
35 normal coronary arteries on angiography and served as a control group. Data 
from 24 of the patients with angiographic 3VD have been previously reported with 
different end-points (diagnostic accuracy rather than pattern of ischaemia or 
ischaemic burden) (16). Additionally, we selected 35 consecutive patients with 
angiographic 1VD or 2VD from this previous study to prevent a spectrum bias for the 
secondary analyses relating to myocardial ischaemic burden (Motwani et al., 2012a). 
Exclusion criteria for all patients were contra-indications to CMR, adenosine or 
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gadolinium; or a history of recent (within 6 months) myocardial infarction, unstable 
angina or revascularisation. Additionally, patients with angiographic 1VD or 2VD and 
co-existing moderate coronary artery stenoses (i.e. 40-69%) in other territories were 
not included. All patients gave written consent and the study was approved by the 
regional ethics committee.  
 CMR protocol 
All patients underwent a standard-resolution and a high-resolution perfusion scan 
on separate days (within 4 weeks) using a 1.5-T scanner (Intera, Philips Healthcare, 
Best, The Netherlands).  
The standard pulse sequence was a saturation recovery gradient-echo method 
accelerated with SENSE (acceleration factor 2, repetition time (TR) 2.7ms, echo time 
(TE) 1.0ms, flip-angle = 15o, acquisition time per slice = 136ms, single-saturation pre-
pulse per R-R interval shared over three slices, matrix=144 x 144, median field-of-
view (FOV) = 360 mm, in-plane spatial resolution = 2.5 mm). The high-resolution 
pulse sequence used a similar saturation recovery gradient-echo method, but was 
accelerated with k-t BLAST (acceleration factor 8 with 11 training profiles, TR = 
3.4ms, TE = 1.7ms, flip-angle = 15o, one saturation pre-pulse per slice, acquisition 
time per slice = 103ms, matrix=192x192, median FOV = 310 mm, in-plane spatial 
resolution = 1.6 mm). For both techniques, perfusion data were acquired in 3 short-
axis slices in each R-R interval. For both studies, stress perfusion started after 
4minutes of an intravenous adenosine infusion (140g/kg/min) during an intravenous 
bolus injection of dimeglumine gadopentetate (Magnevist; Schering AG, West 
Sussex, UK) and a 15mL saline flush delivered at 5mL/s. Contrast dose and 
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administration protocols for both studies were chosen to optimise their visual 
analysis performance based on experience with both pulse sequence and their use 
in previous studies. For the standard-resolution method, a contrast dose of 0.05 
mmol/kg body weight was used during perfusion acquisition, identical to previous 
studies with this pulse sequence (Greenwood et al., 2012; Motwani et al., 2012a). To 
compensate for the lower SNR associated with smaller voxel size, a contrast dose of 
0.1mmol/kg body weight was used for the high-resolution method, consistent with 
previous reports (Motwani et al., 2012a; Plein et al., 2008b, 2007; Manka et al., 
2010). 
Rest perfusion imaging was performed 15minutes later. LGE imaging was performed 
in all patients on their first visit using conventional methods (1.6mm in-plane spatial 
resolution) and a cumulative contrast dose of 0.2mmol/kg body weight (the same 
for both protocols). During standard-resolution perfusion CMR scans, this 
cumulative dose was achieved by administration of an additional contrast bolus of 
0.1mmol/kg body weight immediately after rest perfusion. 
 CMR analysis 
CMR images were anonymised, randomly ordered and visually reported by 2 
observers (S.P., M.M; 10 and 2 years experience respectively) acting in consensus 
and blinded to all clinical and angiographic data (QMASS 6.1.6, Medis, Leiden, The 
Netherlands). In case of disagreement, arbitration from a third observer was sought 
(JPG, 10 years experience). Using a 16-segment model, perfusion in a segment was 
considered abnormal if signal intensity was reduced compared with remote 
myocardium or an endocardial-to-epicardial perfusion gradient was present (Plein et 
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al., 2008a)(Cerqueira et al., 2002). Additionally, any perfusion defect was required 
to persist longer than the contrast first-pass to distinguish it from artefact. 
Corresponding LGE images were reviewed side-by-side with the perfusion data. 
Perfusion defects present at stress but not rest and occurring outside any 
hyperenhanced myocardial tissue on LGE images were considered as inducible 
defects. Perfusion in each segment was graded on a 4-point scale (transmural 
ischaemia index: 0 = normal, 1 = inconclusive, 2 = subendocardial defect, 3 = 
transmural defect). A typical example of perfusion images is seen in Figure 3.1. All 
segmental scores were summed to produce a perfusion score (0-48) for each patient. 
Myocardial ischaemic burden as a percentage of the total myocardium (MIB%) was 
estimated by dividing the perfusion score by 48 and multiplying by 100 
(Hachamovitch et al., 2003a). In patients with 3VD, perfusion scores were also 
calculated for the left anterior descending (LAD), left circumflex (LCX) and right 
coronary artery (RCA) territories according to AHA segmentation adjusted for arterial 
dominance (Cerqueira et al., 2002).  
Image quality was graded 1-4 (1 = unusable, 2 = poor, 3 = adequate, 4 = excellent). 
Occurrence of artefacts related to k-t reconstruction, respiratory motion, 
electrocardiographic gating, and endocardial dark rim was scored 0-3 (0 = none, 1 = 
minor, 2 = moderate, 3 = severe). Where present, the width of dark rim artefact (a 
frequent finding in perfusion CMR at the myocardial-blood pool interface relating to 
cardiac motion, Gibb’s ringing, susceptibility, and partial volume cancellation) was 
measured with electronic callipers (Motwani et al., 2012a; Di Bella et al., 2005).  
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Figure 3.1 Case Example: Standard vs. High-resolution Perfusion CMR 
Standard and high-resolution stress perfusion CMR in a patient with three-vessel coronary 
artery disease. Standard-resolution shows perfusion defects (arrows) in the basal-inferior 
(A), mid-inferior, mid-inferoseptal (B), apical-anterior and apical-inferior segments (C). High-
resolution shows a similar distribution of perfusion defects but demonstrates additional 
ischaemia in the basal-lateral (D), mid-anterior and mid-anterolateral segments (E) with a 
circumferential defect in the apical slice (F). Perfusion defects are also better delineated at 
high-resolution and the transmural extent of ischaemia more clearly seen. 
 
 Quantitative coronary angiography 
Quantitative coronary angiography (QCA) was performed (QCAPlus, Sanders Data 
Systems, Palo Alto, California, USA) by an experienced observer blinded to CMR data 
(M.M.; 7 years of experience in coronary angiography). Stenoses were assigned to 
the appropriate myocardial segments of an AHA 16-segment model using standard 
criteria adjusted for arterial dominance and lesion location (Patel et al., 2010; 
Cerqueira et al., 2002). As per convention, significant CAD was defined as luminal 
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stenosis ≥70% in any of the major epicardial coronary arteries or first-order branches 
≥2 mm. Angiographic 3VD was defined as stenosis ≥70% in all three coronary 
arteries; or the presence of ≥50% stenosis in the left main stem (LMS) with ≥70% in 
the RCA. Normal coronary arteries were defined as an absence of any stenosis ≥40%.  
Collateral circulation was graded according to the Rentrop classification (RC) 
depending on the angiographic findings of the occluded artery using the best 
injection: 0 = no collateral circulation; 1 = collateral filling of side branches without 
visualization of any epicardial segments; 2 = collateral partially filling the epicardial 
segment; 3 = collateral completely filling the epicardial segment (Rentrop et al., 
1985).  
 Statistical analysis  
Analysis was performed using SPSS 17.0 (SPSS, Chicago, IL, USA). Mean values were 
compared using paired Student t-tests. Ordinal data were compared using Chi-
square or Wilcoxon signed-rank tests as appropriate. Paired proportions were 
compared using McNemar’s exact test. The pattern of ischaemia determined by both 
techniques for patients with angiographic 3VD was compared using Cohen’s kappa 
statistic. MIB% was compared across 1VD, 2VD and 3VD groups using one-way 
analysis of variance and Tukey’s post-hoc test.  Receiver-operator characteristic 
(ROC) curve analyses were performed on summed perfusion scores for individual 
territories and on MIB% per patient.  Area-under-the-curve (AUC) for both imaging 
techniques were compared using methods described by DeLong and DeLong. All 
tests were two-tailed and p<0.05 was considered statistically significant. 
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Table 3-1 Patient Clinical Characteristics  
 
 
 Values are mean ±SD or n (%). aSignificant CAD defined as ≥70% QCA. 
Parameter Data (n=105) 
Age, yrs 68 ± 10 
Males 75 (71) 
Medical history  
    Hypertension 65 (62) 
    Hypercholesterolemia 62 (59) 
    Diabetes Mellitus 18 (17) 
    Smoking 43 (41) 
    Family history of CAD 39 (37) 
    Previous MI 14 (13) 
    Previous PCI 10 (9) 
    Atrial Fibrillation 1 (1) 
LV Ejection Fraction, % 55 ± 11 
Angiography findings a  
    No significant disease 35 (33) 
    One-vessel disease 25 (24) 
    Two-vessel disease 10 (9) 
    Three-vessel disease 35 (33) 
    LAD disease 51 (49) 
    LCX disease 50 (48) 
    RCA disease 49 (47) 
   Significant lesions per patient 1.4 ± 1.2 
   Total significant lesions  150 
   70-90% stenoses 109 (73) 
   90-99% stenoses 35 (23) 
   Chronic total occlusions 6 (4) 
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3.4 Results 
 Study population  
105 patients were enrolled in the study, including 35 with 3VD by QCA. Of these 35 
patients, 32 qualified as angiographic 3VD on the basis of significant stenoses in the 
proximal coronary segments; and no patients qualified as angiographic 3VD on the 
basis of distal coronary segment disease. Further demographics are given in Table 
3.1. All 14 patients with a clinical history of MI (but no additional patients) had 
evidence of hyperenhancement on LGE imaging. A chronic total occlusion (CTO) was 
seen in 6 patients (all in the group with prior MI) and 2 of these patients were in the 
3VD group. There were no patients with more than one CTO. In 2 cases of CTO 
(neither in the 3VD group) there was mild collateral flow (RC=2), but in the remaining 
4 cases there was no or minimal collateralization (RC 1).  
 Image quality and artefacts 
There was no significant difference in the haemodynamic stress response during 
standard and high-resolution imaging (rate-pressure-product, mmHg x beats/min: 
10251 ± 2321 vs. 10201 ± 2109; p=0.92). No images were graded as unusable and 
therefore there were no exclusions from the image analysis for either technique. 
Image quality (median score=3 for both; p=0.67) and artefact scores (median=0 for 
both; p=0.06) were similar for both standard and high-resolution imaging across the 
full spectrum of patients (n=105).  Dark rim artefact was significantly less frequent 
with high-resolution (7% vs. 26 %; p=0.03) and when it did occur, it was less marked 
than with standard-resolution (1.6 ± 0.2 vs. 3.2 ± 0.8 mm; p=0.004). Seven high-
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resolution data sets (10%) were affected by k-t reconstruction artefacts at stress 
and/or rest due to respiratory motion, but this did not affect myocardial contrast 
passage and generally occurred at the end of a breath hold. 
 Detection of 3VD pattern  
In patients with angiographic 3VD (n=35), perfusion defects in all three territories 
were detected in 29% of patients (10 of 35) by standard-resolution and in 57% of 
patients (20 of 35) by high-resolution imaging (p=0.04) (Figure 3.2). Overall, there 
was poor agreement between the two techniques in determining the pattern of 
ischaemia in patients with angiographic 3VD (kappa=0.09, 95% CI: -0.10 to 0.29) 
(Figure 3.2). 
 Detection of CAD in each territory  
In patients with angiographic 3VD (n=35), separate ROC analyses of perfusion scores 
for each of the 3 coronary territories were performed. The AUC for each territory in 
patients with angiographic 3VD was greater with high-resolution than with standard-
resolution imaging, but reached statistical significance only for the LCX territory 
(Table 3.2). With standard-resolution imaging, diagnostic accuracy was significantly 
lower for the LCX than for the LAD (0.62 vs. 0.82; p< 0.01) or RCA territory (0.62 vs. 
0.83; p=0.02).  With high-resolution, diagnostic accuracies were more homogenous 
between territories (although still lowest in the LCX territory) with no statistical 
difference between them (LAD: 0.85 vs. LCX: 0.83 vs. RCA: 0.90; all p values>0.05). 
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Figure 3.2 Distribution of Ischaemia Detected by Perfusion CMR  
(A) In patients with 3VD (n=35), hypoperfusion in all three territories was detected in 57% using high-
resolution imaging but in only 29% using standard-resolution (p=0.04). (B) There was also poor 
agreement between high-resolution and standard-resolution imaging in determining the distribution 
of ischaemia in patients with 3VD (kappa=0.09, 95% CI: -0.10-0.29). IT = ischaemic territories. 
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Table 3-2 Diagnostic Performance of Perfusion CMR in Each Territory in Patients 
with 3VD 
 
 
 
 
 
 Detection of subendocardial ischaemia 
560 myocardial segments were available from the 35 patients with angiographic 
3VD. Of these, 420 were determined as angiographically hypoperfused and used for 
further analysis.  With high-resolution acquisition, significantly more of these 
hypoperfused segments were determined as having subendocardial ischaemia than 
with standard-resolution (195 vs. 101; p<0.0001); and there was a significant 
reduction in the number of segments determined as being normal (135 vs. 212; 
p<0.001) or inconclusive (15 vs. 40; p<0.001).  The number of segments assessed as 
having transmural ischaemia was similar with both techniques (75 vs. 67; p=0.25) 
(Figure 3.3). 
Area Under ROC Curve (95% CI) 
 Standard Resolution High Resolution P value 
LAD 0.82  (0.69-0.95) 0.85 (0.73-0.97) 0.62 
LCX 0.62  (0.46-0.79) 0.83 (0.70-0.95) 0.02 
RCA 0.83  (0.70-0.95) 0.90 (0.80-1.00) 0.27 
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 Detection of ischaemic burden 
In patients with angiographic 3VD (n=35), the overall extent of myocardial ischaemia 
detected was significantly greater with high-resolution than standard-resolution 
imaging, with more abnormal segments per patient (7.2 ± 3.8 vs. 5.3 ± 4.0; p=0.004), 
more abnormal territories per patient (2.4 ± 0.9 vs. 1.6 ± 1.1; p=0.002), a higher 
perfusion score per territory (5.9 ± 4.3 vs. 4.7 ± 5.0; p=0.01) and a higher overall 
perfusion score per patient (20.1 ± 7.7 vs. 11.9 ± 9.4; p<0.0001) (Figure 3.1, Table 
3.3).  
Figure 3.3 Distribution of Transmural Ischaemia Index  
In patients with three-vessel disease (n=35), high-resolution perfusion CMR determined 
significantly more segments as having subendocardial ischaemia and fewer as normal or 
inconclusive compared with standard-resolution imaging.  
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Table 3-3 Ischaemic Burden Using Perfusion CMR in Patients with 3VD  
 
 
When the full spectrum of 105 patients were assessed, high-resolution found a 
significant upward trend in estimated MIB% in those with significant CAD (n=70) 
across advancing disease groups (1VD: 12 ± 7% vs. 2VD: 39 ± 15% vs. 3VD: 42 ± 16%; 
p<0.0001)(Motwani et al., 2012a). However, with standard-resolution, there was no 
discriminate difference in estimated MIB% across the disease groups (1VD: 21 ± 11% 
vs. 2VD: 25 ± 6% vs. 3VD: 25 ± 19%; p=0.53) (Figure 3.4).  
Accordingly, on ROC analysis, the AUC for detecting angiographic 3VD using the 
estimated MIB% was significantly greater with high-resolution (AUC=0.90, 95% CI: 
0.84-0.96) than standard-resolution (AUC=0.69, 95% CI: 0.62-0.76; p<0.0001) (Figure 
3.5). For high-resolution the optimal MIB% threshold to detect angiographic 3VD was 
31% which resulted in a sensitivity and specificity of 80% (95% CI: 64-90%) and 90% 
(95% CI: 80-95%) respectively. For standard-resolution, the optimal threshold was 
23%, which resulted in a sensitivity and specificity of 51% (95% CI: 36-67%) and 78% 
(95% CI: 66-86%), respectively (Figure 3.5). 
 Standard-resolution High-resolution P value 
Mean abnormal segments per patient  5.3 ± 4.0 7.2 ± 3.8 0.004 
Mean abnormal territories per patient  1.6 ± 1.0 2.4 ± 0.9 0.002 
Mean perfusion score per patient  11.9 ± 9.4 20.1 ± 7.7 <0.0001 
Mean perfusion score per territory  4.7 ± 5.0 5.9 ± 4.3 0.01 
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Figure 3.4 MIB: Standard-resolution vs High-resolution Perfusion CMR  
 In patients with significant coronary artery disease (n=70), high-resolution perfusion CMR 
was able to detect significant differences in myocardial ischaemic burden (MIB) across 
disease categories unlike standard-resolution imaging (error bars=SEM).  
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3.5 Discussion  
This study shows that in patients with angiographic 3VD, high-resolution perfusion 
CMR detects a greater ischaemic burden than standard-resolution and more 
frequently identifies a 3VD pattern of ischaemia due to a higher detection rate of 
subendocardial ischaemia. 
Figure 3.5 Diagnostic accuracy of MIB to detect 3VD 
(B) The area under curve (AUC) for detecting 3VD using MIB amongst patients with 
suspected angina (n=105) was significantly greater with high-resolution than standard-
resolution (AUC= 0.90 vs.0.69; p<0.0001).VD= vessel disease.  
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The evidence for using perfusion CMR in patients with 3VD is limited. Although 
previous studies evaluating perfusion CMR have included patients with 3VD, they 
have rarely reported separate results for this specific patient population. In the 
published data, the incidence of patients with 3VD was only 2% (2 patients) in the 
study by Sakuma et al, 15% (8 patients) in the study by Ishida et al, and 19% (7 
patients) in the study by Schwitter et al (2005; 2003; 2001).  Although other studies 
may contain larger numbers, patients with 3VD are rarely analysed separately and 
they are usually grouped together with patients found to have 2VD (Schwitter et al., 
2008; Greenwood et al., 2012; Schwitter et al., 2013). Only one study to date has 
been specifically designed to evaluate standard-resolution perfusion CMR in patients 
with 3VD (n=78) and it demonstrated a sensitivity of 85% for CAD detection and 
superiority of perfusion CMR compared with SPECT (Chung et al., 2010). Data on the 
use of high-resolution perfusion CMR in the specific 3VD population is even scarcer. 
However, in a recent related analysis, we reported on 38 patients with angiographic 
multi-vessel disease (24 had 3VD) and found a greater diagnostic accuracy for the 
detection of CAD (any perfusion defect) with high-resolution perfusion CMR 
compared to standard-resolution imaging (AUC, 0.98 vs.0.91; p<0.002); but the 
pattern of perfusion defects detected and the ischaemic burden were not assessed 
(Motwani et al., 2012a). 
 Detection of subendocardial ischaemia 
The finding in the present study that high-resolution acquisition identified 
significantly more ischaemic segments and in particular more segments with 
subendocardial ischaemia in angiographic 3VD is consistent with the expected 
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improvement in subendocardial definition with higher spatial resolution. Although 
we have previously demonstrated this finding across the full spectrum of CAD, it was 
important to confirm that this advantage is maintained in the 3VD population, 
against the competing challenge of balanced ischaemia (Motwani et al., 2012a). It 
means that one of the major limitations of myocardial perfusion imaging and visual 
analysis in 3VD i.e. its dependence on a reference area of normal perfusion, can be 
overcome to some extent with high-resolution techniques that are able to resolve 
subendocardial ischaemia and transmural perfusion gradients, reducing the need for 
intra-patient comparison. An alternative approach is quantitative analysis of 
standard perfusion CMR and although this has been shown to identify patients with 
3VD better than visual analysis, it remains a time-consuming research tool until 
technical developments lead to greater automation (Patel et al., 2010). The 
significant reduction of dark rim artefact with high-resolution may also partially 
account for its improved detection of subendocardial ischaemia and notably there 
were fewer inconclusive segments with high-resolution acquisition compared to 
standard-resolution (Figure 3.3). Previous work investigating dark rim artefact has 
shown the prominent role of spatial resolution on the occurrence and extent of this 
artefact (Plein et al., 2007; Di Bella et al., 2005). 
 Detection of 3VD pattern  
Standard-resolution perfusion CMR identified defects in all three perfusion 
territories in only 29% of patients with angiographic 3VD (10 of 35) (Figure 3.2). In 
the published CMR literature there is only one study that investigates the same 
question and it found a significantly greater figure of over 50% using standard-
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resolution techniques (Chung et al., 2010). However, this previous retrospective 
study only analysed patients with 3VD, without a control group; and additionally did 
not use LGE imaging to exclude areas of infarction from inducible ischaemia, both of 
which are likely to have led to a positive bias. In the comparative SPECT literature, 
we see the ability to detect a 3VD pattern is similarly only 29% in one series and as 
low as 12% in another (Christian et al., 1992; Chung et al., 2010).  
With the high-resolution perfusion CMR method, twice as many patients with 
angiographic 3VD i.e. 57% (20 of 35) were correctly classified as having a 3VD pattern 
of ischaemia (Figure 3.2). The improved detection of a 3VD pattern of ischaemia with 
high-resolution compared to standard–resolution acquisition was due to better 
detection of ischaemia in the LCX territory and more subendocardial ischaemia 
detection. Disease of the LCX territory can be difficult to detect because this territory 
is farthest from the radiofrequency coil and because visual, unlike quantitative 
assessment analysis, cannot correct signal intensity for distance from the coil (Cheng 
et al., 2007; Chung et al., 2010). In keeping with previous studies, high-resolution 
acquisition used a higher contrast dose (in order to compensate for the lower SNR 
associated with smaller voxel size) and arguably this may have contributed to its 
superior performance in the LCX territory (Motwani et al., 2012a; Plein et al., 2008b, 
2007; Manka et al., 2010). 
Rather than inadequacy of the perfusion analysis, the low detection rate of 
ischaemia in multiple territories by different imaging modalities may reflect at least 
in part the inadequacy of the angiographic endpoint in these studies including our 
own. In a sub-analysis of the FAME study, only 14% of patients with angiographic 
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3VD (n=115), had concordant 3-vessel functional disease determined by fractional 
flow reserve (FFR) (i.e. FFR<0.80 in all 3 vessels)(Tonino et al., 2010).  
 Estimation of ischaemic burden 
It can be argued that in clinical practice, it is less relevant whether a functional scan 
depicts a typical three-vessel pattern if there is myocardial ischaemia involving a 
significant proportion of total myocardium. An accurate assessment of ischaemic 
burden is important because the extent of ischaemia is a marker of patient prognosis 
– and a large ischaemic burden supports aggressive medical treatment and 
angiography with a view to revascularization regardless of the territorial pattern of 
perfusion defect (Hachamovitch et al., 1998, 2003a; Wijns et al., 2010; Shaw et al., 
2008).  When MIB% was estimated using high-resolution CMR, it was found to 
reliably discriminate angiographic 3VD from less extensive disease and normal 
controls (AUC=0.89) (Figure 3.5). This was not the case for standard-resolution CMR, 
for which MIB% had a significantly poorer diagnostic accuracy (AUC=0.69; p<0.0001) 
and was not able to reliably differentiate between patients with 1VD, 2VD or 3VD 
(Figure 3.4).  The latter observation regarding standard-resolution perfusion CMR, 
has been previously noted by Patel et al who found similar estimates of ischaemic 
burden in patients with angiographic single-vessel disease and 3VD with visual 
assessment (21% vs. 31%; p=0.26); but a significant difference if quantified with 
myocardial perfusion reserve analysis (25% vs. 60%; p=0.02)(Patel et al., 2010). A 
similar phenomenon has been described with PET (Parkash et al., 2004). The higher 
spatial resolution of k-t BLAST perfusion CMR acquisition appears to overcome this 
limitation seen with lower spatial resolution imaging methods.  
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Although there is no agreed reference standard for MIB% the current data suggest 
that standard-resolution imaging underestimates MIB% - and this should be 
considered in the interpretation of future perfusion CMR studies that may use a 
particular threshold of ischaemic burden as a defined end-point or inclusion criteria. 
In the nuclear sub-study of COURAGE, patients with a MIB% >10% had a lower risk 
of death or MI if they underwent revascularization rather than optimal medical 
therapy alone (Shaw et al., 2008). Notably, there has been no direct comparison of 
CMR and SPECT for MIB% assessment - but if the threshold defined for SPECT is 
applied to the CMR data in this study, 24 of 35 patients with angiographic 3VD had a 
MIB% >10% using standard-resolution perfusion CMR, compared to 33 patients with 
the high-resolution technique. Thus, high-resolution perfusion CMR may offer an 
improved non-invasive assessment of ischaemic burden and help identify the 
optimal therapeutic approach. 
3.6 Study Limitations 
We accept our findings are mainly technical and further studies with clinical outcome 
data would be required to support the proposed incremental value of high-
resolution perfusion CMR. We also accept that although we hypothesise the superior 
performance of high-resolution perfusion CMR relates to greater spatial resolution 
and better detection of subendocardial ischaemia, we cannot exclude the influence 
of other factors such as differences in SNR between scans and the difference in 
contrast protocols used as compensation.  
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A functional endpoint such as FFR would have been preferable - but this is not easily 
achievable given the logistics of performing multiple FFR assessments on serial and 
complex stenoses in three diffusely diseased arteries to define each subject. 
However, our findings predominantly relate to comparative differences in ischaemic 
burden assessment between the two techniques rather than their absolute ability to 
detect any ischaemia.  
Because the visual CMR analysis was performed by two observers acting in 
consensus, inter-observer and intra-observer variability for perfusion scoring were 
not tested; however, arbitration from a third reader was only required in 5 out of 
the 210 analyses (3 with standard and 2 with high-resolution). 
Finally, quantitative methods for the estimation of MBF based on perfusion CMR 
data have been validated in animal models and applied to clinical studies(Patel et al., 
2010). However, in this study, contrast agent dose and administration (single-bolus 
technique) were optimised for visual analysis and therefore quantitative analysis was 
not performed. Although, high-resolution perfusion CMR offers further intriguing 
opportunities for quantitative analysis such as quantitation of transmural perfusion 
gradients, the algorithms applied for the reconstruction of high-resolution perfusion 
CMR data acquired with temporo-spatial undersampling methods give rise to a 
degree of low-pass temporal filtering, posing additional challenges to quantitation 
of MBF including an underestimation bias (Hautvast et al., 2011; Jerosch-Herold, 
2010). Recent developments such as k-t Principal Component Analysis are likely to 
overcome some of these challenges but will require evaluation in future studies 
(Pedersen et al., 2009). 
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3.7 Conclusions 
High-resolution perfusion CMR increases the observed ischaemic burden and 
distribution of ischaemia detected in angiographic 3VD. The incremental value of 
high-resolution acquisition for correctly identifying, stratifying and management of 
this high-risk group has to be determined in further clinical studies. 
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4 Study 3 - Three-Dimensional versus High-Resolution 
Perfusion CMR: A Pilot Study Comparing Myocardial 
Ischaemic Burden Estimates 
 
4.1 Abstract 
Background: Typically, myocardial perfusion imaging with 2-dimensional (2D) 
cardiovascular magnetic resonance (CMR) acquires data in 3-4 myocardial slices at 
a spatial resolution of 2-3mm.  However, accelerated data acquisition can facilitate 
higher spatial resolution (<2mm) or 3D whole-heart coverage (up to 16 slices). This 
study aims to compare image quality, diagnostic confidence and quantitation of 
myocardial ischemic burden (MIB) between 2D high-resolution and 3D whole-heart 
perfusion CMR. 
Methods and results: 27 patients with stable angina underwent both high-resolution 
2D and whole-heart 3D perfusion CMR. Total perfusion defect (TPD) and total scar 
burden (TSB) areas were contoured and expressed as percentage myocardium. MIB 
was calculated by subtracting TSB from TPD. Image quality, artefact and diagnostic 
confidence scores were similar for both techniques (p>0.05). The mean MIB from 
high-resolution and 3D acquisition was similar (4.3 ± 5.2% vs 4.1 ± 4.9%; p=0.81), 
with a strong correlation between techniques (r = 0.72; p<0.001). There was no 
systematic bias for estimates of MIB between techniques (mean bias = -0.17%, 95% 
CI:-1.7 to 1.3%) and the 95% limits of agreement were -7.5% to 7.2%. When used to 
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categorize MIB as >10% or <10%, there was only fair agreement between the two 
techniques (kappa = 0.29, 95% CI: -0.12-0.70). 
Conclusions: There is strong correlation and broad agreement between estimates 
of MIB from both techniques. However, the 95% limits of agreement are relatively 
wide and therefore a larger comparative study is needed before they can be 
considered interchangeable - particularly around the clinically relevant 10% 
threshold. 
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4.2 Introduction 
Myocardial perfusion imaging with CMR is a highly accurate method for diagnosing 
CAD, but its role in quantifying myocardial ischaemic burden (MIB) is less certain 
(Greenwood et al., 2012; Hamon et al., 2010). The lack of complete myocardial 
coverage with standard 2D perfusion CMR (3-4 short axis slices only) means that any 
assessment of MIB is an extrapolation. MIB measured by SPECT, which has the 
advantage of whole-heart coverage, has been shown to be an important prognostic 
marker and can help identify patients most likely to benefit from revascularisation 
compared to medical therapy alone (Hachamovitch et al., 1998; Shaw et al., 2008). 
However, the introduction of accelerated data acquisition using spatio-temporal 
undersampling methods, has led to the option of 3D whole-heart perfusion CMR,  or 
alternatively 2D perfusion CMR with higher spatial resolution (<2mm) (Motwani et 
al., 2013). Potentially, 3D perfusion CMR presents a direct alternative to SPECT for 
the measurement of MIB - without any inter-slice assumptions (Jogiya et al., 2014). 
On the other hand, higher spatial resolution acquisition has been shown to have 
several other benefits such as reduced dark rim artefact, greater detection of 
subendocardial ischaemia and particular diagnostic strength in patients with multi-
vessel disease (Plein et al., 2008a; Manka et al., 2010; Motwani et al., 2012a, 2014a). 
Although both of these methods have been shown to have high diagnostic accuracy 
and have been validated against FFR, it is not known how their estimates of MIB 
compare (Lockie et al., 2011; Jogiya et al., 2012; Manka et al., 2012). The decision 
whether to invest acceleration into 3D coverage for the purpose of MIB assessment, 
or into higher spatial resolution, partly depends on the question of whether MIB 
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estimates differ between the two methods. Therefore, this pilot study directly 
compares image quality, diagnostic confidence and quantification of MIB between 
2D high-resolution and 3D whole-heart perfusion CMR. 
4.3 Methods 
 Patient Population  
Thirty patients with stable angina and scheduled for coronary angiography on a 
clinical basis were recruited to undergo both a high-resolution 2D and a 3D perfusion 
CMR scan on two separate days within 8 weeks. The order of methods was randomly 
chosen. No coronary intervention or clinical events occurred between the two scans. 
The presence or absence of significant CAD in patients was defined by quantitative 
coronary angiography (QCA) as detailed below. Exclusion criteria were contra-
indications to CMR, adenosine or gadolinium contrast agents; a history of recent 
(within 6 months) myocardial infarction or unstable angina; or poorly controlled 
arrhythmias. Patients were instructed to refrain from caffeine for 24hrs prior to their 
CMR study but continue cardiac medications as normal. All patients gave written 
consent to participate and the study was approved by the regional ethics committee. 
 CMR Protocol  
All studies were performed on a 3.0T scanner (Achieva TX, Philips Healthcare, Best, 
The Netherlands) equipped with dual-source parallel radiofrequency transmission 
technology and a 32-channel cardiac receiver coil. 
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High-resolution and 3D perfusion CMR acquisitions used the optimal imaging 
parameters derived from previously published studies (Motwani et al., 2012a; Jogiya 
et al., 2012; Manka et al., 2012, 2011). For high-resolution perfusion imaging, a 
spoiled saturation recovery fast gradient echo sequence was used  (TR/TE/flip angle: 
2.7ms/1.0ms/20°; saturation pre-pulse delay 120ms, 1 saturation prepulse per slice, 
image acquisition time per slice 134ms; no partial Fourier or partial echo acquisition; 
typical field of view 340 x340 mm; 5 fold k-t BLAST [broad-use linear acquisition 
speed-up technique] acceleration with 11 interleaved training profiles; 3 short-axis 
slices [basal, mid ventricle and apical] with 10mm thickness and 1.2 x 1.2mm 
acquired in-plane spatial resolution). For 3D perfusion imaging, a spoiled fast 
saturation recovery gradient-echo sequence was used (TR/TE/flip angle 
1.8ms/0.7ms/15°; saturation prepulse delay 150ms; linear k-space encoding; 70% 
partial Fourier acquisition in two dimensions; typical field of view 350 x 350mm; 10 
fold k-t acceleration and 11 training profiles leading to a net acceleration of 7.0; 
typical acquisition duration 192ms, k-t BLAST reconstruction; reconstructed to 12 
contiguous short-axis slices with voxel size 2.3 x 2.3 x 5mm3). Stress perfusion images 
were acquired during intravenous adenosine-induced hyperaemia administered for 
4min at 140mcg/kg/min. Consistent with previous k-t BLAST facilitated perfusion 
CMR studies, an intravenous bolus of 0.075mmol/kg of gadobutrol (Gadovist, Bayer 
Schering Pharma, Berlin, Germany) was administered at a rate of 4.0ml/s followed 
by a 20ml saline flush. Stress perfusion CMR was followed by cine imaging covering 
the left ventricle in 10-12 short-axis sections. Rest perfusion CMR was performed 
15min after stress, using identical imaging parameters. Late gadolinium 
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enhancement (LGE) imaging was performed in all patients on their first visit only, 
after an additional 10-15min using a 2D T1 weighted segmented inversion recovery 
gradient echo method (TR/TE/flip angle 4.9ms/1.9ms/15°; inversion time 
individually adjusted according to Look-Locker scan; spatial resolution 1.35 x 1.35 x 
10 mm; contiguous short-axis slices to cover LV). Case examples of both acquisitions 
are shown in Figures 1.10-1.13 and Figure 4.1. 
 CMR Analysis 
4.3.3.1 Visual Analysis 
Perfusion CMR images were anonymised, randomly ordered and visually reported 
by 2 observers (SP, AKM; >10yrs and 2yrs experience respectively) (Qmass MR 7.5, 
Medis, Leiden, The Netherlands). The presence or absence of a perfusion defect was 
recorded by both observers acting independently. In case of disagreement, 
arbitration from a third observer was sought (JPG, >10yrs experience). A perfusion 
defect was defined as an area of reduced signal intensity on stress perfusion images 
compared to remote myocardium or the presence of an endocardial-to-epicardial 
perfusion gradient(Plein et al., 2008a). Additionally, any perfusion defect was 
required to persist longer than the contrast first-pass to distinguish it from artefact. 
Corresponding LGE images were reviewed side-by-side with the perfusion data. 
Perfusion defects present at stress but not rest and occurring outside any hyper-
enhanced myocardial tissue on LGE images were considered as inducible defects 
(ischaemia)(Motwani et al., 2012a).  Image quality and diagnostic confidence were 
graded by both observers in consensus. Image quality was graded 0 to 3 (0 = un-
interpretable, 1 = poor, 2 = adequate, 3 = high). Occurrence of artefacts related to k-
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t reconstruction, respiratory motion, electrocardiographic gating, and endocardial 
dark rim artefact was scored between 0 and 3 (0 = none, 1 = minor, 2 = moderate, 3 
= severe).  Using the AHA 16 segment model, diagnostic confidence was recorded 
for each perfusion territory (0 = uncertain, 1 = low confidence, 2 = high 
confidence)(Cerqueira et al., 2002) .  
4.3.3.2 Myocardial Ischaemic Burden 
For both high-resolution and 3D acquisitions, the total perfusion defect (TPD) as 
percentage myocardium was determined by dividing the area of any perfusion 
defect by the area of total myocardium (both contoured on stress perfusion images) 
and multiplying by 100.  All perfusion defects were contoured by an experienced 
observer (AKM, 2yrs experience) at the frame of maximal myocardial signal intensity 
determined by a region of interest drawn in remote myocardium. Contiguous 
perfusion defects across different perfusion territories were contoured as a whole; 
non-contiguous perfusion defects were contoured separately and summed. Total 
scar burden (TSB) in percentage myocardium was determined by dividing the total 
area of any hyperenhancement by the area of total myocardium (both contoured on 
LGE images) and multiplying by 100. Myocardial hyperenhancement for LGE images 
were defined as areas with signal intensity ≥2 SD above the mean signal intensity of 
remote myocardium(Kidambi et al., 2013). For each acquisition, MIB as percentage 
myocardium was calculated as by subtracting TSB from TPD.  Any negative values for 
MIB were normalised to zero (i.e. no ischaemia). To determine the reproducibility of 
MIB assessment, the analysis was repeated in 10 randomly selected patients 1 
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month later by the same observer (AKM), and  by a second observer (DPR, >3 years 
of experience) blinded to the results of all previous analyses.   
 Quantitative coronary angiography 
Quantitative coronary angiography (QCA) was performed (QCAPlus, Sanders Data 
Systems, Palo Alto, CA, USA) on all anonymised X-ray angiography images (M.M. 8 
years experience in coronary angiography). Significant CAD was defined 
angiographically as luminal stenosis ≥70% diameter in any of the main epicardial 
coronary arteries or their branches with a diameter of ≥2mm. 
 Statistical Analysis 
Analysis was performed using SPSS version 21.0 (SPSS Inc, Chicago, Illinosis, USA). All 
data are presented as mean ± SD unless otherwise stated. Group means were 
compared using paired Student t-tests. Ordinal data were compared using the 
Wilcoxon signed-rank test. Linear correlations were assessed using Pearson 
correlation coefficients. All statistical tests were 2-tailed and a p value <0.05 was 
considered significant. Agreement between high-resolution and 3D perfusion CMR 
measurements for TPD and MIB were was assessed using Bland-Altman analysis; and 
the degree of agreement was determined as mean absolute difference (bias) ± 2 SDs 
of the mean difference (95% limits of agreement). The categorisation of MIB as < 
10% or >10% by both techniques was compared using Cohen’s kappa statistic. To 
assess reproducibility, the coefficients of variation (CoV) for intra- and inter-observer 
measurements were calculated. 
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Figure 4.1 3D versus High-resolution Perfusion CMR – Case 5 
A 45-year-old man with previous PCI to the LAD presented with significant angina. The top panel shows 
3D perfusion CMR (12 slices) at stress; the middle panel shows LGE imaging; and the bottom panel shows 
2D high-resolution (1.1 mm in-plane) perfusion CMR at stress, all performed at 3.0 T. 3D perfusion CMR 
shows stress-induced hypoperfusion throughout the anterior wall from base to apex, well beyond the 
area of scar seen in the mid-anterior wall on LGE imaging (solid arrows = scar; dashed arrows = ischaemia 
beyond scar). The 3-slice 2D high-resolution technique did not demonstrate any significant ischaemia 
beyond the established scar in the mid-ventricle. X-ray angiography confirmed a subtotal occlusion of a 
large diagonal branch, accounting for the anterior ischaemia.  
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4.4 Results 
 Study population  
Of the 30 recruited patients, 28 completed both perfusion CMR acquisitions (2 
patients did not return for a second scan due to claustrophobia). Data from one 
patient was excluded due to a mistimed contrast injection during their high-
resolution perfusion acquisition. Therefore, paired perfusion CMR scan data from 27 
patients were available for the final analysis. All of these 27 patients underwent 
coronary angiography within 6 weeks of their second CMR scan (8 patients before 
CMR; and 19 patients after CMR), and all had evidence of significant CAD as defined 
by QCA. Further clinical details of the 27 patients are summarised in Table 4.1. The 
mean interval between perfusion CMR scans was 17 ± 38 days. There was no 
significant difference in the haemodynamic stress response during 2D high-
resolution and 3D whole-heart perfusion CMR imaging (rate–pressure product, 
mmHg × beats/min: 10274 ± 2246 vs. 10219 ± 2259; p=0.89). 
 Diagnostic Confidence and Image Quality 
No images were graded as unusable and therefore there were no further exclusions 
from the image analysis for either technique. Image quality (median score = 2 for 
both; p=0.52) and artefact scores (median = 1 for both; p=0.87) were similar for both 
techniques. Diagnostic confidence was high for both techniques in all three perfusion 
territories (all median scores = 2; all p values between methods were > 0.05). 
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Table 4-1 Patient Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCS = Canadian Cardiovascular Society Angina Grading Scale; LV = left ventricular; EDV= 
end-diastolic volume; ESV = end-systolic volume; EF = ejection fraction; CAD = coronary 
artery disease (defined as stenosis ≥70%); VD = vessel disease 
  
Parameter Data (n=27) 
Age (yrs ± SD) 64 ± 11 
Sex, n (%)  
    Male 23 (85) 
    Female 4 (15) 
Clinical history, n (%)  
    Hypertension 11 (41) 
    Hypercholesterolemia 15 (56) 
    Diabetes Mellitus 4 (15) 
    Smoking 9 (33) 
    Previous MI 16 (59) 
    Previous PCI 8 (30) 
CCS Angina Scale, n (%)   
No angina or atypical symptoms 1 (4) 
Class 1 11 (41) 
Class 2  11 (41) 
Class 3 4 (15) 
Class 4 0 (0) 
CMR Imaging data  
LV EDVi (ml/m2) 90 ± 21 
LV ESVi (ml/m2) 40 ± 14 
LV SVi (ml/m2) 49 ± 10 
LV mass index (g) 48 ± 11 
LV EF (%) 54 ± 8 
Angiographic data  
No significant CAD 0 (0) 
1VD 17 (63) 
2VD 5 (19) 
3VD 5(19) 
  
LAD disease 19(70)  
LCX disease 11 (41)  
RCA disease 12 (44)  
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 Total Perfusion Defect 
All 27 patients (100%) were found to have perfusion defects by both observers. TPD 
by 2D high-resolution and 3D whole-heart acquisition showed strong positive 
correlation (r= 0.75; p<0.001) and there was no significant difference in mean TPD 
values (9.1 ± 5.7% vs 7.8 ± 5.8% respectively; p=0.12). There was no systematic bias 
for estimates of TPD between techniques (mean bias = -1.26%, bias 95% CI:-2.8 to 
0.4%) and the 95% limits of agreement were -9.3% to 6.8% (Figure 4.2). 
 Myocardial Ischaemic Burden 
MIB by 2D high-resolution and 3D whole-heart acquisition showed strong positive 
correlation (r = 0.72; p<0.001) and there was no significant difference in mean MIB 
values (4.3 ± 5.2% vs 4.1 ± 4.9% respectively; p = 0.81) (Figure 4.3). There was no 
systematic bias for estimates of MIB between techniques (mean bias = -0.17%, bias 
95% CI:-1.7 to 1.3%) and the 95% limits of agreement were -7.5% to 7.2% (Figure 
4.4). 
Out of the 27 patients, MIB was found to be >10% by both methods in 3 patients; 
and <10% by both methods in 17 patients (including 4 patients with an MIB of 0% by 
both methods).  In 7 of the 27 patients the two methods disagreed at the 10% 
threshold:  in 3 patients, the high-resolution method estimated MIB as > 10% but 3D 
acquisition estimated it as <10% (MIB difference = 4.1 ± 2.6%); and in 4 patients, the 
high-resolution method estimated MIB as <10% but 3D acquisition estimated it > 
10% (MIB difference = 9.3 ± 1.2%). Overall, when used to categorise MIB as >10% or 
<10%, there was only fair agreement between the two techniques (kappa = 0.29, 
95% CI: -0.12-0.70) (Figure 4.3).  
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All 16 patients with a prior history of MI had evidence of hyperenhancement on LGE 
imaging. There were no cases of LGE hyperenhancement without a clinical history of 
MI. In 8 out of the 16 patients (50%) with prior MI, a negative MIB value was 
determined with both 2D and 3D methods (normalized to zero for subsequent 
agreement analyses). There were no cases where only one of the techniques 
determined a negative MIB value.  
After categorising patients into prior MI (n=16) or no MI (n=11), there were no 
significant differences in mean MIB values between 2D and 3D methods for either 
group (MI: 1.9 ± 3.9% vs 1.4 ± 3.3%, p = 0.55; No MI: 8.4 ± 4.7% vs 8.6 ± 3.7%, p = 
0.93). Similarly, there was no systematic bias for estimates of MIB between 
techniques for either the MI group (mean bias = -0.41%, bias 95% CI:-1.8 to 1.0%, 
95% limits of agreement: -5.7% to 5.0%) or the no MI group (mean bias = 0.23%, bias 
95% CI:-3.5 to 4.0%, 95% limits of agreement: -10.0% to 10.5%). 
 Reproducibility 
The intra-observer CoV for MIB estimates from high-resolution and 3D perfusion 
CMR were 9% and 12% respectively. Corresponding CoV for inter-observer 
reproducibility were 14% and 15%, respectively.  
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Figure 4.2 TPD (%): 2D High-resolution vs. 3D Perfusion CMR  
The Bland-Altman plot shows no systematic bias for estimates of TPD between 2D high-
resolution and 3D techniques (mean bias = -1.26%, bias 95% CI:-2.8 to 0.4%) and the 95% limits 
of agreement were -9.3% to 6.8%.  TPD = total perfusion defect as percentage myocardium 
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Figure 4.3 Correlation between High-resolution and 3D estimates of MIB 
There was strong positive correlation between estimates of MIB from high-resolution 2D 
perfusion CMR and from 3D perfusion CMR (r = 0.72; p<0.001). The dotted line indicates 
the 10% MIB threshold. MIB = myocardial ischaemic burden 
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Figure 4.4 MIB (%): 2D High-resolution vs. 3D Perfusion CMR 
The Bland-Altman plot shows no systematic bias for estimates of MIB between 2D high-
resolution and 3D perfusion CMR techniques (mean bias = -0.17%, bias 95% CI: -1.7 to 
1.3%) and the 95% limits of agreement were -7.5% to 7.2%. MIB = myocardial ischaemic 
burden as percentage myocardium 
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4.5 Discussion 
The main findings of this study are: 1) image quality and diagnostic confidence scores 
are similar for both 2D high-resolution and 3D whole-heart perfusion CMR; and 2) 
although there is strong correlation and broad agreement between estimates of MIB 
from both techniques, the 95% limits of agreement are relatively wide and therefore 
a larger comparative study is needed before they can be considered interchangeable 
- particularly when categorising MIB as either side of 10%. 
An accurate assessment of MIB is important because the extent of ischaemia is a 
marker of patient prognosis. In the nuclear imaging sub-study of COURAGE, patients 
with a MIB >10% had a lower risk of death or MI if they underwent revascularisation 
rather than optimal medical therapy alone (Shaw et al., 2008). Most data on MIB 
have been derived from SPECT studies, but with advances in accelerated data 
acquisition, 3D whole-heart perfusion CMR has become feasible and its role in 
assessing MIB has also been evaluated in a number of recent studies (Shin et al., 
2008; Jogiya et al., 2012; Manka et al., 2012; Jogiya et al., 2014; Manka et al., 2011). 
In the first study, 3D perfusion CMR was shown to perform better than conventional 
2D acquisition in estimating the size of perfusion defects in phantoms (Shin et al., 
2008). Since then, several clinical studies have demonstrated its feasibility and high 
level of reproducibility for measuring MIB in patients (Jogiya et al., 2012; Manka et 
al., 2012, 2011). In particular, estimates of MIB from 3D perfusion CMR have been 
used to confirm a reduction in ischaemic volume following PCI, have shown strong 
correlation with the Duke Jeopardy Score (an invasive index of ischaemic burden) 
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and have also been validated against FFR for the detection of significant CAD (Manka 
et al., 2011; Jogiya et al., 2012; Manka et al., 2012). 
A recent study by Jogiya et al found strong correlation between 3D perfusion CMR 
and SPECT estimates of MIB in 38 patients with confirmed perfusion defects on both 
modalities (2014). Although the latter study found no systematic bias between 3D 
perfusion CMR and SPECT estimates of MIB, and therefore suggested potential 
interchangeability, the 95% limits of agreement were relatively wide (-14.3% to 
13.1%). Considering that a 10% MIB threshold is often used to direct clinical 
management, this caution is particularly relevant at the lower end of the MIB 
spectrum given the clinical impact of even a 5-10% absolute difference. Nonetheless, 
disagreement between 3D perfusion CMR and SPECT estimates of MIB at the 10% 
threshold only occurred in 3 out of 38 cases in the latter study (Jogiya et al., 2014). 
On the other hand, investing acceleration into high-resolution 2D perfusion CMR 
rather than 3D whole-heart coverage, also has potential benefits for MIB estimation 
compared to standard 2D acquisition. As well as being less-susceptible to dark rim 
artefact and having better in-slice correlation with LGE (which is acquired at a similar 
spatial resolution), high-resolution perfusion CMR has also  been shown to detect 
greater amounts of subendocardial ischaemia compared to standard-resolution 2D 
acquisitions - with particular benefit in patients with multi-vessel disease (Motwani 
et al., 2012a, 2014a).  In one direct comparison, in 35 patients with angiographically 
confirmed 3-vessel CAD, only 24 patients were found to have a MIB >10% with a 2D 
standard-resolution perfusion CMR method compared to 33 with the high-resolution 
technique (Motwani et al., 2014a). However, unlike 3D whole-heart perfusion CMR, 
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the 2D high-resolution method has not yet been compared to SPECT or angiographic 
scores for MIB estimation. 
As both 3D and high-resolution 2D perfusion CMR offer competing benefits in MIB 
estimation, their comparison in the current study is well justified. Although there has 
been no previous direct comparison of 3D whole-heart and 2D high-resolution 
perfusion CMR, the study by Jogiya et al did compare MIB estimates from 3D 
acquisition with estimates from 3 slices selected from the same 3D whole-heart 
dataset (2014). The authors explicitly acknowledged the limitations of such an 
extrapolation, including the impact of resolution and timing of acquisition in the 
cardiac cycle, but the data offer some insight into the impact of three-slice versus 
whole heart estimates of MIB. Although MIB estimates in Jogiya et al.’s study were 
smaller from the three-slice analysis compared to whole-heart analysis (5.7% vs 6.8% 
p=0.03), there was no difference in assigning patients to either medical or 
revascularisation therapy when using a clinical threshold of 10% MIB (Jogiya et al., 
2014).   
In our study, which is the first direct comparison of high-resolution 2D and whole-
heart 3D perfusion CMR acquisition, there was only fair agreement across the 10% 
MIB threshold (kappa = 0.29). In 4 of 27 cases, 3D perfusion CMR identified a 
MIB>10%, but estimates with 2D high-resolution perfusion CMR were <10%; and 
conversely there were 3 cases where MIB was > 10% with 2D high-resolution 
perfusion CMR but not with 3D acquisition. These differences with potential clinical 
impact likely relate to the competing merits of both techniques, i.e. complete spatial 
coverage for ischemia detection including the apical cap with 3D acquisition, versus 
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better detection of subendocardial ischemia with high-resolution acquisition. As 
these factors are likely to affect individual patients differently according to their 
specific distribution of CAD, a single-best approach is difficult to define. 
Furthermore, with similar image quality, artefact and diagnostic confidence scores 
for both 3D and high-resolution perfusion CMR, it remains difficult to conclude on 
the preferred approach for MIB estimation – particularly in the absence of a true 
reference standard. 
An additional finding in this study was a negative MIB value, with both techniques. 
This was seen in 50% of patients with prior MI and for the purpose of analysis was 
considered to represent inducible ischemia. A potential reason for the occurrence of 
negative MIB values may be an issue of inadequate co-registration between 
perfusion and LGE imaging slices. Such misregistration would be expected to have 
most impact on the 2D perfusion technique in which only 3 perfusion slices must be 
related to 12 LGE imaging slices. However, whilst 3D perfusion CMR may offer better 
slice-to-slice registration with LGE imaging by virtue of greater spatial coverage, the 
2D high-resolution perfusion technique offers better intra-slice registration by virtue 
of the similar spatial resolution as LGE (1.2 vs 1.3 mm). Which of these effects is the 
most important in an individual patient, for an individual perfusion defect, cannot be 
predicted, and depends on the precise intra-slice and inter-slice extent of any 
perfusion defect, as well as the relative contributions of scar and ischemia. However, 
both effects clearly have the potential to lead to the scenario where quantified TSB 
from LGE imaging is larger than the TPD from either the 2D high-resolution or 3D 
whole-heart perfusion sequence. Furthermore, it is recognized that an infarct 
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detected on LGE imaging may sometimes be underestimated or not seen on 
perfusion imaging as a result of small size, heterogeneous infarct tissue 
characteristics, or recanalization of the culprit vessel (Klem et al., 2006). The findings 
in this study highlight the difficulties in reliably assessing peri-infarct ischemia which 
ideally requires intimate registration of perfusion and LGE images in terms of both 
spatial coverage and spatial resolution – and not just one variable in isolation. 
Finally, the relatively wide 95% limits of agreement between 3D and high-resolution 
estimates of MIB in this study, suggest that estimates of MIB may not be used 
interchangeably at present – particularly when categorising patients either side of 
the 10% threshold.  We would also apply the same argument to previous 
comparisons of MIB by SPECT and 3D perfusion CMR. Instead, there is a need to 
define the optimal prognostic MIB threshold for each of these techniques separately 
in future studies.  
 Study Limitations 
We acknowledge this is a pilot study and only a larger study with prognostic 
outcomes will determine whether the differences seen in MIB between techniques 
are clinically meaningful. Nonetheless, the findings from this exploratory data are a 
reminder of the heterogeneity of available perfusion CMR methods and the need for 
greater standardisation given the potential influence of factors such as spatial 
resolution, temporal resolution and spatial coverage (Nagel & Shaw, 2014).  
This study investigated a population with a relatively high prevalence of previous MI 
(n=16), but we were primarily interested in the assessment of inducible ischaemia. 
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In some cases, the presence of scar may have limited the detection of superimposed 
inducible ischaemia, and it is possible that the assessment of ischaemia may have 
been more accurate in populations without previous MI. Similarly, although a 
population with a broader spectrum of MIB would have been more comprehensive, 
our focus at the lower end around the 10% threshold is the most clinically relevant. 
We acknowledge the use of QCA is an imperfect reference standard for ischemia. 
However, our main aim was to compare the size of perfusion defects in patients with 
CAD between techniques, rather than re-examine their diagnostic accuracy which 
has been done previously. Although FFR is clearly a better endpoint for perfusion 
studies, we considered QCA an adequate end-point for this purpose. Following this 
initial pilot study, a larger study with an FFR end-point is planned.  
4.6 Conclusion 
This study adds to the ongoing debate about the comparative benefits of either 
higher spatial resolution or greater spatial coverage in perfusion CMR - and where 
the optimal trade-off lies. Although estimates of MIB from high-resolution and 3D 
perfusion CMR are strongly correlated, the 95% limits of agreement are relatively 
wide and therefore a larger comparative study is needed to determine if they can be 
considered freely interchangeable – particularly around the clinically relevant 10% 
threshold. Moreover, there is a need to define the optimal prognostic MIB threshold 
for each of these techniques separately. 
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5 Study 4 - Systolic versus Diastolic Acquisition in 
Myocardial Perfusion Imaging with CMR 
 
5.1 Abstract 
Aim: The aim of this study was to compare myocardial blood flow (MBF) between 
systole and diastole and determine the diagnostic accuracy of both phases in 
patients with suspected CAD. 
Methods: All patients gave written consent and the study was approved by the 
regional ethics committee. Following coronary angiography, 40 patients (27 men, 64 
± 8 yrs) underwent stress/rest perfusion CMR at 1.5T, acquired at end-systole and 
mid-diastole simultaneously. Based on angiographic stenosis >70%, patients were 
classified as having ‘CAD’ or ‘no significant CAD’. In patients with CAD, myocardial 
segments were grouped as ‘stenosis-dependent’ (downstream of significant 
stenosis) or ‘remote’.  MBF and myocardial perfusion reserve (MPR) were calculated 
for each segment; and mean values in each phase were compared with paired t tests. 
The diagnostic accuracy of each phase was determined with receiver-operator 
characteristic analysis.  
Results: Twenty-one patients (53%) had CAD. Resting MBF was similar in both phases 
for normal and CAD patients (p>0.05). Stress MBF was greater in diastole than 
systole in normal, remote and stenosis-dependent segments (3.75 ± 1.50 vs. 3.15 ± 
1.10 ml/g/min; 2.75 ± 1.20 vs. 2.38 ± 0.99 ml/g/min; 2.49 ± 1.07 vs. 2.23 ± 0.90 
ml/g/min; p<0.01). MPR was greater in diastole than systole in all segment groups 
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(p<0.05). The diagnostic accuracy of diastole and systole were similar (area under 
curve 0.79 vs. 0.82; p=0.30).  
Conclusion: Perfusion CMR estimates of stress MBF and MPR were greater in 
diastole than systole in patients with and without CAD. However, both phases had 
similar diagnostic accuracy. These observations may be relevant to other dynamic 
perfusion methods, including CT and echocardiography. 
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5.2 Introduction  
The mechanical interaction between the myocardium and intramyocardial vessels 
yields a unique coronary blood flow profile. Left coronary artery (LCA) blood flow is 
predominantly diastolic when myocardial tension is low. Cardiac contraction in 
systole causes compression of intramyocardial vessels with virtually no forward or 
even retrograde systolic flow in the LCA (Yada et al., 1993; Hiramatsu et al., 1998; 
Chilian & Marcus, 1982; Kajiya et al., 1985; Sabsiton Jr & Gregg, 1957). Blood flow in 
the right coronary artery (RCA) shows less phasic variation with a small systolic 
preponderance because right ventricular peak systolic pressure is much lower than 
aortic peak systolic pressure and because the right ventricular wall offers less 
mechanical compressive resistance. The distal RCA segments which supply part of 
the left ventricle are however subject to the same haemodynamic conditions as the 
LCA (Heller et al., 1994).  
In dynamic myocardial perfusion imaging by CMR, CT, or contrast echocardiography, 
myocardial blood flow (MBF) is estimated by tracing the myocardial passage of a 
contrast agent. In order to limit the effects of cardiac motion, data acquisition needs 
to be limited to short windows in the cardiac cycle. 2D acquisition methods, which 
prevail in CMR, typically acquire several sections of the heart in different phases of 
the cardiac cycle in order to maximise spatial coverage, while in 3D methods, such 
as CT or recent 3D CMR methods, one cardiac phase is typically pre-determined for 
data read-out. In particular in view of the technical constraints, the potential effects 
of cardiac phase on the acquired data and on estimates of MBF are generally not 
considered in 2D CMR methods. However, given the variability of coronary arterial 
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inflow throughout the cardiac cycle, the impact of the cardiac phase on estimates of 
MBF may be substantial.  
A recent volunteer study has demonstrated significantly greater perfusion CMR-
estimates of MBF during hyperaemic stress and myocardial perfusion reserve (MPR) 
in diastole than systole (Radjenovic et al., 2010). Whether these relationships exist 
in disease and whether there are potential diagnostic consequences of varying 
estimates of MBF between cardiac phases has not been investigated before. 
The aim of this study was to compare MBF between systole and diastole and 
determine the diagnostic accuracy of both phases in patients with suspected CAD. 
5.3 Methods 
 Study Population 
Forty patients who had undergone clinically indicated diagnostic coronary 
angiography within the previous 30 days were recruited. All patients gave written 
consent and the study was approved by the regional ethics committee. No coronary 
intervention or clinical events occurred between angiography and recruitment. 
Exclusion criteria were contra-indications to CMR imaging, adenosine or gadolinium 
contrast agents or acute coronary syndrome within 6 months. Patients refrained 
from caffeine for 24hrs prior to CMR. Cardiac medications were continued as normal.  
 CMR Imaging 
CMR imaging was performed on a 1.5-T Intera CV system (Philips Healthcare, Best, 
the Netherlands) with a five-element cardiac phased array receiver coil. Stress 
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perfusion imaging was performed after 4 minutes of intravenous adenosine (140 
mcg/kg/min) infusion. A bolus of 0.05 mmol/kg dimeglumine gadopentetate (Gd-
DTPA)  (Magnevist, Schering, Berlin, Germany) followed by 15 mls of saline flush 
were injected into an antecubital vein at 5 ml/s  (Spectris®, Medrad, Indianola, PA). 
Rest perfusion images were acquired 15 minutes later followed by LGE imaging using 
a standard protocol (Kramer et al., 2008).  
Perfusion data were acquired in the same 2D mid-ventricular slice in both end-
systole and mid-diastole using identical preparation and readout settings 
(Radjenovic et al., 2010). Pulse sequence details were as follows:  saturation recovery 
gradient-echo, 150ms preparation pulse delay, repetition time (TR) 2.7ms, echo time 
(TE) 1.0ms, flip angle 15°, acquisition duration 135ms, two-fold parallel imaging 
(SENSE), field of view 320mm, matrix 160 x 160mm, spatial resolution 2 x 2 x 10 mm3.   
 Image Quality 
Image quality was graded as (1 = poor, 2 = adequate, 3 = excellent) by consensus of 
two observers (S.P., M.M., 10 years and 1 year experience in perfusion CMR 
imaging). The occurrence of endocardial dark rim artefacts was scored as (0 = none, 
1 = mild, 2 = moderate, 3 = severe). The width of any artefacts was measured using 
electronic callipers with standardized window settings. All systolic and diastolic 
images were analysed in separate reporting sessions and randomly ordered by 
readers blinded to the results for the other phase.  
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 Quantitative Image Analysis 
Myocardial contours excluding any dark rim artefact were outlined in QMass 6.1.6 
(Medis, Leiden, the Netherlands) and segmented into 6 equiangular segments 
(Cerqueira et al., 2002). The systolic arterial input function (AIF) was used for both 
systolic and diastolic analysis to avoid potential variations in the AIF between phases 
(Radjenovic et al., 2010). Signal intensity/time data were converted to 
concentration/time data and MBF at stress and rest estimated with Fermi-
constrained deconvolution in MATLAB (The Mathworks Inc., Natick, MA) (Jerosch-
Herold et al., 1998; Biglands et al., 2011). MPR was calculated by dividing hyperaemic 
by resting MBF.  
Ten random studies (60 segments) were re-analysed one month later by the same 
observer (M.M.) and by a second observer (A.L.) blinded to all previous analyses (one 
and 5 years’ experience, respectively). 
 Coronary Angiography Analysis 
 X-ray angiography images were analysed by an experienced observer (M.M, 6 years 
experience) blinded to CMR and clinical data. Quantitative coronary angiography 
(QCA) was performed with QCAPlus (Sanders Data Systems, Palo Alto, California, 
USA). ‘Significant CAD’ was defined as at least 1 stenosis of >70% (luminal diameter 
reduction) in vessels with a diameter of >2mm. Stenoses were assigned to 
myocardial segments adjusted for arterial dominance and lesion location (Patel et 
al., 2010; Cerqueira et al., 2002; Marie et al., 1993). In patients with significant CAD, 
myocardial segments were classified as either ‘stenosis-dependent ‘(i.e. considered 
downstream of a significant stenosis) or ‘remote’ (i.e. supplied by a non-obstructed 
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coronary vessel or considered upstream of any significant stenosis) - and these two 
groups were analysed separately. This distinction was undertaken as MBF and MPR 
is reduced in remote segments in patients with CAD. Segments from patients without 
any significant stenoses were considered the ‘normal’ control group. 
 Statistical Analysis 
Analysis was performed using SPSS version 17.0 (SPSS, Chicago, IL, USA). Data are 
presented as mean ± SD. Group means were compared using paired and unpaired 
Student t test as appropriate.  Discrete data were compared using Fisher’s exact test 
or Wilcoxon signed-rank tests as appropriate.  All tests were two-tailed and a p value 
<0.05 was considered statistically significant. 
 Receiver operating characteristic (ROC) analyses were used to determine the 
diagnostic accuracy of quantitative CMR analysis in systole and diastole and to 
determine the MPR with the greatest sensitivity and specificity to detect significant 
CAD. Areas under the curve (AUC) were determined from the ROC analyses for 
systole and diastole and then compared using validated methods described by 
Delong and Delong (DeLong et al., 1988). 
 A repeated measures one-way analysis of variance test for within-subject difference 
(with Greenhouse–Geisser correction for multi-sample sphericity and Bonferroni 
adjustment for post-hoc analysis) was used to compare the relationship (and any 
trends) between MPR and severity of disease. Sensitivity and specificity were 
compared between systole and diastole using the McNemar test. Intra- and inter-
observer variabilities for MPR quantification were calculated as the absolute 
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difference between two measurements in percent of their mean and according to 
the methods of Bland and Altman (Martin Bland & Altman, 1986) 
5.4 Results 
 Study Population 
The patient characteristics of the 40 study patients (27 men, mean age 64 ± 8 yrs) 
are outlined in Table 5.1. QCA confirmed significant CAD in 21 patients (53%).  
Thirteen patients (33%) had one vessel disease, seven (18%) had two-vessel disease 
and one (3%) had three-vessel disease (Table 5.2).  
All CMR scans and data analyses were completed. A typical example of a patient with 
ischaemia is shown in Figure 5.1. A total of 240 segments in 40 patients were 
therefore available for analysis in both systole and diastole. From the 19 patients 
with no significant CAD on QCA, 114 ‘normal’ segments were derived. From the 21 
patients with significant CAD on QCA, 126 segments were derived and these were 
further divided into 38 ‘stenosis-dependent’ segments (downstream of a significant 
stenosis) and 88 ‘remote’ segments (supplied by a non-obstructed vessel or 
upstream of significant stenosis). Only 5 patients had evidence of myocardial 
infarction on LGE imaging (the same 5 patients with a clinical history) and this 
involved only 4 of the 240 segments in the perfusion analysis (bearing in mind that 
only the mid-ventricular slice was analysed).  
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Table 5-1 Baseline Patient Characteristics 
 
  
 All (n=40)  CAD (n=21) No CAD (n=19) p Value 
Demographics     
    Male, n (%) 27 (68) 16 (76) 11 (58) 0.37 
    Age, yrs 64 ± 8 65 ± 8 63 ± 8 0.49 
Risk Factors for CAD, n (%)     
    Smoking  9 (23) 8 (38) 1 (5) 0.02 
    Hypertension  22 (55) 16 (76) 6 (30) 0.01 
    Diabetes  5 (13) 5 (24) 0 (0) 0.05 
    Previous PCI 4 (10) 4 (19) 0 (0) 0.11 
    Previous MI 5 (13) 5 (24) 0 (0) 0.05 
Medications, n (%)     
    Aspirin 32 (80) 21 (100) 11 (58) <0.01 
    Beta-Blocker 25 (63) 19 (90) 6 (32) <0.01 
    ACE-Inhibitor 23 (58) 19 (90) 4 (21) <0.01 
    Statin 25 (63) 20 (95) 5 (26) <0.01 
    Nitrate 6 (15) 6 (29) 0 (0) 0.02 
    Calcium Channel blocker 12 (30) 6 (29) 6 (32) 1.00 
CMR imaging data     
     LVEF % 60 ± 6 61 ± 7 59 ± 5 0.42 
     LVEDV, ml 150 ± 22 153 ± 16 147 ± 27 0.44 
     LVESV, ml 63 ± 14 66 ± 14 60 ± 14 0.19 
     LV Mass, g/m2 93 ± 25 100 ± 25 87 ± 24 0.11 
     Stress Heart Rate (beats/min)  80 ± 15 79 ±12 82 ± 13 0.65 
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Table 5-2 Coronary Angiography Findings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
QCA findings Patients, n (%) 
No significant stenoses 19 (48) 
Any stenoses >70% 21 (53) 
 1-vessel disease  13 (33) 
 2-vessel disease  7 (18) 
3-vessel disease  1 (3) 
LMS disease 3 (8) 
LAD disease 9 (23) 
LCX disease 4 (10) 
RCA disease 6 (15) 
Figure 5.1 Case Example: Systolic vs. Diastolic Acqusition 
Example perfusion CMR images with acquisition in diastole and systole.  This patient 
had a subtotal occlusion of the left anterior descending artery. Corresponding stress 
perfusion defects (white arrows) are seen in the anterior, anteroseptal and 
inferoseptal segments of a mid-ventricular slice acquired in both diastole and systole 
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 Image Quality 
On per patient analysis (n=40), overall image quality was better for systole than 
diastole (mean score 2.73 ± 0.51 vs. 2.25 ± 0.74 respectively; p=0.002) with a greater 
incidence of dark rim artefact in diastolic images (n=10 [25%] vs. n=1 [3%]) (Figure. 
5.2). The corresponding mean artefact scores were 0.53 ± 1.01 for diastole and 0.03 
± 0.16 for systole (p=0.008). The mean artefact width was 2.4 mm for diastole; and 
the single dark rim artefact in systole had a width of 2.2 mm and was graded as only 
mild. Four of the 10 artefacts in diastole were graded as severe, 3 as moderate and 
3 as mild.  
  
Figure 5.2 Dark rim artefact: Systole vs Diastole 
 In this example, dark rim artefacts (white arrows) are seen on the diastolic CMR perfusion 
image (mid-ventricular level) in the septal and lateral segments during adenosine stress but are 
not seen on the corresponding systolic image. 
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 Quantitative Image Analysis 
5.4.3.1 Per Patient Analysis 
In the patients with CAD (n=21), the mean resting MBF was similar between phases 
(1.13 ± 0.46 ml/g/min in systole vs. 1.14 ± 0.47 ml/g/min in diastole; p=0.40). Stress 
MBF however was greater in diastole than systole (2.49 ± 1.07 ml/g/min vs. 
2.23±0.90 ml/g/min; p=0.004) and so was the MPR (2.26 ± 0.77 vs. 2.03 ± 0.56; 
p=0.02). The same relationship was found in patients with no significant CAD (n=19). 
The mean resting MBF was similar between systole and diastole (1.12 ± 0.32 
ml/g/min vs. 1.12 ± 0.31 ml/g/min; p=0.5). Stress MBF was greater in diastole than 
systole (3.57 ± 1.22 ml/g/min vs. 3.18 ± 1.07 ml/g/min; p=0.02) and so was the MPR 
(3.44 ± 1.78 vs. 3.05 ± 1.61; p=0.10). 
5.4.3.2 Per Segment Analysis 
The above relationships remained present on segmental analysis (n=240) in each of 
the three groups of segments (Figures 5.3 and 5.4) i.e. MBF was not different 
between phases at rest, but both stress MBF and MPR were significantly greater in 
diastole than systole in ‘stenosis-dependent’ (n=38), ‘remote’ (n=88) and ‘normal’ 
control segments (n=114) (p values<0.01). There was a good correlation between 
systolic MPR and diastolic MPR (r=0.78; p<0.0001) between all segments. 
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 Diagnostic Performance 
In both systole and diastole, the mean MPR was highest in the ‘normal’ control 
segments (systole 2.73 ± 0.75, diastole 3.10 ± 1.11), intermediate in the ‘remote’ 
CAD segments (systole 2.28 ± 0.69, diastole 2.52 ± 0.89) and lowest in the ‘stenosis-
dependent’ CAD segments (systole 1.58 ± 0.57, diastole 1.80 ± 0.75) with a significant 
difference between all segment categories (p values <0.05) and for the trend 
(p<0.001) (Figures 5.3 and 5.4). 
Figure 5.3 MPR: Systole versus Diastole 
A comparison of MPR between systole and diastole. Segmental MPR (mean ± SEM) is shown 
for normal segments, remote CAD segments and stenosis-dependent CAD segments. 
 
154 
 
  
Figure 5.4 MPR for CAD detection - Sytolic and Diastolic Boxplots  
Systolic and diastolic MPR by disease category. Boxplots show mean (dot), median, quartile and 
standard deviation values for each category. Optimal diagnostic MPR cut-offs are plotted as 
dashed line (1.95 in systole, 2.04 in diastole). 
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ROC analysis (using all 240 segments) for distinguishing angiographically significant 
stenosis from non-significant stenosis (combining remote CAD and normal control 
segments), revealed similar diagnostic accuracies for the MPR in both systole and 
diastole (AUC of 0.82 and 0.79 respectively; p=0.30). The optimal MPR cut-off value, 
defined as the value with optimal sensitivity and specificity, was 1.95 for systole and 
2.04 for diastole. At these thresholds the sensitivity and specificity were 79% and 
76% respectively for systole and 77% and 73% for diastole. There was no significant 
difference between systole and diastole for diagnostic accuracy (AUC), sensitivity or 
specificity (p values >0.05) (Figure 5.5, Table 5.3). 
There was no significant difference between the ratio of diastolic stress MBF to 
systolic stress MBF across the three groups of segments (‘normal’ 1.20±0.36, ‘remote 
CAD’ 1.17 ± 0.25, ‘stenosis-dependent’ 1.21 ± 0.34; p=0.40). 
 
 
 
 
 
 
 
  
Figure 5.5 ROC curve of quantitative perfusion CMR using MPR. 
The area under the curve was 0.82 for systole and 0.79 for diastole (p=0.30). 
 
156 
 
Table 5-3 Diagnostic Performance of Perfusion CMR: Systole vs. Diastole 
*(95% CI given in brackets). Sensitivity and specificity expressed as % [fraction] 
 
 
 Intra-observer and Inter-observer Variability  
Intra-observer variability of MPR measurement was similar in systole and diastole 
(2.0 ± 12.6% vs. 2.1 ± 16.7%; p=0.96); as was inter-observer variability (4.8±17.9% vs. 
4.9 ± 19.1%; p=0.98). On Bland-Altman analysis the intra- and inter-observer bias 
was similar for both phases (intra-observer bias: -0.04 ± 0.49 vs. -0.10 ± 0.71; inter-
observer bias: 0.07 ± 0.72 vs. 0.16 ± 0.81, for systole vs. diastole, respectively). 
5.5 Discussion  
This study has shown that in patients with suspected and confirmed CAD, estimates 
of MBF by CMR imaging are similar in systole and diastole at rest, but are significantly 
higher in diastole during maximal hyperaemic stress. Accordingly, the MPR is greater 
in diastole. Diagnostic accuracy is similar between the two phases.  
The differences in hyperaemic MBF between systole and diastole in this study are 
consistent with the reduced effects of adenosine-mediated vasodilatation in systole 
when myocardial contraction compresses intramyocardial vessels (Hiramatsu et al., 
1998; Yada et al., 1993). Our data are also consistent with the sparse existing 
 Systole Diastole p Value  
AUC  0.82 (0.76-0.89) 0.79 (0.72-0.87) 0.30 
Sensitivity  79% [30/38](64-90) 76% [29/38] (60-88) 0.99 
Specificity  77% [155/202] (71-82) 73% [147/202] (67-79) 0.31 
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literature. A study of 5 healthy subjects with a dual-phase 3D perfusion CMR method 
showed no differences between the two phases with semi-quantitative analysis of 
resting perfusion (Shin et al., 2010). A study in 17 healthy volunteers using a 2D 
perfusion CMR method confirmed similar MBF values at rest but higher estimates of 
diastolic MBF at stress (Radjenovic et al., 2010). One small animal study using real-
time myocardial contrast echocardiography demonstrated higher estimates of MBF 
using end-diastolic frames than with end-systolic frames under hyperaemic stress 
(Leongpoi et al., 2001). Our results show that the differences between systolic and 
diastolic MBF seen in animal and volunteer studies are also found in patients with 
CAD and in the presence of myocardial ischaemia.   
The optimal MPR cut-off values to detect significant CAD (1.95 for systole and 2.04 
for diastole) were within the range (1.5-2.06) reported in previous studies (Rieber et 
al., 2006; Futamatsu et al., 2007; Al-Saadi et al., 2000; Watkins et al., 2009; Costa et 
al., 2007). Quantitative analysis with MPR yielded high diagnostic accuracies in both 
systole and diastole (AUC 0.82 and 0.79 respectively). Importantly, due to study 
design and the limitations of 2D acquisition, these results were obtained from only 
a single mid-ventricular section. Sensitivity in particular may be higher if more 
sections are acquired, for example in future 3D perfusion CMR imaging studies.  
Dark rim artefact is a frequent finding in myocardial perfusion CMR imaging and it is 
thought to relate to several factors including cardiac motion, Gibb’s ringing caused 
by truncation of k-space, non-uniformity of k-space weighting due to saturation 
recovery and readout, and partial volume cancellation between the myocardium and 
blood pool (Kellman & Arai, 2007). Although dark rim artefacts may mimic perfusion 
158 
 
defects, they can usually be distinguished by characteristic features i.e. they are most 
intense at peak signal intensity in the left ventricle cavity, are transient (persist for 
less than 10 dynamic images) and their location is usually typical for a particular pulse 
sequence. Our study found dark rim artefact was significantly more abundant in 
diastole (only 1 mild artefact in systole) and this is consistent with previous studies 
(Plein et al., 2007, 2008b). Dark rim artefact may be more pronounced in diastole 
because the myocardium is thinner, making it more prone to partial volume effects 
at a given spatial resolution (Kellman & Arai, 2007).  
In conventional 2D myocardial perfusion CMR methods, cardiac phase cannot be 
freely chosen as multiple 2D sections of the heart are acquired successively 
throughout the entire cardiac cycle. Thus, the impact of phase on estimates of MBF 
in 2D myocardial perfusion CMR imaging may be difficult to consider and potentially 
even complicate data analysis. However, the advent of 3D CMR and CT imaging 
allows for contiguous coverage of the whole left ventricle in a single cardiac phase, 
which avoids misregistration problems - but the optimal phase has yet to be 
determined (Shin et al., 2008). In mid-diastole the heart is usually at its most 
stationary, but as shown, may be more affected by dark rim artefact. End-systole has 
a shorter quiescent period, but is less sensitive to R-R variability and arrhythmia, 
which is relevant to the increasing burden of patients with atrial fibrillation (Kellman 
& Arai, 2007). Systole is less affected by dark rim artefacts and contour delineation 
is easier because of the thicker myocardium. Given the comparable diagnostic 
performance between the two phases in this study, systole may thus be the favoured 
cardiac phase for data acquisition in CMR imaging, if a choice can be made. 
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In this study, MPR was greatest in segments of patients with no CAD, intermediate 
in remote segments of patients with CAD and smallest in segments downstream of 
a significant stenosis (Figure 5.3). This stepwise reduction in MPR related to the 
severity of CAD has been shown in previous studies using positron emission 
tomography and fractional flow reserve (Lockie et al., 2011; Watkins et al., 2009; 
Costa et al., 2007; Al-Saadi et al., 2000; Rieber et al., 2006; Patel et al., 2010). As 
shown in previous PET studies, coronary flow and myocardial perfusion reserve are 
impaired in patients with CAD even in the absence of flow-limiting stenosis due to 
endothelial dysfunction and alterations in the microcirculation associated with CAD 
and its risk factors (Beanlands et al., 1995; Muzik PhD & Duvernoy, 1998; Wang et 
al., 2006). In addition to existing literature, our data have shown that the ratio of 
diastolic to systolic stress MBF is similar in the absence of CAD, in the presence of 
significant coronary stenosis and in remote myocardium in CAD patients. 
5.6 Limitations  
Like the majority of previous myocardial perfusion CMR studies, we used X-ray 
angiography to determine the presence of significant coronary stenosis. Although 
MPR performed well in our study, perfusion imaging is a measurement of the 
haemodynamic consequences of a stenosis rather than its anatomy so that QCA is 
an imperfect reference standard (Lockie et al., 2011). It is also important to 
acknowledge that myocardial segments and vessel territories do not always match; 
and that both remote and stenosis-dependent myocardium can be found in the same 
myocardial segments which are limitations of per segment analyses. 
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In order to obtain systolic and diastolic perfusion data in the same location and 
within the same acquisition using conventional 2D CMR imaging, this study was 
limited to the assessment of a single mid-ventricular slice. This was a technical 
necessity and only by compromising temporal resolution with consequent impact on 
the validity of MBF estimates could we have overcome this limitation. Clearly, only 
analysing a single slice will have led to an underestimation of diagnostic performance 
in both systole and diastole. Furthermore, this study could not assess differences 
between cardiac phases in apical and basal myocardial segments, which may behave 
differently to the mid-ventricular location. Future studies using 3D myocardial 
perfusion CMR will be needed to address these issues.  
Qualitative visual analysis was not performed as the limitation to a single slice is not 
in keeping with clinical practice and it was felt this would be an inadequate endpoint 
to judge the difference between the two phases. 
5.7 Conclusion 
In conclusion, systole and diastole provide similar estimates of MBF at rest in 
patients with suspected CAD; but measurements of MBF during stress are 
consistently greater in diastole - in normal, remote CAD and stenosis-dependent CAD 
segments. However, in this study the overall diagnostic accuracy of both phases was 
similar. If open to choice, systole may be the preferred phase as the thicker 
myocardium is less demanding on spatial resolution and is less prone to artefact. 
These results are relevant to any form of dynamic myocardial perfusion assessment 
and are of particular relevance to the promising developments in 3D CMR and CT 
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perfusion imaging where the cardiac phase for data acquisition can be specifically 
chosen. 
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6 Study 5 - Quantitative Three-Dimensional Perfusion 
CMR in Systole and Diastole 
6.1 Abstract   
Background: 2D perfusion CMR remains limited by a lack of complete myocardial 
coverage. 3D perfusion CMR addresses this limitation and has recently been shown 
to be clinically feasible. However, the feasibility and potential clinical utility of 
quantitative 3D perfusion measurements, as already shown with 2D perfusion CMR 
and PET, has yet to be evaluated. The influence of systolic or diastolic acquisition on 
myocardial blood flow (MBF) estimates, diagnostic accuracy and image quality is also 
unknown for 3D perfusion CMR. The purpose of this study was to establish the 
feasibility of quantitative 3D perfusion CMR for the detection of CAD and to compare 
systolic and diastolic estimates of MBF. 
Methods: Thirty-five patients underwent 3D perfusion CMR with data acquired at 
both end-systole and mid-diastole. MBF and myocardial perfusion reserve (MPR) 
were estimated on a per patient and per territory basis by Fermi-constrained 
deconvolution. Significant CAD was defined as stenosis ≥70% on quantitative 
coronary angiography.  
Results: Twenty patients had significant CAD (involving 38 out of 105 territories). 
Stress MBF and MPR had a high diagnostic accuracy for the detection of CAD in both 
systole (area under curve [AUC]: 0.95 and 0.92, respectively) and diastole (AUC: 0.95 
and 0.94). There were no significant differences in the AUCs between systole and 
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diastole (p values >0.05). At stress, diastolic MBF estimates were significantly greater 
than systolic estimates (no CAD: 3.21 ± 0.50 vs. 2.75 ± 0.42ml/g/min, p<0.0001; CAD: 
2.13 ± 0.45 vs. 1.98 ± 0.41ml/g/min, p<0.0001); but at rest, there were no significant 
differences (p values >0.05). Image quality was higher in systole than diastole 
(median score 3 vs. 2, p=0.002).  
Conclusions: Quantitative 3D perfusion CMR is feasible. Estimates of MBF are 
significantly different for systole and diastole at stress but diagnostic accuracy to 
detect CAD is high for both cardiac phases. Better image quality suggests that systolic 
data acquisition may be preferable.  
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6.2 Background 
Myocardial perfusion imaging with CMR is a highly accurate technique for the 
detection of CAD (Greenwood et al., 2012). However, conventional acquisition with 
2D methods covers only 3-4 non-contiguous slices of the LV at each R-R interval, and 
therefore incomplete myocardial coverage remains a significant limitation. 
Recent technological advances have allowed unprecedented acceleration of 
dynamic CMR and the development of 3D myocardial perfusion CMR methods 
providing full LV coverage with preserved temporal and spatial resolution(Vitanis et 
al., 2011; Shin et al., 2013; Chen et al., 2012). Three recent studies have shown 3D-
perfusion CMR to be clinically feasible and highly accurate for the detection of CAD 
with visual perfusion assessment (Manka et al., 2011, 2012; Jogiya et al., 2012). 
However, the feasibility and potential clinical application of deriving quantitative 
estimates of MBF from 3D perfusion CMR has not yet been studied. 
A further limitation of conventional 2D perfusion CMR is that each slice is acquired 
in a different period of the cardiac cycle. Two recent quantitative studies have shown 
a significant difference in MBF estimates derived from the same mid-ventricular slice 
acquired in systole and diastole with 2D perfusion CMR (Radjenovic et al., 2010; 
Motwani et al., 2012b). As well as limiting quantitative comparisons between slices, 
these significant phasic differences impact on inter-study and longitudinal 
comparisons of MBF. Unlike 2D perfusion CMR, 3D acquisition allows acquisition of 
data from the entire myocardium in the same, optimised period of the cardiac cycle. 
Most previous 3D perfusion CMR studies have acquired data in systole but to date it 
is unknown whether systolic or diastolic acquisition leads to better image quality and 
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diagnostic yield. Furthermore, it is unknown whether quantitative estimates of MBF 
from 3D data demonstrate the same phasic differences previously reported for 2D 
techniques (Radjenovic et al., 2010; Motwani et al., 2012b). 
The purpose of this study was therefore to establish the feasibility of quantitative 3D 
perfusion CMR for the detection of CAD and to compare systolic and diastolic 
estimates of MBF. 
6.3 Methods 
 Population 
Forty consecutive patients with known or suspected CAD were recruited. All patients 
were imaged within 30 days of clinically scheduled diagnostic coronary angiography. 
No revascularization or clinical events occurred between angiography and CMR. 
Exclusion criteria were contraindications to CMR, adenosine, or gadolinium contrast 
agents, recent myocardial infarction (MI) or unstable angina (within 6 months), or 
poorly controlled arrhythmias. Patients were instructed to refrain from caffeine for 
24 hours before their CMR study but continue cardiac medications as normal. The 
study was approved by the regional ethics committee and all patients gave written 
consent. 
 CMR protocol 
All studies were performed on a 3.0T scanner (Achieva TX, Philips Healthcare, Best, 
The Netherlands) equipped with dual-source parallel radiofrequency transmission 
technology and a 32-channel cardiac coil. For perfusion imaging, a 3D spoiled turbo 
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gradient-echo sequence was used (TR/TE/flip angle 1.8ms/0.7ms/15°; saturation 
prepulse delay 150ms; linear k-space encoding; 70% partial Fourier acquisition in two 
dimensions; typical field of view 350 x 350mm; 10 fold k-t acceleration and 11 
training profiles leading to a net acceleration of 7.0; typical acquisition duration 
192ms, k-t principal component analysis (PCA) reconstruction; reconstructed to 12 
contiguous slices with voxel size 2.3x2.3x5mm3)(Jogiya et al., 2012; Vitanis et al., 
2011).  
Two k-t undersampled 3D data sets were acquired in each R-R interval, each 
preceded by a non-selective saturation prepulse. Vertical and horizontal long-axis 
cine images were used to identify appropriate trigger delays for systolic and diastolic 
acquisition(Radjenovic et al., 2010; Shin et al., 2010; Motwani et al., 2012b). 
Additionally, because of the longitudinal lengthening of the heart from systole to 
diastole, the position of the end-systolic and mid-diastolic perfusion stacks (12 slices 
each) were individually planned from the chosen systolic and diastolic cine frames 
(Figure 6.1)(Radjenovic et al., 2010; Motwani et al., 2012b). The same trigger delays 
were used for stress and rest acquisitions. 
Stress perfusion images were acquired during intravenous adenosine-induced 
hyperaemia administered for 4min at 140mcg/kg/min. Consistent with previous 3D-
perfusion CMR studies, an intravenous bolus of 0.075mmol/kg of gadobutrol 
(Gadovist, Bayer Schering Pharma, Berlin, Germany) was administered at a rate of 
4.0ml/s followed by a 20ml saline flush. Stress perfusion CMR was followed by cine 
imaging covering the left ventricle in 10-12 short-axis sections. Rest perfusion CMR 
was performed 15min after stress, using identical imaging parameters. LGE imaging 
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was acquired in the same short-axis geometry as perfusion imaging after an 
additional 10-15min using conventional 2D methods (T1 weighted segmented 
inversion recovery gradient echo; TR/TE/flip angle 4.9ms/1.9ms/15°; inversion time 
individually adjusted according to Look-Locker scan; spatial resolution 1.35 x 1.35 x 
10 mm). 
 
 
 
 Image quality 
Systolic and diastolic perfusion images were analysed in separate reporting sessions 
in random order (MM, 2 years experience of perfusion CMR).  Overall image quality 
was scored as follows: 0 = non-diagnostic, 1 = poor, 2 = adequate and 3 = excellent. 
The occurrence of artefact related to respiratory-motion, k-t reconstruction or dark 
rim artefact was scored as follows: 0 = none, 1 = mild, 2 = moderate and 3 = severe. 
Figure 6.1 3D Acquisition Planning for Systole and Diastole 
Because of the longitudinal lengthening of the heart from systole to diastole, the position of the mid-
diastolic (red) and end-systolic perfusion stacks (yellow) (12 slices each) were individually planned from 
the chosen diastolic (Panel A) and systolic (Panel B) 4-chamber cine frames.  Panel C shows both stacks 
superimposed on the chosen end-systolic frame.  
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 Myocardial blood flow estimation 
Perfusion images were processed offline using previously validated in-house 
software (PMI 0.4; written in IDL 6.4 (ITT Visual Information Systems, Boulder, 
CO)(Huber et al., 2012). All short-axis slices with clearly identifiable LV cavity 
enhancement during first-pass perfusion and with >75% circumferential LV 
myocardium were included in the analysis (Manka et al., 2011, 2012).  
6.3.4.1 Per patient analysis 
Following manual rigid motion-correction, a circular region of interest (ROI) was 
drawn in the basal LV cavity in diastole, to derive the arterial input function (AIF).  
The same (diastolic) AIF was used for both systolic and diastolic estimates of MBF in 
order to avoid potential variations in the AIF between phases with subsequent 
effects on MBF estimation (Radjenovic et al., 2010). 
A whole-heart myocardial region of interest (ROI) excluding any dark rim artefact 
was drawn for both systolic and diastolic perfusion images. Signal intensity–time 
data were converted to concentration-time data by subtracting the baseline signal, 
and global MBF was estimated at stress and rest using constrained deconvolution 
with a delayed Fermi-model applied to the first pass (Jerosch-Herold et al., 1998; 
Costa et al., 2007; Motwani et al., 2012b). MPR was calculated as stress MBF divided 
by rest MBF.  
6.3.4.2 Per territory analysis     
The above analysis was repeated on a per territory basis using the 17-segment AHA 
model adjusted for coronary dominance (Cerqueira et al., 2002). All slices from an 
individual patient were first visually allocated to basal, mid or apical sections of the 
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model. For each perfusion territory, a myocardial ROI was then outlined including all 
segments pertaining to that territory across all slices according to the 17-segment 
AHA model. MBF and MPR estimates were obtained using the same algorithm as for 
the whole-heart ROI. 
6.3.4.3 Intra-observer and inter-observer variability 
Thirty random territories were re-analysed 1 month later by the same observer 
(M.M.) and by a second observer A.K. (2yrs and 1yr experience respectively). A.K. 
was blinded to the results of all previous analyses. 
 Quantitative coronary angiography 
Quantitative coronary angiography was performed (QCAPlus, Sanders Data Systems, 
Palo Alto, CA, USA) on anonymised X-ray angiography images (M.M. 6 years 
experience in coronary angiography). Significant CAD was defined as luminal stenosis 
≥70% diameter in any of the main epicardial coronary arteries or their branches with 
a diameter of ≥2mm. 
 Statistical analysis 
Analysis was performed using SPSS 17.0 (SPSS, Chicago, IL). Data are presented as 
mean±SD.  Group means were compared using paired or unpaired Student t-tests; 
or within-subjects analysis of variance with Greenhouse-Geisser correction for multi-
sample sphericity, as appropriate. Ordinal data were compared using the Wilcoxon 
signed-rank test. Receiver-operating characteristic (ROC) analysis was performed on 
a per territory basis, to determine the diagnostic accuracy of MPR to detect 
significant CAD. Diagnostic accuracies are presented as area under the ROC curve 
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(AUC); and were compared between systole and diastole using methods described 
by Delong and Delong. Optimal MPR cut-off values, for both cardiac phases, were 
defined as values that maximised the sum of sensitivity and specificity. A secondary 
ROC analysis was performed to evaluate the diagnostic accuracy of stress MBF 
diastolic/systolic ratio. To assess reproducibility, the coefficients of variation (CoV) 
for intra- and inter-observer measurements were calculated. Because three 
coronary territories were examined per patient, the intra-cluster correlation 
coefficient (ICC) was calculated for MPR estimates to determine the design effect 
and the need to adjust data for clustering. All statistical tests were 2-tailed and a p 
value <0.05 was considered significant.  
6.4 Results 
 Study population 
Five of the 40 recruited patients were excluded: 3 because of claustrophobia and 2 
owing to technical problems (1 mistimed contrast injection; 1 significantly altered 
patient position between stress and rest scans). A total of 35 patients (105 coronary 
territories) were therefore available for analysis. Table 6.1 shows the baseline 
patient characteristics. QCA confirmed significant CAD in 20 patients (57%) and 38 
coronary territories (36%). Only 3 patients had evidence of MI on LGE imaging (the 
same 3 patients with a clinical history of MI), and this involved only 3 of the 105 
territories analysed. Figure 6.2 shows an example of the stress perfusion images 
acquired in a patient with significant CAD. 
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Table 6-1 Patient Characteristics 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Significant disease defined as coronary stenosis ≥70% on quantitative coronary analysis.  
Parameter Data (n=35) 
Age (yrs ± SD) 62 ± 8 
Sex, n (%)  
    Male 26 (74) 
    Female 9 (26) 
Risk Factors, n (%)  
    Hypertension 18 (51) 
    Hypercholesterolemia 19 (54) 
    Diabetes Mellitus 6 (17) 
    Smoking 14 (40) 
    Previous MI 3 (9) 
    Previous PCI 3 (9) 
Angiography findings, n (%) *  
    No significant disease 15 (43) 
    One-vessel disease 6 (17) 
    Two-vessel disease 10 (29) 
    Three -vessel disease 4 (11) 
    LAD disease 17 (49) 
    LCX disease 10 (29) 
    RCA disease 11 (31) 
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Figure 6.2 Case Example: 3D-Perfusion CMR in Systole and Diastole 
This example shows 3D-perfusion CMR in a 75-year-old man with angina. Stress-induced 
perfusion defects are seen infero-laterally from base to apex and antero-laterally from mid-
ventricle to apex in both diastole and systole. However, perfusion defects are difficult to 
discern from dark rim artefact in diastole and are more clearly delineated with systolic 
acquisition. Late-gadolinium enhancement imaging did not reveal any myocardial infarction. 
X-ray coronary angiography revealed 80% stenosis of a large diagonal branch and significant 
proximal disease in a large dominant left circumflex artery. 
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 Image quality 
Overall image quality was better in systole than in diastole (median image quality 
score: 3 vs. 2 respectively; p=0.002). In diastole, there was a greater frequency of 
dark rim artefact (19 patients [54%] vs. 9 patients [26%] and a higher overall artefact 
score compared to systole (median scores: 1 vs. 0 respectively; p<0.0001). In 5 
patients (14%), perfusion images (both cardiac phases) were affected by k-t 
reconstruction artefacts at stress and/or rest due to respiratory motion, but all of 
these artefacts occurred at the end of the breath-hold and did not affect analysis of 
the first-pass perfusion images. 
 
 Myocardial blood flow estimation 
Estimates of MBF and MPR for both cardiac phases are seen in Tables 6.2-6.4. On per 
patient (n=35) and per territory analysis (n=105), mean resting MBF was similar in 
both cardiac phases (all p values>0.05); but mean stress MBF and MPR were 
significantly greater in diastole than systole (all p values <0.001). These relationships 
existed in normal and CAD subgroups, as well as overall (all p values <0.01) (Tables 
6.2-6.4). In both cardiac phases, stress MBF and MPR were significantly lower in the 
presence of CAD than in normal patients (all p values<0.01) or normal territories (all 
p values<0.0001) (Tables 6.2-6.4). 
Analysis of the normal patient group (n=15) found no significant regional differences 
in stress MBF, rest MBF or MPR between the LAD, LCX or RCA perfusion territories 
in both phases (all p values <0.05) (Table 6.5).
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Table 6-2 Estimates of MBF and MPR from 3-Dimensional Perfusion CMR - Per Patient Analysis 
 
 
 
 
 
 
Table 6-3 Estimates of MBF and MPR from 3-Dimensional Perfusion CMR - Per Territory Analysis 
 
 
 
 
 
All values expressed as mean ± SD; MBF = myocardial blood flow; MPR = myocardial perfusion reserve
  Stress MBF (ml/min/g) Rest MBF (ml/min/g) MPR 
  Systole Diastole P Systole Diastole p Systole Diastole p 
Normal (n=15) 2.88 ± 0.32 3.47 ± 0.41 p<0.0001 1.28 ± 0.17 1.26 ± 0.15 p=0.45              2.27 ± 0.37 2.78 ± 0.40 p<0.0001 
CAD (n=20) 2.32 ± 0.42 2.53 ± 0.47 p<0.0001 1.32 ± 0.19 1.28 ± 0.21 p=0.06 1.82 ± 0.54 2.08 ± 0.74 p<0.001 
Overall (n=35) 2.56 ± 0.47 2.93 ± 0.65 p<0.0001 1.30 ± 0.18 1.27 ± 0.19 p=0.06 2.01 ± 0.08 2.38 ± 0.05 p<0.0001 
  Stress MBF (ml/min/g) Rest MBF (ml/min/g) MPR 
  Systole Diastole p Systole Diastole p Systole Diastole p 
Normal (n=67) 2.75 ± 0.42 3.21 ± 0.50 p<0.0001 1.24 ± 0.15 1.25 ± 0.15 p=0.27 2.26 ± 0.43 2.59 ± 0.44 p<0.0001 
CAD (n=38) 1.98 ± 0.41 2.13 ± 0.55 p<0.0001 1.24 ± 0.15 1.26 ± 0.14 p=0.20 1.63 ± 0.14 1.72 ± 0.19 p<0.01 
Overall (n=105) 2.47 ± 0.55 2.82 ± 0.71 p<0.0001 1.24 ± 0.15 1.25 ± 0.15 p=0.10 2.03 ± 0.52 2.27 ± 0.61 p<0.0001 
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Table 6-4 Regional Estimates of MBF and MPR - Per Territory (n=105) 
 
All values expressed as mean ± SD. MBF = myocardial blood flow; MPR = myocardial 
perfusion reserve; LAD = left anterior descending coronary artery; LCX = left circumflex 
coronary artery; RCA= right coronary artery. 
 
Based on MPR estimates, the ICC for this study was low (r1 =0.09 [95% CI: -0.25 to 
0.41]) with a design effect of 1.18 where cluster size=3. This shows that the study 
design of using 3 'related’ coronary territories per patient (n=35) to derive a sample 
size of 105 coronary territories does not significantly diminish statistical power. 
 Normal   CAD  
 Systole Diastole p  Systole Diastole p 
Stress MBF (ml/min/g)       
LAD 2.91 ± 0.35 3.43 ± 0.46 p<0.0001  2.11 ± 0.46 2.28 ± 0.52 p<0.001 
LCX 2.63 ± 0.33 3.10 ± 0.44 p<0.0001  1.90 ± 0.28 2.04 ± 0.28 p<0.01 
RCA 2.77 ± 0.51 3.16 ± 0.55 p<0.0001  1.85 ± 0.39 1.97 ± 0.40 p<0.0001 
Rest MBF (ml/min/g)       
LAD 1.26 ± 0.17 1.30 ± 0.17 p=0.10  1.21 ± 0.12 1.23 ± 0.12 p=0.52 
LCX 1.26 ± 0.17 1.24 ± 0.13 p=0.56  1.22 ± 0.14 1.20 ± 0.10 p=0.27 
RCA 1.20 ± 0.13 1.23 ± 0.15 p=0.28  1.28 ± 0.13 1.24 ± 0.16 p=0.26 
MPR        
LAD 2.35 ± 0.42 2.68 ± 0.48 p<0.0001  1.75 ± 0.37 1.87 ± 0.51 p=0.02 
LCX 2.12 ± 0.35 2.52 ± 0.38 p<0.0001  1.58 ± 0.32 1.72 ± 0.29 p<0.01 
RCA 2.33 ± 0.51 2.59 ± 0.48 p<0.001  1.46 ± 0.34 1.60 ± 0.34 p<0.01 
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Table 6-5 Comparison of Regional MBF and MPR Estimates – in Normal Patients 
(n=15) 
 
 
All values expressed as mean ± SD. MBF = myocardial blood flow; MPR = myocardial 
perfusion reserve; LAD = left anterior descending coronary artery; LCX = left circumflex 
coronary artery; RCA= right coronary artery. 
 
 
 Diagnostic performance  
6.4.4.1 Stress MBF 
On a per territory analysis (n=105), the use of stress MBF alone had a high overall 
diagnostic accuracy for the detection of CAD - which was similar in both cardiac 
phases (AUC=0.95 for both; p=0.70). The optimal stress MBF cut-off value was 
                       Perfusion Territory 
 LAD LCX RCA p 
Stress MBF (ml/min/g)     
Systole 2.95 ± 0.36 2.66 ± 0.29 2.88 ± 0.46 P=0.11 
Diastole 3.51 ± 0.46 3.19 ± 0.27 3.27 ± 0.47 P=0.10 
Rest MBF (ml/min/g)     
Systole 1.27 ± 0.17 1.29 ± 0.19 1.20 ± 0.13 p=0.25 
Diastole 1.29 ± 0.17 1.27 ± 0.14 1.22 ± 0.15 p=0.47 
MPR     
Systole 2.36 ± 0.42 2.10 ± 0.32 2.45 ± 0.53 P=0.06 
Diastole 2.76 ± 0.45 2.54 ± 0.33 2.71 ± 0.48 P=0.27 
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2.31ml/min/g for systole and 2.60ml/min/g for diastole. At these thresholds, the 
sensitivity and specificity were 92% and 93% respectively for systole; and 95% and 
96% for diastole. There was no significant difference between the diagnostic 
accuracy of MPR or stress MBF alone for either cardiac phase (both p values >0.05) 
(Figure 6.3) 
6.4.4.2 MPR 
On per territory analysis (n=105), MPR also had a high overall diagnostic accuracy for 
the detection of significant CAD, and this was similar in both cardiac phases (AUC, 
systole: 0.92 vs. diastole: 0.94; p=0.41) (Figure 6.3). The optimal MPR cut-off value 
was 1.75 for systole and 2.02 for diastole (Figure 6.4). At these thresholds, the 
sensitivity and specificity were 82% and 93% respectively for systole; and 87% and 
94% for diastole. The diagnostic accuracy of MPR to detect CAD in each of the 3 
coronary territories is shown in Table 6.6 – and no significant differences were seen 
between cardiac phases.  
6.4.4.3 Diastolic/systolic stress MBF ratio  
The diastolic/systolic stress MBF ratio was significantly lower for territories with CAD 
than in normal territories (1.07±0.06 vs. 1.17±0.11; p<0.0001). On ROC analysis, the 
diagnostic accuracy (AUC) of this ratio to detect significant CAD was 0.79. The 
optimal cut-off value for the ratio was 1.10 which gave a sensitivity of 82% and 
specificity of 76% (Figure 6.5). 
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Figure 6.3 Diagnostic Accuracy of Quantitative 3D-Perfusion CMR 
(A) Receiver-operator characteristic curves shows a high diagnostic accuracy in both systole and 
diastole for MPR (area under curve [AUC]: 0.92 vs. 0.94 respectively; p=0.41). (B) Use of stress MBF 
alone also had a high diagnostic accuracy in both cardiac phases (AUC: 0.95 for both; p=0.70) and 
in fact there was no significant difference compared to MPR (p>0.05 for both cardiac phases).  
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Table 6-6 Diagnostic Accuracy of Quantitative 3D-perfusion CMR – Per Territory 
(n=105) 
 
 
 
 
 
 
 
 
 
Area under the curve (AUC) and (95% confidence interval). LAD = left anterior descending 
coronary artery; LCX = left circumflex coronary artery; RCA= right coronary artery. 
 AUC for MPR  
 
Systole Diastole P 
All territories 0.92 (0.87-0.98) 0.94 (0.88-0.99) p=0.41 
LAD  0.89 (0.78-0.99) 0.90 (0.79-1.00) p=0.76 
LCX  0.88 (0.77-0.99) 0.98 (0.93-1.00) p=0.34 
RCA  0.92 (0.86-0.99) 0.98 (0.93-1.00) p=0.50 
Figure 6.4 Myocardial Perfusion Reserve Threshold 
The scatter-plots show myocardial perfusion reserve (MPR) values from normal and significantly 
diseased perfusion territories with both systolic and diastolic 3D-perfusion CMR (x=mean value, solid 
line = median value). The optimal MPR cut-off values determined by receiver-operating characteristic 
analysis are also plotted (dashed lines, 1.75 for systole and 2.02 for diastole). 
180 
 
 
 
 
 
 
  
Figure 6.5 Diastolic/Systolic Stress Myocardial Blood Flow Ratio 
The ratio of diastolic to systolic myocardial blood flow at stress was significantly lower for 
territories with coronary artery disease (CAD) than in normal territories (1.07 ± 0.06 vs. 1.17 
± 0.11; p<0.0001). On receiver-operator characteristic analysis, the diagnostic accuracy (area 
under the curve) of this ratio to detect significant CAD was 0.79. The optimal cut-off value for 
the ratio was 1.10, which gave a sensitivity of 82% and specificity of 76%. 
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 Reproducibility 
6.4.5.1 Stress MBF 
The mean absolute difference between intra-observer measurements of stress MBF 
was similar in systole and diastole (0.33 ± 0.14 vs. 0.35 ± 0.16; p=0.18); and the 
corresponding CoVs were 16% and 17% respectively. The mean absolute difference 
between inter-observer measurements of stress MBF was also similar in systole and 
diastole (0.41 ± 0.22 vs. 0.45 ± 0.20; p=0.11) with corresponding CoVs of 18% for 
both. 
6.4.5.2 MPR 
The mean absolute difference between intra-observer measurements of MPR was 
similar in systole and diastole (0.30 ± 0.15 vs. 0.36 ± 0.13; p=0.09); and the 
corresponding CoVs were both 18%. The mean absolute difference between inter-
observer measurements of MPR was also similar in systole and diastole (0.35 ± 0.17 
vs. 0.41 ± 0.15; p=0.07) with corresponding CoVs of 20% and 21% respectively. 
6.5 Discussion 
The main findings of this study are 1) quantitative 3D perfusion CMR is feasible and 
has a high diagnostic accuracy for the detection of CAD; 2) similar to 2D studies, 
estimates of stress MBF and MPR from 3D data are significantly greater in diastole 
than systole; and 3) the diastolic dominance of stress MBF estimates is reduced in 
ischaemia. 
One of the limitations of myocardial perfusion imaging and standard visual 
interpretation is the dependence on a reference area of normal perfusion. This is a 
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particular impediment in diffuse or balanced multi-vessel disease. This limitation can 
be avoided by using absolute quantification of MBF (Patel et al., 2010). At present, 
the most robust technique to quantify MBF noninvasively is PET - but its wide-spread 
clinical application has been slowed by limited access (Kajander et al., 2011). PET 
imaging also involves exposure to ionizing radiation, and its spatial resolution limits 
evaluation of transmural flow differences in normal thickness myocardium. 
Over the last decade, several animal, normal volunteer and patient studies have 
validated the use of CMR for absolute MBF quantification against microsphere and 
invasive coronary flow reserve measurements (Christian et al., 2004; Jerosch-Herold 
et al., 2002; Wilke et al., 1997). Furthermore, several clinical studies have 
demonstrated high diagnostic accuracy of CMR derived estimates of absolute MBF 
and MPR against both QCA and fractional flow reserve (Costa et al., 2007; Lockie et 
al., 2011; Motwani et al., 2012b; Patel et al., 2010; Futamatsu et al., 2007).  
Nonetheless, the lack of complete myocardial coverage has been a significant 
limitation of conventional 2D-perfusion CMR for this purpose.  
This study has for the first time demonstrated the feasibility of quantitative whole-
heart 3D perfusion CMR. Shin et al have previously reported semi-quantitative 
measures (time-intensity curve indices) of resting myocardial perfusion from a 3D 
acquisition in 3 healthy volunteers - but no stress acquisition or absolute MBF 
quantitation was performed (Shin et al., 2010).  The MBF values derived with 3D 
perfusion CMR in normal patients in the present study are comparable to values 
from PET studies and the previous CMR literature (Sdringola et al., 2011; 
Chareonthaitawee et al., 2001). For example, in a large study of 160 healthy men and 
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women with PET, the mean resting MBF was 0.98 ± 0.23 ml/min/g (range 0.59-2.05 
ml/min/g) and the mean stress MBF was 3.77 ± 0.85ml/min/g (range 1.85-5.99 
ml/min/g)(Chareonthaitawee et al., 2001).  Intra-  and inter-observer reproducibility 
for stress MBF and MPR  in our study was also similar to that seen  in  2D perfusion 
CMR and PET studies (Morton et al., 2012; Larghat et al., 2013).  
The finding of lower estimates of stress MBF in systole compared to diastole is 
consistent with the expected physiology and a number of previous studies. 
Physiologically, one explanation is that during systole, the effect of adenosine-
mediated vasodilatation is diminished by the compression of intramyocardial vessels 
(Hiramatsu et al., 1998). Two previous 2D-perfusion CMR studies have shown the 
same phasic differences with higher stress MBF estimates in diastole, but no 
difference between the phases at rest (Radjenovic et al., 2010; Motwani et al., 
2012b). One previous 3D perfusion CMR study confirmed similar semi-quantitative 
measures of resting myocardial perfusion between systole and diastole - but no 
stress perfusion was performed (Shin et al., 2010). Our study has now demonstrated 
that these phasic differences are also seen with 3D perfusion CMR quantitation and 
underline the importance of stating the phase of acquisition in future studies to 
allow comparison in the literature. 
Quantitative analysis with MPR yielded high diagnostic accuracies in both systole and 
diastole (AUC: 0.92 and 0.94 respectively).  The optimal MPR cut-off values for 
detecting significant CAD (1.75 for systole and 2.02 for diastole) were within the 
range of 1.50–2.06 reported in previous 2D-perfusion CMR studies (Lockie et al., 
2011; Rieber et al., 2006; Costa et al., 2007; Motwani et al., 2012b; Futamatsu et al., 
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2007). Recently, in 2D-perfusion CMR, Huber et al (n=31) showed that the use of 
stress MBF alone had  a similar diagnostic accuracy as MPR (AUC 0.92 vs. 0.84 
respectively; p<0.18)(Huber et al., 2012). Our study has shown a similar finding in 3D 
perfusion CMR and the implication is that a rest perfusion sequence could potentially 
be omitted in quantitative studies, thus reducing both scanning and post-processing 
times without a loss in diagnostic yield (Figure 6.3). 
The noted reduction in diastolic/systolic stress MBF ratio in territories with CAD is 
consistent with  previous invasive studies measuring coronary flow velocity 
throughout the cardiac cycle (Segal et al., 1992). The loss of diastolic dominance has 
been explained by the increased influence of a significant stenosis on flow during 
periods of low vascular resistance and low intramyocardial tension (diastole); as 
compared with that during periods of high vascular resistance and high 
intramyocardial tension (systole)(Spaan et al., 1981). As such, the diastolic/systolic 
stress MBF ratio is a novel diagnostic index with moderate diagnostic accuracy 
(AUC=0.79) – and this may warrant further evaluation in future studies.  
In our quantitative study, both phases had similar diagnostic performance and 
reproducibility. However, similar to previous 2D studies, diastole was more prone to 
dark rim artefact with an adverse effect on image quality; and this is thought to relate 
to the thinner myocardium, making it more prone to partial volume effects at a given 
spatial resolution (Motwani et al., 2012b). For this reason, as well as the fact that 
contour delineation is easier in systole because of the thicker myocardium, we would 
suggest systole as the preferred phase for 3D perfusion CMR acquisition - particularly 
for quantitative studies. Although analysis time was not specifically measured, each 
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3D perfusion dataset took approximately 20min to analyse on a per patient basis 
(including stress and rest analyses for either the systolic or diastolic cardiac phase). 
Quantifying 3D perfusion CMR can be simpler than quantifying conventional 2D 
datasets, because as in our study, fewer dynamic images are often acquired and 
there is a degree of temporal filtering due to the undersampling in the temporal 
domain which reduces the amount of time-consuming manual motion correction 
required. 
Finally, there is considerable scope for quantitative perfusion CMR in clinical practice 
and therefore the feasibility of 3D whole-heart coverage and quantitation is an 
important step forward.  Nonetheless, there still remain a number of other 
limitations that hold back the wider clinical adoption of quantitative perfusion CMR.  
The current lack of standardisation in image acquisition, contrast dosing protocols, 
post-processing, mathematical modelling and interpretation is addressed by an 
international standardisation task force (Kramer et al., 2013; Schulz-Menger et al., 
2013). There is also no widely available and validated analysis software for 
quantitative analysis of perfusion CMR data and research groups generally use in-
house solutions. Analysis can be time-consuming, precluding routine clinical 
application. Finally, the incremental value of quantitative analysis of myocardial 
perfusion CMR analysis needs to be shown in large clinical studies. 
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6.6 Study Limitations 
The spatio-temporal undersampling methods required for 3D data acquisition are 
sensitive to respiratory motion, cardiac arrhythmia and low-pass temporal filtering - 
all of which pose additional challenges to quantitative assessment. Low-pass 
temporal filtering in particular may lead to underestimation of MBF. We reduced 
these limitations by use of the constrained  k-t PCA framework for image 
reconstruction, which  has been shown to improve temporal fidelity, permitting 
robust measurements of MBF at very high acceleration factors(Pedersen et al., 
2009).  The latter is also less prone to respiratory artefact as temporal basis functions 
are derived based on the low-resolution training data acquired in every heartbeat 
(Vitanis et al., 2011).  
Although MPR performed well in our study, perfusion imaging is a measurement of 
the haemodynamic consequences of a stenosis rather than its anatomy, and 
therefore our use of QCA is an imperfect reference standard. Following this initial 
feasibility study, future validation against fractional flow reserve is planned in a 
larger clinical population.  Another limitation, common to many previous studies, is 
the potential effect of data clustering as three perfusion territories are examined per 
patient (Lockie et al., 2011; Rieber et al., 2006). However, the design effect of this 
was low (1.18) owing to a small ICC and cluster size.  
Finally, the model used for estimating MBF assumes  a linear relation between signal 
and contrast agent concentration i.e. ignoring saturation effects in the LV blood pool  
which  can lead to underestimation of MBF (Sourbron, 2010). This is particularly 
relevant as we used a relatively high contrast agent dose of 0.075mmol/kg 
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bodyweight to be consistent with previous 3D perfusion CMR studies. Proposed 
solutions include the use of a non-linear signal model combined with precontrast T1-
mapping and/or the use of a small pre-bolus to measure the AIF. However, such 
methods add further complexity to data acquisition and post-processing - and 
therefore neither was used in this study. Furthermore, there is currently no evidence 
that either of these potential solutions actually leads to improved diagnostic 
accuracy for the detection of CAD in the clinical setting. In fact the only study directly 
addressing this question came to the opposite conclusion i.e. the use of a pre-bolus 
AIF was found to reduce diagnostic accuracy compared to a single-bolus approach 
(Groothuis et al., 2010). 
6.7 Conclusions 
We have shown that quantitative 3D perfusion CMR is feasible and can be used to 
detect CAD with high diagnostic accuracy. In addition, we have shown that there are 
significant differences in systolic and diastolic MBF estimates and therefore the 
phase of acquisition and AIF should always be stated in future 3D quantitative 
studies. Both cardiac phases provide comparable diagnostic yield, albeit at different 
thresholds. Because systolic images had fewer artefacts and higher image quality, 
systole may be the preferred phase for acquisition of 3D perfusion data.  
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7 Study 6 - Quantification of Myocardial Blood Flow 
with Cardiovascular Magnetic Resonance throughout the 
Cardiac Cycle 
7.1 Abstract  
Background: Myocardial blood flow (MBF) varies throughout the cardiac cycle in 
response to phasic changes in myocardial tension. 
Objectives: This aim of this study was to determine if quantitative myocardial 
perfusion imaging with CMR can accurately track physiological variations in MBF 
throughout the cardiac cycle. 
Methods: 30 healthy volunteers underwent a single stress/rest perfusion CMR study 
with data acquisition at 5 different time points in the cardiac cycle (early-systole, 
mid-systole, end-systole, early-diastole and end-diastole). MBF was estimated on a 
per-subject basis by Fermi-constrained deconvolution. Interval variations in MBF 
between successive time points were expressed as percentage change. Maximal 
cyclic variation (MCV) was calculated as the percentage difference between 
maximum and minimum MBF values in a cardiac cycle.  
Results: At stress, there was significant variation in MBF across the cardiac cycle with 
successive reductions in MBF from end-diastole to early-, mid- and end-systole, and 
an increase from early- to end-diastole (end-diastole: 4.50 ± 0.91 vs. early-systole: 
4.03 ± 0.76 vs. mid-systole: 3.68 ± 0.67 vs. end-systole 3.31 ± 0.70 vs. early-diastole: 
4.11 ± 0.83 ml/g/min; all p values <0.0001). In all cases, the maximum and minimum 
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stress MBF values occurred at end-diastole and end-systole respectively (mean MCV 
= 26 ± 5%). There was a strong negative correlation between MCV and peak heart 
rate at stress (r=-0.88, p<0.001). The largest interval variation in stress MBF occurred 
between end-systole and early-diastole (24 ± 9% increase).  At rest, there was no 
significant cyclic variation in MBF (end-diastole: 1.24 ± 0.19 vs. early-systole: 1.28 ± 
0.17 vs.mid-systole: 1.28 ± 0.17 vs. end-systole: 1.27 ± 0.19 vs. early-diastole: 1.29 ± 
0.19 ml/g/min; p=0.71). 
Conclusion: Quantitative perfusion CMR can be used to non-invasively assess cyclic 
variations in MBF throughout the cardiac cycle. In this study, estimates of stress MBF 
followed the expected physiological trend, peaking at end-diastole and falling 
steadily through to end-systole.  This technique may be useful in future 
pathophysiological studies of coronary blood flow and microvascular function.  
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7.2 Introduction 
Myocardial blood flow (MBF) varies throughout the cardiac cycle in response to 
changes in myocardial tension and phasic compression of the myocardial 
microcirculation (Sabsiton Jr & Gregg, 1957; Goto et al., 1991; Spaan et al., 1981; 
Matsumoto & Kajiya, 2005). The squeezing effect of myocardial contraction causes 
arterial blood inflow to peak during diastole when myocardial tension is low, and 
venous outflow to peak during systole when myocardial tension is high. Diseases 
such as diabetes, atherosclerosis, cardiomyopathies, and arterial hypertension result 
in functional and morphologic microvascular changes, which may precede clinical 
signs and symptoms. Quantitative assessment of MBF and characterization of cyclic 
myocardial perfusion variation in these diseases may offer valuable additional 
information relating to microvascular integrity and function. 
Over the last decade, several animal, normal volunteer and patient studies have 
validated the use of CMR for absolute MBF quantification against microsphere and 
invasive coronary flow reserve measurements (Christian et al., 2004; Jerosch-Herold 
et al., 2002; Wilke et al., 1997). With conventional CMR methods perfusion data are 
acquired in a different cardiac phase for each slice. Previous volunteer and patient 
studies have now shown a significant difference in MBF quantified using CMR 
between acquisition in systole and diastole, suggesting that cardiac phase needs to 
be considered when interpreting CMR-derived MBF values (Radjenovic et al., 2010; 
Motwani et al., 2012b, 2014b). Although the development of 3D perfusion CMR, 
which allows the specific phase of data acquisition to be chosen, may overcome this 
concern in the future, these differences remain a challenge for CMR perfusion. 
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However, they also provide the opportunity to interrogate cyclic variations in 
perfusion as a unique diagnostic tool, not assessable by positron-emission 
tomography, which assess myocardial perfusion cumulatively.  
So far, temporal and spatial constraints on dynamic CMR perfusion imaging have 
restricted previous volunteer and patient studies to assessing MBF between only two 
different time points in the cardiac cycle, and it is therefore unknown whether CMR 
has the capability to track changes in MBF throughout the cardiac cycle (Radjenovic 
et al., 2010; Motwani et al., 2012b, 2014b). Advanced acceleration techniques, based 
on spatiotemporal undersampling, which have mostly been employed to achieve 
higher spatial resolution, can also be used to improve temporal resolution in 
perfusion CMR studies. The purpose of the study was to capitalise on the dynamic 
aspect of CMR perfusion data acquisition and assess whether quantitative perfusion 
CMR can accurately follow the expected physiological variation in MBF throughout 
the cardiac cycle.  
7.3 Methods 
 Study Population 
Thirty-three healthy volunteers were recruited. Exclusion criteria included any 
history of cardiovascular disease, diabetes mellitus, hypertension, hyperlipidaemia, 
smoking or any contraindications to CMR, adenosine, or gadolinium-based contrast 
agents. The study protocol was approved by the local ethics committee, and written 
informed consent was obtained from all volunteers. All volunteers were instructed 
to refrain from caffeine for 24 hours before their CMR study.  
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 CMR protocol 
All volunteers underwent a single stress and rest perfusion CMR study performed on 
a 1.5T scanner (Intera, Philips Healthcare, Best, the Netherlands) equipped with a 
five-element cardiac phased array receiver coil. Perfusion data were acquired in a 
single mid-ventricular 2D slice at 5 different time points in each R-R interval (early-
systole, mid-systole, end-systole, early-diastole and end-diastole) facilitated by k-t 
BLAST acceleration (Figure 7.1). Details of the perfusion pulse sequence were as 
follows:  2D saturation recovery gradient-echo sequence accelerated with 8-fold k-t 
BLAST and 11 interleaved training profiles, no partial Fourier or partial echo 
acquisition, TR 3.4ms, TE 1.7ms, flip angle 15o, one saturation pre-pulse per slice (i.e. 
per time point), image acquisition time per slice 103ms, matrix 192 x 192, median 
FOV 310 mm and in-plane spatial resolution 1.6 x 1.6 mm. 
Vertical and horizontal long-axis cine images were used to identify appropriate 
trigger delays for each of the 5 time points (Radjenovic et al., 2010; Motwani et al., 
2012b, 2014b; Shin et al., 2010). Additionally, because of the longitudinal 
lengthening of the heart from systole to diastole, the position of the mid-ventricular 
perfusion slice at each time point was individually planned from the chosen end-
diastolic, early systolic, mid-systolic, end-systolic and early-diastolic cine frames 
(Radjenovic et al., 2010; Motwani et al., 2012b, 2014b). 
Stress perfusion images were acquired during intravenous adenosine-induced 
hyperaemia (140mcg/kg/min administered for 4min). An intravenous bolus of 0.05 
mmol/kg gadopentetate dimeglumine (Magnevist, Schering, Germany) was 
administered at a rate of 4.0ml/s followed by a 20ml saline flush. Stress perfusion 
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CMR was followed by cine imaging covering the left ventricle in short-axis sections. 
Rest perfusion CMR was performed 15min after stress, using identical imaging 
parameters. LGE imaging was not performed. 
  
Figure 7.1 Quantitative Perfusion CMR throughout the Cardiac Cycle 
This example shows stress perfusion CMR (top row) in a healthy volunteer acquired at 5 different time 
points throughout the cardiac cycle in a single mid-ventricular slice facilitated by 8-fold k-t BLAST 
acceleration. Corresponding stress and rest MBF estimates are shown as myocardial maps (middle 
and bottom row respectively). Stress MBF shows significant cyclic variation peaking in end-diastole 
and steadily falling throughout systole. The maximal interval change in stress MBF is seen between 
end-systole and early-diastole. No significant cyclic variation was seen in rest MBF. CMR = 
cardiovascular magnetic resonance; BLAST = broad linear acquisition speed-up technique; MBF = 
myocardial blood flow  
194 
 
 MBF estimation  
Perfusion images were processed offline using previously validated in-house 
software (PMI 0.4; written in IDL 6.4 (ITT Visual Information Systems, Boulder, 
CO)(Motwani et al., 2014b; Huber et al., 2012).  
7.3.3.1 Per-subject analysis 
Following manual rigid motion-correction, a circular region of interest (ROI) was 
drawn in the LV cavity at end-diastole, to derive the arterial input function (AIF). The 
same (end-diastolic) AIF was used for all estimates of MBF in order to avoid potential 
variations in the AIF between phases with subsequent effects on MBF estimation 
(Radjenovic et al., 2010; Motwani et al., 2012b, 2014b). 
A whole-slice myocardial ROI excluding any dark-rim artifact was drawn on perfusion 
images for each of the 5 time points. Signal intensity–time data were converted to 
concentration-time data by subtracting the baseline signal. Global MBF was 
estimated at stress and rest using constrained deconvolution with a delayed Fermi-
model applied to the first pass(Jerosch-Herold et al., 1998). Myocardial perfusion 
reserve (MPR) was calculated as stress MBF divided by rest MBF. 
Interval variations in MBF or MPR between successive time points were expressed 
as percentage change. Maximal cyclical variation (MCV) in MBF was calculated as the 
percentage difference between maximum and minimum values in a cardiac cycle. 
7.3.3.2 Per-territory analysis 
The above analysis was repeated on a per territory basis by segmenting the perfusion 
slices according to the 17-segment American Heart Association model(Cerqueira et 
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al., 2002). For each perfusion territory, a myocardial ROI including all segments 
pertaining to that territory was outlined. MBF and MPR estimates at each time point 
were obtained using the same algorithms as for the per subject analysis. 
7.3.3.3 Reproducibility 
Per-subject analysis was repeated on perfusion data from ten random volunteers 1 
month later by the same observer (M.M.) and by a second observer A.K. (3yrs and 
2yrs experience respectively). A.K. was blinded to the results of all previous analyses. 
 
 Statistical analysis 
Analysis was performed using SPSS 17.0 (SPSS, Chicago, IL). Data are presented as 
mean±SD. Mean perfusion values (MBF and MPR) were compared at the 5 different 
time points using one-way repeated measures analysis of variance (ANOVA) with 
Greenhouse-Geisser correction for multi-sample sphericity and Bonferonni 
adjustment for post-hoc analysis. Mean perfusion values at each time point were 
compared between perfusion territories using standard ANOVA. Intra- and inter-
observer reproducibility for MBF, MPR and MCV were assessed by calculating 
coefficients of variation (CoVs): SD of the differences divided by the mean. All 
statistical tests were two-tailed and a p value <0.05 was considered significant. 
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7.4 Results 
 Study population 
Thirty-three healthy volunteers were recruited. One volunteer could not complete 
the scan due to claustrophobia. Data from 2 other volunteers were excluded due to 
technical problems preventing analysis (1 excessive heart rate variability, 1 mistimed 
contrast injection). All remaining images were of analysable quality. Data from a total 
of 30 volunteers (90 perfusion territories) were therefore available for the final 
analysis. Clinical details of the 30 study volunteers (18 men; mean age 22±2yrs) are 
summarized in Table 7.1. 
Table 7-1 Healthy Volunteer Demographics 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data n ± SD; EDV= end-diastolic volume; ESV = end-systolic volume; RPP = rate-pressure product 
 
Parameter Data (n= 30) 
Age (yrs) 22 ± 2 
Sex, n (%)  
     Male 18 (60) 
     Female 12 (40) 
LV function   
     EF % 61 ± 5 
     EDV, ml 140 ± 26 
     ESV, ml 59 ± 14 
     LV Mass, g/m2 82 ± 22 
Hemodynamics at Peak Stress  
     Heart Rate (beats/min)  81 ± 9 
     Systolic blood pressure (mmHg) 127 ± 20 
     RPP (mmHg x beats/min) 10226 ± 2319 
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 Myocardial blood flow estimation 
7.4.2.1 Per subject analysis 
Estimates of MBF and MPR at each of the 5 time points in the cardiac cycle are seen 
in Table 7.2. There was significant cyclic variation in stress MBF (p<0.0001) and MPR 
(p<0.0001) with successive reductions from end-diastole to early-, mid- and end-
systole, followed by an increase from early- to end-diastole (all post-hoc p values 
<0.01) (Table 7.2, Figures 7.2-7.4). In all cases, the maximum and minimum stress 
MBF values occurred at end-diastole and end-systole respectively with a mean MCV 
of 26±5% (Figure 7.4). There was a strong negative correlation between MCV and 
peak heart rate at stress (r=-0.88, p<0.001) (Figure 7.5). The largest interval variation 
in stress MBF occurred between end-systole and early-diastole (24 ± 9% increase) 
(Figure 7.2). The largest interval variation in MPR occurred between end-systole and 
early-diastole (31 ± 20% increase) (Figure 7.3).  At rest, there were no significant 
cyclical variations in MBF (p=0.71) (Table 7.2) (Figure 7.1).  
7.4.2.2 Per territory analysis 
Estimates of MBF and MPR in each perfusion territory at each of the 5 time points in 
the cardiac cycle are seen in Table 7.2. There were no significant differences in stress 
MBF, rest MBF or MPR between perfusion territories at each of the 5 cardiac phases 
assessed (all p values > 0.05) (Table 7.2). There was significant cyclic variation in 
stress MBF and MPR in all 3 perfusion territories (all p values <0.0001) (Table 7.2). 
MCV for stress MBF was similar in all perfusion territories (left anterior descending 
[LAD]: 27±8% vs. left circumflex [LCX]: 27 ± 5% vs. right coronary artery [RCA]: 25 ± 
5%; p=0.45). The largest interval variation in the LAD, LCX and RCA perfusion 
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territories was the increase in stress MBF and MPR between end-systole and early-
diastole and the magnitude was similar in all 3 territories (stress MBF: 26 ± 12% vs. 
25 ± 9% vs. 24 ± 9%, p=0.62; MPR: 31 ± 22% vs. 27 ± 23% vs. 27 ± 24%, p=0.79 
respectively). There was no significant cyclical variation in rest MBF in any territory 
(Table 7.2). 
Table 7-2 Estimates of MBF and MPR throughout the Cardiac Cycle 
 
* Additionally there were no significant differences in mean perfusion values (MBF or MPR) between 
territories at any point in the cardiac cycle (all p values >0.05). MBF = myocardial blood flow in 
ml/min/g; MPR = myocardial perfusion reserve; LAD = left anterior descending; LCX = left circumflex; 
RCA = right coronary artery  
 End-diastole Early-systole Mid-systole End-systole Early-diastole P  
Global        
Stress MBF 4.50 ± 0.91 4.03 ± 0.76 3.68 ± 0.67 3.31 ± 0.69 4.11 ± 0.83 p<0.0001 
Rest MBF 1.24 ± 0.19 1.28 ± 0.17 1.28 ± 0.17 1.27 ± 0.19 1.29 ± 0.19 p=0.71 
MPR 3.63 ± 0.95 3.19 ± 0.66 2.92 ± 0.66 2.62 ± 0.63 3.40 ± 0.92 p<0.0001 
LAD perfusion territory*      
Stress MBF 4.38 ± 0.87 3.88 ± 0.78 3.59 ± 0.64 3.19 ± 0.67 3.99 ± 0.80 p<0.0001 
Rest MBF 1.25 ± 0.16 1.30 ± 0.14 1.24 ± 0.11 1.25 ± 0.13 1.21 ± 0.13 p=0.14 
MPR 3.54 ± 0.74 3.01 ± 0.60 2.91 ± 0.53 2.58 ± 0.58 3.35 ± 0.80 p<0.0001 
LCX perfusion territory*      
Stress MBF 4.40 ± 0.94 3.93 ± 0.70 3.58 ± 0.67 3.21 ± 0.69 4.01 ± 0.85 p<0.0001 
Rest MBF 1.25 ± 0.08 1.28 ± 0.17 1.24 ± 0.14 1.24 ± 0.14 1.23 ± 0.12 p=0.60 
MPR 3.52 ± 0.73 3.12 ± 0.65 2.93 ± 0.63 2.60 ± 0.56 3.29 ± 0.85 p<0.0001 
RCA perfusion territory*      
Stress MBF 4.55 ± 0.90 4.13 ± 0.76 3.78 ± 0.67 3.41 ± 0.69 4.21 ± 0.85 p<0.0001 
Rest MBF 1.33 ± 0.15 1.38 ± 0.17 1.38 ± 0.20 1.39 ± 0.19 1.33 ± 0.19 p=0.50 
MPR 3.46 ± 0.78 3.03 ± 0.60 2.78 ± 0.60 2.49 ± 0.57 3.24 ± 0.83 p<0.0001 
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Figure 7.2 Cyclic Variation in Stress MBF 
Mean stress MBF in healthy volunteers (n=30) showed significant cyclic variation throughout 
the cardiac cycle (p<0.0001). Box plots for stress MBF show the interquartile range (box), 
median (dividing black line) and mean (red cross) with whiskers extending to 1.5 x 
interquartile range. There were successive reductions in stress MBF from end-diastole to 
early-, mid- and end-systole, and a significant increase from early- to end-diastole (all p 
values <0.0001) (trend shown by red line). The maximal interval change in stress MBF was 
between end-systole and early-diastole (25% increase). MBF = myocardial blood flow 
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Figure 7.3 Cyclic Variation in MPR 
Mean MPR in healthy volunteers (n=30) showed significant cyclic variation throughout the 
cardiac cycle (p<0.0001). Box plots for MPR show the interquartile range (box), median 
(dividing black line) and mean (red cross) with whiskers extending to 1.5 x interquartile range. 
There were successive reductions from end-diastole to early-, mid- and end-systole, and a 
significant increase from early- to end-diastole (all p values <0.01) (trend shown by red line). 
The maximal interval change in MPR was between end-systole and early diastole (31% 
increase). MPR = myocardial perfusion reserve 
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Figure 7.4 Individual Stress MBF estimates in Healthy Volunteers 
There was significant cyclic variation in stress MBF in all volunteers (n=30). In all cases the peak 
MBF occurred at end-diastole and the minimum at end-systole. The mean maximal cyclic variation 
in stress MBF was 26%. MBF = myocardial blood flow 
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Figure 7.5 Correlation between MCV and Peak Heart Rate at Stress  
 There was a strong linear negative correlation between the maximal cyclic variation (MCV) in 
stress MBF and the peak heart rate during adenosine-induced maximal hyperaemia in healthy 
volunteers (n=30). MBF = myocardial blood flow  
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7.4.2.3 Reproducibility 
Intra-observer CoVs for stress MBF, rest MBF, MPR and MCV in stress MBF were 9%, 
11%, 15% and 10%, respectively. Corresponding CoVs for inter-observer 
reproducibility were 14%, 16%, 18% and 12% respectively.  
7.5 Discussion 
The main findings of this study are 1) quantitative perfusion CMR can track 
physiological changes in myocardial perfusion throughout the cardiac cycle; 2) 
estimates of stress MBF and MPR in healthy volunteers show significant cyclic 
variation with successive reductions throughout systole and an increase in diastole; 
3) the greatest interval change in stress MBF and MPR occurs between end-systole 
and early-diastole; 4) there is no significant cyclic variation in rest MBF estimates. 
The finding of significant cyclic variation in stress MBF and MPR is consistent with 
the expected physiology relating to phasic changes in myocardial tension. In vivo 
animal studies directly visualising the microcirculation with angiography show 
significant compression of intramyocardial vessels during systole (Yada et al., 
1993)(15). In humans, coronary flow patterns across the cardiac cycle have been 
directly measured with intracoronary pressure wires. Davies et al showed that blood 
flow in the left coronary artery (LCA) is predominantly diastolic i.e. when myocardial 
tension is low (2006). During systole, they found a dominant forward-travelling 
pushing wave, which is reflected when reaching the microvascular bed because of 
the higher myocardial tension, and this results in virtually no forward flow, or even 
retrograde flow. Therefore, our observation that MBF estimates successively fall 
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throughout systole and increase in diastole is consistent with these described 
coronary flow patterns. 
The greatest interval change in stress MBF and MPR was seen between end-systole 
and early-diastole (Table 7.2, Figures 7.1-7.3). This is in keeping with invasive studies 
that show LCA inflow velocity peaks in early-diastole (Davies et al., 2006). It is also 
consistent with an observation by Davies et al that there is a transient secondary 
forward-travelling pushing wave in early diastole seen in LCA waveforms. This 
secondary wave coincides with closure of the aortic valve and accelerates blood 
further towards the myocardium.  
Heller et al showed that arterial waveforms in the proximal RCA have significantly 
less phasic variation because right ventricular peak systolic pressure is much lower 
than aortic peak systolic pressure and because the right ventricular wall offers less 
mechanical compressive resistance (Heller et al., 1994). However, they also showed 
that distal RCA branches (posterior descending and posterolateral coronary arteries) 
show the same diastolic dominance as the left coronary system as they subtend LV 
myocardial segments subjected to the same phasic changes in myocardial tension as 
the rest of the LV. Consistent with this observation, we found no significant 
differences in MCV in stress MBF between the left coronary (LAD and LCX) and RCA 
perfusion territories - and they showed the same pattern of phasic variation across 
the 5 time points (Table 7.2). 
Three previous quantitative perfusion CMR studies (including 1 utilising 3D data 
acquisition) have also shown significant differences in stress MBF and MPR according 
to phase, with significantly higher values in diastole (Radjenovic et al., 2010; 
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Motwani et al., 2012b, 2014b). A recent semi-quantitative study also found steeper 
myocardial time-intensity curves in diastole compared to systole (Nchimi et al., 
2014). However, all of these previous studies have been limited to the assessment 
of myocardial perfusion at only two different time points in the cardiac cycle. The 
current study is the first to assess variation in MBF estimates throughout the cardiac 
cycle in humans and determine the overall trend between 5 selected time points. 
Recently, cyclic changes in myocardial perfusion have also been examined in rats 
(n=6) by Troalen et al using a novel steady-pulsed arterial spin labelling (ASL) 
approach to map MBF (2014). Dynamic MBF maps were obtained with an extremely 
high temporal resolution (6ms) offering even more comprehensive coverage 
throughout the cardiac cycle than in our study. However, the acquisition time using 
this technique in rats was approximately 12min (at a heart rate of 400 bpm), 
preventing application of this method to humans where even longer acquisition 
times would be required. Furthermore, the use of myocardial ASL in humans to 
quantify MBF remains limited by inadequate signal-to-noise ratio (SNR) efficiency, 
high physiological noise, and timing restrictions related to cardiac and respiratory 
motion (Zun et al., 2009). Nonetheless, this small study in rats showed a similar 
phasic variation in stress MBF estimates, which peaked in diastole and steadily fell in 
systole with an overall mean MCV of 18 ± 8%.  
In our study, there was no significant cyclic variation in rest MBF estimates (Table 
7.2, Figure 7.1). This is in keeping with the result of the 3 previous volunteer and 
patient studies, which also showed no significant difference between rest MBF 
estimates in systole and diastole (Radjenovic et al., 2010; Motwani et al., 2012b, 
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2014b). A fourth study assessing semi-quantitative measures of resting myocardial 
perfusion also found no significant difference between systole and diastole (Shin et 
al., 2010). A possible explanation for a lack of cyclic variation in resting MBF is 
sufficient autoregulation in the microvascular network at rest, which is only 
overcome in the stress state by adenosine-induced maximal hyperaemia or 
significant tachycardia. Only the recent study in rats utilising ASL showed a significant 
cyclic variation in resting MBF, but this was under the influence of isoflurane 
anaesthesia which is known to induce coronary vasodilatation and therefore not 
representative of a true physiological resting state (Troalen et al., 2014; Iltis et al., 
2005). Additionally, the resting heart rate in rats is significantly higher than in 
humans (322±43 bpm in the study by Troalen et al) and therefore these findings are 
not necessarily translatable to human physiology (Troalen et al., 2014). 
Finally, we found a strong negative linear correlation between MCV and peak heart 
rate during stress (Figure 7.5). Notably, this observation was also seen in the 
aforementioned study in rats by Troalen et al (2014). A possible explanation is the 
capacitive property of the myocardial vascular system due to an abundant capillary 
network. The latter serves to dampen the rapid fluctuations in pressure seen with 
increasing heart rates in order to maintain a steady downstream blood flow – the so-
called ‘windkessel’ effect (Frank, 1990). At lower heart rates the effects of phasic 
myocardial tension are relatively unopposed by capacitance and thus a greater MCV 
is seen which is in keeping with our findings.  
In summary, we have demonstrated that significant phasic differences in MBF 
estimates quantified with CMR are seen not only at polar ends of the cardiac cycle 
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but also throughout the cardiac cycle. Considering the nature of coronary 
haemodynamics, cyclic MBF changes may reveal new physiological information 
because they are a function of coronary flow, myocardial contraction and 
microvascular condition. Therefore, using CMR to assess MBF throughout the cardiac 
cycle and determine parameters such as MCV, may be useful in the future 
assessment of diseases known to alter microvascular function such as diabetes or 
atherosclerosis - but further studies in these disease states are needed. 
7.6 Study Limitations 
The spatio-temporal undersampling method required to accelerate perfusion data 
acquisition is sensitive to respiratory motion, cardiac arrhythmia and low-pass 
temporal filtering - all of which pose challenges to quantitative assessment. Low-
pass temporal filtering in particular may have led to underestimation of MBF. 
To obtain systolic and diastolic perfusion data in the same location and within the 
same acquisition, this study was limited to the assessment of a single mid-ventricular 
section. This was a technical necessity and meant we could not assess phasic 
differences in apical and basal myocardial segments, which may behave differently 
from the mid-ventricle. Future studies with more advanced acceleration and 3D 
perfusion data acquisition are needed to address these issues - but these strategies 
also come with additional challenges for absolute MBF quantitation. 
Finally, the model used for estimating MBF assumes a linear relationship between 
signal and contrast agent concentration i.e. ignoring saturation effects in the LV 
blood pool, which can lead to underestimation of MBF (Sourbron, 2010). Proposed 
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solutions include the use of a non-linear signal model combined with pre-contrast 
T1-mapping and/or the use of a small pre-bolus to measure the AIF. However, such 
methods add further complexity to data acquisition and post-processing - and 
therefore neither was used in this study. Furthermore, there is currently no evidence 
that either of these potential solutions actually leads to improved diagnostic 
accuracy in the clinical setting (e.g. for the detection of CAD). In fact the only study 
directly addressing this question came to the opposite conclusion i.e. the use of a 
pre-bolus AIF was found to reduce diagnostic accuracy compared to a single-bolus 
approach (Groothuis et al., 2010). Additionally, our findings are based on intra-
individual comparisons and the relative changes in perfusion values throughout the 
cardiac cycle, and therefore underestimation in absolute MBF due to saturation 
effects is less relevant.  
7.7 Conclusions 
Quantitative perfusion CMR can be used to non-invasively track cyclical variations in 
MBF throughout the cardiac cycle. In this study, estimates of MBF followed the 
expected physiological trend, peaking at end-diastole and falling steadily through to 
end-systole.  This technique may be useful in future physiological or pathological 
studies of coronary flow and microvascular function.  
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8 Final Conclusions 
The evidence for the use of perfusion CMR in the assessment of CAD, both as a 
clinical and cardiovascular research tool, continues to grow rapidly. Many important 
perfusion CMR studies have been published over the last 5 years—some providing 
large-scale clinical validation and prognostic data, and others describing more 
technical advances in acquisition and quantitation. 
In this thesis we have focused on recent advances in accelerating perfusion data 
acquisition. Advanced acceleration techniques have been used to improve spatial 
resolution, or alternatively achieve 3D whole-heart coverage – but at the initiation 
of this thesis, it was not clear if either strategy offered any incremental benefit over 
standard techniques or how they compared to each other.  
Acceleration (or sacrifice of spatial coverage) can also be used to simultaneously 
acquire perfusion data at different time-points in the cardiac cycle.  This is important 
as the impact of a variable cardiac phase of acquisition on quantitative estimates of 
MBF with CMR was also poorly understood at the outset of this research. 
Accordingly, this thesis included studies that manipulated the standard approach to 
perfusion CMR using advanced acceleration techniques, in order to investigate the 
relative impact of spatial resolution, spatial coverage and cardiac phase of 
acquisition on both qualitative and quantitative assessment of ischaemia. Our main 
findings were as follows: 
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8.1 Spatial Resolution  
i. High spatial resolution perfusion CMR has greater overall diagnostic accuracy 
than standard-resolution acquisition for the detection of CAD in both single and 
multi-vessel disease, and also detects more subendocardial ischaemia. 
ii. High-resolution perfusion CMR increases the observed MIB and distribution of 
ischaemia detected in angiographic 3VD compared to standard-resolution 
acquisition due to better detection of subendocardial ischaemia. However, the 
incremental value of high-resolution acquisition for correctly identifying, 
stratifying and managing this high-risk group has to be determined in further 
clinical studies. 
iii. There is significantly less dark rim artefact with high-resolution compared to 
standard-resolution perfusion CMR. The high-resolution technique is however 
more prone to respiratory and k-t reconstruction artefacts. Overall therefore, 
image quality scores are similar between high-resolution and standard-
resolution techniques. 
8.2 Spatial coverage 
i. Image quality, artefact and diagnostic confidence scores are similar for both 2D 
high-resolution and 3D perfusion CMR 
ii. There is strong correlation and broad agreement between estimates of MIB from 
both 2D high-resolution and 3D whole-heart perfusion CMR techniques. 
However, the 95% limits of agreement are relatively wide and therefore a larger 
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comparative study is needed before they can be considered interchangeable - 
particularly around the clinically relevant 10% MIB threshold.  
8.3 Cardiac Phase 
i. In both 2D and 3D quantitative perfusion CMR studies, systolic estimates of MBF 
are significantly lower than diastolic estimates, but both phases can be used to 
detect CAD with high diagnostic accuracy.  
ii. The phase of acquisition should ideally be stated in future quantitative perfusion 
CMR studies 
iii. For both 2D and 3D perfusion CMR, there was significantly higher image quality 
and less dark rim artefact with systolic acquisition compared to diastolic – but 
similar diagnostic accuracy for detecting CAD. Therefore, where open to choice, 
such as with 3D techniques, perfusion data acquisition in systole is preferable. 
iv. Quantitative perfusion CMR can be used to non-invasively track cyclical 
variations in MBF throughout the cardiac cycle, and estimates of MBF appear to 
follow the expected physiological trend, peaking at end-diastole and falling 
steadily through to end-systole. This technique may be useful in future 
pathophysiological studies of coronary blood flow and microvascular function. 
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